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Abstract 
 
Healthcare partnerships with third-party commercial companies have been met with 
reservations from the public about the privacy of health information and concerns about how this 
data is used. While research points to the need to provide patients greater control over the use of 
their data, or notification of data use, it is not yet clear how to move forward with this effort 
while balancing the needs of researchers for quality data sets. To better understand and 
characterize the public’s comfort with third-party commercial companies and perhaps manage 
and address the public’s concern, in this dissertation I examine the relationships between the 
public’s comfort with sharing health data with third-party commercial companies for patient and 
business purposes in relation to the public’s comfort with demographic characteristics, perceived 
healthcare access, trust in the health system and trust in providers, privacy concerns, and 
altruism. I also explore the effect of a past data breach and concern about recent data breach 
events, comfort with researchers, quality analysts, commercial companies, and law enforcement, 
confidence in existing health data laws, and desire for greater control over health data or 
notification of data use on the public’s comfort with sharing health data with third-party 
commercial companies.  
In this dissertation I present the results of a survey of the US public (n = 1841) to assess 
comfort with sharing health data with third-party commercial companies for patient or business 
purposes. Weighted Ordinary Least Squares (OLS) Regression analysis was used to first estimate 
the relationship between comfort with third-party commercial companies for patient and business 
purposes (dependent variables) and the aforementioned independent variables, followed by 
stepwise regression modeling to estimate a full model of contributing factors to the public’s 
comfort with sharing health data with third-party commercial companies.  
In the final analysis, variables that were significantly (𝑝 < 0.05) related to comfort with 
data sharing for patient purposes included: comfort with researchers and commercial companies, 
comfort with law enforcement accessing genetic data, altruism, individuals between the ages of 
45-59, and educational attainment. Statistically significant variables associated with data sharing 
 xiii 
for business purposes included: comfort with researchers, quality analysts, and commercial 
companies, comfort with law enforcement accessing genetic data, concern about Memorial Sloan 
Kettering’s startup company, Paige.AI, and employment status. The most salient factors 
associated with respondent’s comfort with sharing health data with third-party commercial 
companies for both patient and business purposes were trust in the health system, confidence in 
existing laws and policies, and desire for notification.  
The results of this study suggest that increasing trust in the health system may have a 
greater impact on the public’s comfort than efforts to address privacy concerns alone. Desire for 
notification was also more important to the public’s comfort with third-party commercial 
companies than the desire for control over health data. Patients may be better served by focusing 
on efforts to build trust in healthcare organizations and by providing notification of health data 
use instead of more granular control over health data use.  
  
 
 1 
Chapter 1 Introduction 
 
1.1 Background 
In September 2018, the New York Times, in partnership with Propublica, published a 
story detailing the undisclosed conflict of interest entanglements of former Memorial Sloan 
Kettering Cancer Center’s Chief Medical Officer, Dr. Jose Baselga. Dr. Baselga, a renowned 
oncologist who revolutionized treatments for breast cancer, failed to disclose to Memorial Sloan 
Kettering the extent of his corporate connections (Ornstein & Thomas, 2018a). In response to the 
negative public press, all corporate affiliations of Memorial Sloan Kettering were subsequently 
scrutinized. One corporate affiliate, Paige.AI, launched in February 2018 with $25 million in 
venture capital and a promise to “transform how cancer is diagnosed”, was reviewed for its 
exclusive deal to use the Cancer Center’s archive of 25 million patient tissue slides and the 
diagnostic work of hundreds of pathologists. A second article published by the New York Times 
about the Memorial Sloan Kettering and Paige.AI arrangement noted that Memorial Sloan 
Kettering pathologists have “strongly objected [to the deal], saying that it is unfair that the 
Paige.AI founders and medical partners received equity stakes in a company that relied on the 
pathologists’ expertise and work amassed over 60 years” and “questioned the use of patient’s 
data – even if anonymous – without their knowledge in a profit-driven venture”. The article went 
on to note that patients were “nervous that their health data was being commercialized by the 
institution” (Ornstein & Thomas, 2018b). Former Memorial Sloan Kettering Cancer Center 
patient Steve Petrow wrote in an open letter to the hospital: “My sense of betrayal only deepened 
when ProPublica and the New York Times reported on an artificial intelligence startup called 
Paige.AI [...] Are the slides of my cancer among them? My mom’s? My sister’s? I’m uneasy 
wondering whether they are being commercialized without our consent, or even without our 
being notified. The hospital claims that the data are anonymous, but anonymous data these days 
has a habit of somehow becoming identifiable” (Petrow, 2018).  
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The Paige.AI project, however, had been approved by Memorial Sloan Kettering’s 
institutional review board (IRB) for human subject research, and, despite the characterization in 
the New York Times, the actual tissue samples of patients were not going to be shared with the 
corporate startup venture, only de-identified images and notes. In response to the story printed in 
the New York Times, on September 23, 2018, Memorial Sloan Kettering put out a press release 
stating “there are several similar computational pathology efforts underway across the country 
that have emerged from academic medical centers and have faculty founders”, and that “the 
research and sharing of images and data complies with Memorial Sloan Kettering rules and legal 
requirements” (Memorial Sloan Kettering, 2018). Despite this press release, however, and 
despite Memorial Sloan Kettering’s regulatory and legal compliance, articles continued to be 
written about the possible ethics violation of the deal, and partner healthcare systems proceeded 
to distance themselves and their patients from Memorial Sloan Kettering’s corporate start up 
effort, reassuring their communities that “the New York-based health system does not have 
access to [our] patient data, diagnostic information, or tissue images” (Huang, 2018).  
 
I open with this story because of the complicated issues at work for Memorial Sloan 
Kettering. First, the unflattering story in the New York Times diminished national and 
institutional trust in Memorial Sloan Kettering’s leadership. In response to this deterioration of 
trust, all corporate ties to the institution fell under increased scrutiny and criticism, despite their 
adherence to existing protocols (IRB) and despite the de-identified nature of the information 
shared with corporate partners such as Paige.AI, which follow the existing regulations outlined 
in the Health Insurance Portability and Accountability Act (HIPAA). The questions, then, are 
these: if meeting legal and regulatory requirements is insufficient to quell patient concerns and 
negative public press, what can Memorial Sloan Kettering and other healthcare institutions in 
similar circumstances do to anticipate and mitigate public fallout over the use of personal 
medical data and what do these stories tell us about future uses of healthcare data in other 
artificial intelligence and big data efforts? If patients indicate concerns about the 
commercialization of their data, what do those concerns imply for how partnerships are created? 
Approaching answers to these questions can help prevent violations of patient and consumer 
trust.  
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As patients behave as healthcare consumers and seek leading edge innovation and 
treatment, healthcare systems can feel pressured to pursue corporate partnerships that promise 
innovation such as Paige.AI without the input of patients and the public. While these 
partnerships may hold significant breakthroughs for patient care, few healthcare systems have 
obtained explicit consent for sharing, and, as of this writing, progress has not been forthcoming. 
Recent reports on the use of IBM Watson for Health has shown that the data product has done 
little to improve or impact care, and in some instances recommended “unsafe and incorrect 
treatment recommendations”(Ross & Swetlitz, 2018). Internal documents from IBM Watson 
blame these issues on the “small number of synthetic cases” provided to IBM Watson by 
Memorial Sloan Kettering. In response, IBM Watson and other companies focused on artificial 
intelligence will likely request larger and larger samples of raw patient data. 
 
1.2 Problem Statement 
The confluence of data breaches, broken trust, and the creep of cookies and web trackers 
gathering and analyzing 2.5 quintillion bytes of data daily (Marr, 2018) has brought concerns 
about the use and power of personal data to the forefront of news. In the case of Memorial Sloan 
Kettering, it appears current regulations and approaches are insufficient to quell patient concerns 
about the use of their healthcare data, and that organizational and individual reputations can be 
severely damaged if these reservations about data use are not addressed. In this dissertation I 
explore the predictors for comfort with data sharing with commercial companies for patient 
purposes (i.e. improving the diagnosis and treatment of other patients, developing tailored care 
predictions) and for business purposes (i.e. information storage by third party companies, sale of 
de-identified information to pharmaceutical companies). Healthcare systems do indeed blur the 
use of patient and commercial use and benefit, however, there may be an underlying assumption 
that the patient is aware of how business uses of patient data improve patient care. In the case of 
Sloan Kettering, healthcare organizations may emphasize the innovative nature of the partnership 
and the benefits accrued to the health system instead of tangible improvements to patient care 
(CooperKatz, 2018). I dichotomize patient uses and business uses, even though these two 
concepts are intertwined, interrogating comfort when data is shared for patient purposes, i.e., to 
improve care, diagnosis, or treatment, versus comfort when data is shared for business purposes, 
i.e., the sale of de-identified data for artificial intelligence efforts, allowing for examination of 
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the effect of communicated purpose of use on comfort with sharing health data with third-party 
commercial companies. This division is consistent with existing models of consumer willingness 
to provide access to PHI. Previous research indicates patients desire more control if their health 
data will be used for profit-generating research (Willison et al., 2009), and are more willing to 
provide access to their health information if the potential health benefits to the public are clear 
(Anderson & Agarwal, 2011; Castell & Evans, 2016). The public has been found to be less 
accepting of data sharing partnerships not only when the public health benefits of the partnership 
are not made clear, but also if the data sharing relationship was determined to be of only private 
benefit (Castell & Evans, 2016). In a study of US veterans, participants expressed to the study 
team that research studies must have “high value with an ‘overall impact on society’ and not be 
‘an academic exercise’ and should consider whether ‘just a few hundred [people] or several 
thousands’ would benefit” (Damschroder et al., 2007).  
 
The goal of this dissertation is to examine public comfort with the sharing of patient 
health information with third-party commercial companies for patient and business purposes and 
examine the differences in comfort that arise from these two presentations of use. This research 
also explores the factors associated with comfort with both purposes. Based on a survey of the 
general public (see Appendix), my research addresses the following questions:  
 
● Paper 1:  
o Which demographic and health characteristics are associated with comfort with 
providing health data to third party commercial companies for patient purposes 
and business purposes?  
o To what extent do privacy concerns impact this comfort? 
 
● Paper 2:  
o To what extent are a) attitudes towards trust in the healthcare system, b) trust 
towards providers, c) altruism, d) experience with a past data breach, and e) 
concern about recent data breach and data-use-violation events associated with 
comfort with sharing health data with third party commercial companies for 
patient purposes and business purposes? 
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● Paper 3:  
o To what extent is comfort with researchers, quality analysts, commercial 
companies broadly, and law enforcement associated with comfort with sharing 
health data with third party commercial companies for patient and business 
purposes?  
o What is the relationship between confidence in existing laws governing health 
data and comfort with sharing health data with third-party commercial 
companies?  
o What is the relationship between a) desire for control over health data and b) 
desire for notification of data use and comfort with sharing health data with 
third-party commercial companies for patient and business purposes?  
 
In the following sections I provide definitions important to this research, followed by a 
review the policy and regulatory landscape that shape the rules for sharing health information as 
well as additional background on the emergence of new corporate entities in the context of 
digitized healthcare, and their impact on the public. I then consider relevant theories of privacy, 
trust, and transparency. I follow this brief review of the literature with the conceptual framework 
that informs my dissertation research and the key concepts hypothesized here to be associated 
with comfort with data sharing.  
 
Defining third-party commercial companies 
Throughout this dissertation I refer to “third-party commercial companies”. Third-party 
commercial companies are those companies that fall outside of usual “covered entities”, covered 
entities being healthcare systems or providers who transmit any health information, health care 
plans, and health care clearinghouses (billing services, community health information systems, 
etc.) (Office for Civil Rights (OCR), 2013). Traditionally, “third-party” referred to 
administrators or payors of healthcare expenses—intermediaries that network with other 
providers and systems to fairly price medical billing claims or facilitate in some other capacity 
tasks critical to the administration of a health system. More recently, however, “third-party” has 
also come to refer to companies that purchase de-identified health data from providers, payors, 
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and pharmacies in order to gain market strategy insights (Arndt, 2018). The business of third-
party medical data trading has grown tremendously, with some companies leading this field 
making over $2 billion in revenue in one year alone (Tanner, 2016). Once a data transaction is 
completed between a covered entity and a third-party commercial company, that company is then 
able to re-sell this de-identified information on the secondary data market. This dissertation 
research focuses on third-party commercial companies that support the growing field of precision 
health, and precision oncology in particular.  Precision oncology leverages genomic, electronic 
health record, and other large data sets for the treatment of cancer and other diseases.  Because 
genomic sequencing and data stewardship is beyond the scope of many health systems, health 
providers engage private companies to collect, analyze, and interpret data.  Costs of genomic 
sequencing are made more affordable by negotiating data sharing agreements in which 
commercial companies may keep the data for future use.   
 
Defining comfort 
In this dissertation I employ the word “comfort” to describe the public’s “acceptance”, 
“willingness”, “or openness” to sharing health data. As an example, “comfort with sharing data” 
can be used in place of “openness to sharing data”. This usage has been used similarly in 
previous research (Dhopeshwarkar et al., 2012; McKnight et al., 2002a; O’Brien et al., 2019).   
 
1.3 Policy and regulation shape the rules for sharing health information: Electronic 
Health Records and Patient Privacy 
1.3.1 Health IT Legislation and The Development of EHRs 
Health information technology legislation in the United States has spurred the adoption of 
Electronic Health Records (EHRs) and, with these newly available data, the possibility of 
unprecedented insight into the quality of healthcare delivery across populations and 
organizations, as well as for the individual patient. Legislation key to this transformation include 
the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted 
under Title XIII of the 2009 American Recovery and Reinvestment Act (ARRA), as well as Title 
III of the 21st Century Cures Act signed in 2016 (Burde, 2011). Under HITECH, the United 
States Department of Health and Human Services (HHS) was tasked with spending $25.9 billion 
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to expand adoption of health information technology. Incentives for adoption and definitions of 
“Meaningful Use”, or the use of certified EHR technology that improves the quality of care, 
spurred healthcare systems across the country to direct enormous amounts of time and resources 
towards transitioning their paper-dependent organizations to certified EHR systems by January 
2014—as well as financial penalties of a 1% reduction in Medicare reimbursement if the 
transition was not demonstrated by 2015 (Burde, 2011).  
 
As previously mentioned, one requirement of “meaningful use” is the implementation of 
a certified EHR technology to facilitate health information exchange (HIE) to improve the 
quality of care. As this occurred, healthcare and businesses turned their attention toward a new 
frontier of possibilities digitized data could unlock for healthcare quality improvement, 
healthcare operations, and research. The 2016 Precision Medicine Initiative of the National 
Institutes of Health (NIH) and its paired research program, “All of Us”, the concept of a 
Learning Health System defined by the Institute of Medicine (IOM) in 2015, and the release of 
HealthKit by Apple in 2014 (Farr, 2014) are just some of the efforts in electronic healthcare data 
that have gained momentum since HITECH’s incentivization of electronic health records. The 
2016 Cures Act expands on HITECH efforts and tasked the Office of the National Coordinator 
(ONC) by developing or supporting a “trusted exchange framework and common agreements to 
address policies and practices between health information networks” (Rucker, 2018) and setting 
electronic health system interoperability standards for “(1) vocabulary and terminology, (2) 
content and structure, (3) transport, (4) security, (5) services, and (6) querying and requesting 
information for access, exchange, and use” (Upton, 2015).  
 
1.3.2 Health Information Exchanges and New Risks 
Within the HITECH act is the provision that among the responsibilities of the HIT policy 
committee established by the HITECH act, the HIT policy committee may make 
recommendations in the additional areas of “I) the appropriate uses of a nationwide health 
information infrastructure for the purposes of (I) the collection of quality data and public 
reporting; (II) bio surveillance and public health; (III) medical and clinical research; and (IV) 
drug safety.” The section goes on to include: telemedicine, technologies that facilitate the 
continuity of care among health settings, methods to facilitate secure access by an individual to 
 8 
such individuals protected health information, and any other technology with the greatest 
potential to improve the quality and efficiency of healthcare (HITECH Act, 2009). Health 
information exchange (HIE) is the expansive effort to allow health care professionals and 
patients to appropriately access clinical information, and as indicated in the previous sentence, 
there are myriad uses of healthcare data and myriad problems that accompany those uses. As an 
example, healthcare leaders have voiced reservations about wholesale publishing of medical 
claims information, indicating that such information is difficult to compare – procedural costs 
differ from institution to institution due to physician expertise, types of cases seen, and varied 
operation costs (T. Curran, personal communication, October 29, 2019). Additionally, growth in 
value-based payments and risk sharing have accelerated efforts to share health information, but 
many smaller healthcare organizations still lack the technological infrastructure necessary to 
securely provide this information to partner institutions. 
 
Increased data connectivity poses greater risks to the privacy and security of personal 
health information (PHI). Electronic information can be more easily located, accessed, and 
duplicated than paper records. Over two thousand healthcare data breaches have been reported to 
the Department of Health and Human Service Office for Civil Rights since 2009, resulting in the 
disclosure of 194,853,404 healthcare records as of 2018, the equivalent to 59.8% of the US 
population. The number of healthcare data breaches reported yearly are up 83% since 2010, with 
a 157% year-over-year increase in the number of individual compromised records (HIPAA 
Journal, 2019). The public, enduring a steady stream of data breaches and compromised 
passwords from all service sectors, have responded by indicating their desire for greater control 
over all data, including healthcare data (Caine & Hanania, 2013).   
 
In 2016, the Obama administration noted that “the success of the digital economy 
ultimately relies on individuals and organizations trusting computing technology and trusting the 
organizations that provide products and services that collect and retain data. That trust is less 
sturdy than it was several years ago because of incidents and successful breaches that have 
given rise to fears that corporate and personal data are being compromised and misused” 
(Donilon, 2016). Deterioration of trust can compromise the quality of medical data because it 
may affect willingness to disclose necessary health information, with potentially life-threatening 
 9 
consequences (Agaku et al., 2014; ONC, 2015). Patients have reported withholding information 
from their provider or avoiding treatment entirely because of privacy concerns (Agaku et al., 
2014; The Privacy Advisor, 2012) or engaging in “defensive” practices to limit the amount of 
sensitive information in their health records (Rothstein, 2011).   
 
Although detailed health information can be of benefit to public health, to improvements 
in the quality of healthcare, and in realizing the goals of precision medicine, the research and 
data model implied by the use of artificial intelligence in healthcare are incompatible with 
current policies governing the usage of patient data (Kuchinke et al., 2016) and requires 
leveraging clinical data for purposes beyond individual care and payment for services. If, 
however, trust in healthcare remains low or decreases, and consequently information important 
to the physician-patient encounter is withheld, “benefits may be realized incompletely or 
inadequately at best.” (Francis & Francis, 2017). 
 
1.3.3 How is privacy protected in healthcare? 
Privacy and ethics in healthcare and research are currently guided by the following: The 
Health Insurance Portability and Accountability Act (HIPAA), the Federal Policy for the 
Protection of Human Subjects, also known as the “Common Rule”, broadly by the Privacy Act 
of 1974, and more recently by the Health Information Technology for Economic and Clinical 
Health Act (HITECH) signed as part of the American Recovery and Reinvestment Act in 2009.  
Warning that “the net effect of computerization is that it is becoming easier for record keeping 
systems to affect people then for people to affect record keeping systems”, the advisory 
committee on automated personal data systems recommended in 1972 that “although there is 
nothing inherently unfair in trading some measure of privacy for a benefit, both parties to the 
exchange should participate in setting the terms“ (Medicare et al., 2013). That same committee 
proposed a framework of data use that included five principles of use: 1) forbid the use of secret 
databases, 2) require that people know what records are kept about them, 3) require a statement 
of clear purpose and consent as purposes shift, 4) provide the ability to correct or amend and 5) 
provide adequate security and reliability (Nissenbaum, 2009). The resulting of this committee 
was the Privacy Act of 1974, establishing these principles as the Code of Fair Information 
Practice, which govern the collection, maintenance, use, and dissemination of 
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personally identifiable information and prohibits disclosure of this information unless one of 
twelve exemptions can be applied. These exemptions are 1) “need to know”, which authorizes 
intra-agency disclosure, 2) required disclosure under the Freedom of Information Act (FOIA), 3) 
“routine use” or compatibility with the purposes for which the data was collected, 4) the US 
Census, 5) statistical research where the record is not individually identifiable, 6) National 
Archives or historical information whose value warrants preservation by the US government, 7) 
law enforcement requests, 8) compelling circumstances affecting the health or safety of an 
individual, 9) congressional documents, 10) the duties of the General Accountability Office, 11) 
as part of a court order, or 12) as part of debt collection activities. The Privacy Act forms the 
general guidelines by which identifiable information collected by federal agencies is protected 
and provides a common protection backdrop for all other privacy protections.  
 
The Health Insurance Portability and Accountability Act (HIPAA), signed by President 
Clinton in 1996, established the federal policies and procedures that protect health insurance 
coverage and the privacy and security of health information. HIPAA is comprised of two parts, 
Title I and Title II. Title I of HIPAA protects an individual’s ability to procure insurance 
regardless of their pre-existing conditions and prohibits group plans from restricting benefits for 
a specific disease or treatment. Title II establishes the policies and procedures governing the 
privacy and security of individually identifiable health information. Protected health information 
includes names, birth dates, telephone number, and other identifying numbers. Under 
HIPAA, patients reserve the right to request a list of individuals and entities their protected, 
identifiable healthcare information has been disclosed to. HIPAA’s shortcomings were known 
even at the point at which it became law and was derided for being “too narrow” by applying 
only to “covered entities” – clinicians, health care facilities, pharmacies, health plans, and health 
care clearinghouses – HIPAA does not apply to individuals or groups outside of these roles 
(Cohen & Mello, 2018).  
 
The Common Rule was introduced in 1981 and revised in 1991, and provides our 
basic ethical principles in research involving human subjects. Origins for the Common Rule are 
found in the Belmont Report, a 1978 document that defined core principles for ethical human 
research in response to a number of abusive, unethical clinical studies that had been conducted 
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without oversight, focusing specifically on the Tuskegee Syphilis Experiment (cite the Belmont 
report). Outlined in the Common Rule are protections for “vulnerable populations”, or any 
disadvantaged population, and guidelines for Institutional Review Boards (IRB), informed 
consent, and assurances of compliance. These protections now form the requirements for ethical 
enrollment and treatment of human subjects in clinical study. Studies that follow these guidelines 
are presumed to be acting ethically and in the best interests of their enrolled study population. 
Because HIPAA was signed in 1996, there was some mismatch between the compliance 
requirements of HIPAA and the Common Rule. A Common Rule revision, first announced in 
2011, attempted to resolve some of these mismatch issues. In January 2017, the Revised 
Common Rule was published. Included in the Revised Common Rule were 1) new policies 
providing researchers with the option of broad consent for future research and 2) exemptions 
for secondary research involving identifiable information if the research is regulated by HIPAA. 
 
As detailed in earlier sections of this review, in 2009, the HITECH act was signed as part 
of the American Recovery and Reinvestment Act (ARRA). Intended to expand the use of 
electronic health record (EHR) system among providers, the HITECH act also widened the scope 
of privacy and security protections available under HIPAA with the addition of legal liability for 
HIPAA violations and the requirement for Notification of Breach, whereby patients must be 
notified of any unauthorized uses or disclosures of their health information. HITECH also 
expanded HIPAA’s scope to also include “business associates” of covered entities, or any 
company or persons who conduct business with one of the previously mentioned covered 
entities. As healthcare information becomes increasingly digitized, the ability of these laws and 
regulations to meet the evolving needs of providers and patients will continue to face greater 
challenges. As healthcare research efforts such as precision health make use of increasingly large 
data sets, the line between research and practice becomes increasingly blurred.  
 
1.3.4 How will big data threaten current legal conceptions of privacy? 
Companies that collect large amounts of user data, such as Google and Facebook, profit 
from the insight gained from this data that is analyzed, packaged, and sold. If people are aware of 
data collection at all, it’s likely at the initial point of contact, not as data are combined and 
recombined, sold and transferred to others, or put to uses that might never have been anticipated 
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at the time of the original collection (Ohm, 2010). Additionally, given the size and scope of data 
collection and use, approaches to controlling or protecting what is done with big data that rely on 
individual notice, monitoring, and choice are unlikely to be effective (Ohm, 2010). 
 
HIPAA’s general requirement for written patient authorization for disclosure of 
identifiable health information has led to routine practices for compliance within systems that 
conduct most research in universities and health care systems, but the health information 
landscape is growing to include entities who are not necessarily business associates of healthcare 
providers (i.e. Apple, Google, Fitbit) and are therefore not governed by HIPAA. These 
companies are taking increasing interest in medical records and in the purposeful or accidental 
generation of health information. Loyalty cards that track purchases of over-the-counter drugs 
can indicate purchasing patterns consistent with certain diseases or acute illnesses. Web search 
activity that is tracked and provided to a myriad number of businesses interested in more targeted 
marketing towards consumers can also provide information about healthcare concerns, age and 
health status, and overall lifestyle. One notorious example is Target’s algorithmic determination 
that a teen was pregnant based on her search history, followed by the pre-emptive deployment of 
coupons for baby clothes and cribs to her home to the outrage of her father, who did not yet 
know his daughter was pregnant (Hill, 2012). The increasing availability of health information 
outside of the healthcare setting as well as the analytic capabilities conferred by big data methods 
threaten the assumption that data can actually be fully de-identified and protect an individual 
patient’s privacy (Cohen & Mello, 2018).  
 
1.3.5 New corporate entrants into the healthcare sector 
Complicating these regulatory issues are the tech companies that “target shortcomings 
and legacy systems that are no longer efficient [in healthcare]” (Beaver, 2018). This interest is 
driven by the massive market transformation precipitated by the 2010 Affordable Care Act. In a 
2016 report, the Department of Health and Human Services estimated a net reduction of 20 
million uninsured adults since ACA’s enactment (Uberoi et al., 2016). With 20 million new 
users, the U.S. healthcare system finds itself having to innovate in search of care optimization 
and cost savings. Within the existing healthcare industry, examples of these innovation attempts 
include Sloan Kettering, whose Paige.AI partnership was detailed in earlier sections, as well as 
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Mount Sinai, University of Maryland Medical Systems, Novant Health in North Carolina, and 
the Cleveland Clinic. Hardin Memorial Health in Kentucky and Health Quest Systems in New 
York have both announced partnerships with IBM Watson to improve clinical trial matching and 
extract unstructured health information from medical records (Park, 2019). Cedars-Sinai 
launched a health tech accelerator program to attract innovators with a range of healthcare 
disrupting ideas and the opportunity to test those ideas alongside physicians. Innovative 
technologies proposed include an interface for shared decision making, a wearable blood 
collection system, and content management platforms to streamline data collection for clinical 
trials (Sullivan, 2017). 
 
Outside of the healthcare setting, marketplace interest in fitness trackers, health sensors, 
online vision tests, and clinical communications is outpacing other industries in attracting 
venture capitalist dollars. One example of a new healthcare entrant is Amazon’s addition of 
“healthcare skills” to the Amazon Alexa voice-controlled speaker system. Working with 
Providence St. Joseph Health and pharmacy benefit manager Express Scripts, Amazon has made 
their online and voice platform HIPAA compliant to provide prescription tracking, assist parents 
in providing updates to their child’s physician team to report on recovery after surgery, book 
appointments, and track blood sugar levels (Ramsey, 2019). Although now in partnership with 
healthcare systems, and therefore falling under rules HIPAA, other commercial healthcare skills 
hosted by Alexa were created before Amazon established HIPAA compliance in early 2019. 
These applications include timers for pregnancy contractions, weight loss assistants, sleep 
trackers, and food and calorie management voice assistants. Amazon skills and comparable 
applications on other platforms sit outside of traditional modes of healthcare delivery and 
therefore outside of the laws and policies that have thus far governed the use of healthcare data. 
While any one of these applications alone might have small risks for patient privacy, as with any 
large data source, in aggregate the data generated by multiple applications and “skills” can create 
a comprehensive profile of patient health.  
 
In 2017, JOANY, a Los Angeles-based start-up designed as an “insurance concierge” 
service that assisted people in navigating their insurance company, find new physicians, and 
secure health services, recruited participants for a health insurance study by advertising online 
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and offering a $25 payment for participation. Qualifications for participation included purchasing 
health insurance for 2017 through Healthcare.gov and not receiving health insurance through an 
employer or university, among other requirements. Qualifying participants were then asked to 
text a photo of their health insurance card to the study team to complete their application to 
participate in the survey study (Kohler, 2017). Although the announcement indicated that 
JOANY was HIPAA compliant, it was not clear from the article promoting this effort what IRB 
approval the study received if any, and who participants could contact if they had additional 
questions. Interested participants may not have sought this information. As of this writing, 
however, JOANY health concierge has folded, a churn typical of start-up companies. It is 
unknown what was done with participants data or how that data is handled now that the company 
has ceased to exist. In their frustration, study participants and JOANY customers have taken to 
business review sites like Yelp.com to voice their concerns. One reviewer on Yelp.com writes: “I 
am deeply concerned because I had input my complete billing information on their site […] All I 
want is what they promised me: a less-hassled way to “renew” the health insurance I need for my 
family before this upcoming enrollment period ends. [I am] waiting on joany.com to let me know 
what they did with my financial and personal information (Anonymous, 2018).” An estimated 
70-90% of all startup ventures “fail”, or close within 10 years. Depending on the reporting 
source, the failure rate of digital health startups is higher than other industries at 98% (Beckers 
Hospital Review, 2016). With each sign-up and click to participate and subsequent start up 
failure, by degrees, individuals lose control over information and data they contribute.  
 
1.3.6 The Public’s Response 
As of now, legal recourse for consumers who have entrusted health data to commercial 
companies that go out of business appears to be lacking. While frustrated customers wait for 
legal remedies, patients have already indicated their desire for more control over their data in 
established healthcare systems (Rothstein, 2011). Reservations about the use and sharing of 
health information predates the current rise of data breaches. In a 2003 literature review 
conducted before widespread use of current social media platforms, Sankar et al. reviewed 110 
papers written between 1966 and 2001 on patient views of medical confidentiality and 
categorized papers into one of four types: 1) understanding and awareness, or the patient’s 
understanding of the confidentiality of their healthcare information; 2) limits of access, or who 
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should be allowed access to their medical information; 3) effect on seeking care, or how patients’ 
perceptions of the confidentiality of their data affects the decision to seek care; 4) effect on 
disclosure, or how perceptions of confidentiality influence what patients share with providers 
(Sankar et al., 2003). Their findings are consistent with health information survey research today: 
patients are 1) generally comfortable with the sharing of their health information with other 
providers; 2) patients generally accept that in exceptional circumstances (reason to suspect harm 
to the welfare of the patient) providers must share health information with law enforcement or 
other like individuals; and 3) patients reject or are uncomfortable with sharing their health 
information with employers, family, and third parties (Sankar et al., 2003). The research 
presented here focuses on this final point: If healthcare partnerships such as those detailed in 
earlier sections are only going to increase in number, under what circumstances are patients and 
the public more comfortable with sharing their health data with third-party commercial 
companies?  
 
1.4 Trust and Privacy Concerns 
1.4.1 Trust and Transparency  
 Without trust, our complex ecosystem of interdependencies would cease to function. I 
trust my bank to safeguard my money, a restaurant to provide me with food that won’t make me 
sick, and my pharmacy to provide me the right medication in the right amounts. Patients trust 
that their physicians are well trained and able to treat their ailments. Patients also entrust 
providers with their most sensitive information with the expectation that data they generate in 
their healthcare encounter will be private and secure. Trust has been defined as “a willingness to 
impart authority and accept vulnerability to another in the fulfillment of a given set of tasks” 
(Platt et al., 2018), or “a bet about the future contingent actions of others” (Sztompka, 1999). We 
make these bets and accept vulnerability based on the information available to us about an 
entity’s reputation, credentials, and applicable laws and regulations. The Health Information 
Portability and Accountability Act (HIPAA) is a regulatory control aimed at “reducing the risk 
of, and harm caused from, sharing and misuse of health data” (Platt et al., 2018), protecting the 
privacy of patient information and providing patients with the assurance of the law.  
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Research suggests that individuals are more likely to disclose personal information when 
higher levels of trust in the benevolence of the trustee and as well as trust in the integrity of the 
trustee exist (McKnight et al., 2002b). In marketing research, studies of trust economics show 
that buyers, or consumers of goods, are more likely to do business with “virtuous sellers” 
(Matouschek, n.d.). Although being virtuous may not mean the most profit in a single 
transaction, virtuous (or ethical) sellers maintain customer relationships and loyalty and over the 
long term and generate stronger brands than sellers who view every transaction with the greatest 
short-term profit in mind (Gensler, 2015; Sinek, 2009). Gaining and maintaining trust, and thus, 
business loyalty, is ever more important as healthcare tech companies compete for patient 
business and as the Centers for Medicare and Medicaid’s Hospital Value-Based Purchasing 
program (VBP) shift organizational priorities toward the patient experience (CMS, 2019; Elliott 
et al., 2016). Whether patients are truly consumers of healthcare or whether this conception is 
helpful is debatable (Durrah, 2019; Gusmano et al., 2019), but healthcare systems will have to 
balance aggressive innovation and cutting edge research with the requirements of a strong 
trustee-trustor relationship.  
 
In an article about building brand trust, Forbes magazine cited “transparency” as one of 
the 12 most important ways to build brand trust (Council, 2016) and in their 2018 Health Care 
Engagement Survey, Deloitte concluded that “to continue to foster consumer trust, organizations 
should focus on developing resources and tools that are centered around consumer needs, 
including privacy and clarity about how data will be used and shared” (Betts & Korenda, 2018). 
Approaches of patient data transparency are currently being promoted at the national level 
through the 2018 MyHealthEData Initiative, which aims to give “every American control of their 
medical data” and Medicare’s Blue Button 2.0, “a secure way for Medicare beneficiaries to 
access and share their personal health data in a universal digital format, [enabling patients…] to 
connect their claims data to the secure applications, providers, and research programs they trust” 
and “foster increased competition among technology innovators to serve Medicare patients and 
their caregivers” (CMS Press Release, 2018)  
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1.4.2 Privacy 
Addressing privacy concerns can improve trust in organizations that share health 
information, but characterizing the meaning and scope of “privacy concerns” is not a 
straightforward or simple undertaking. Privacy can be defined as “the right to be left alone” 
(Warren & Brandeis, 1890) or “custody of the facts of one’s life” (McCreary, 2008). Privacy 
violations occur when system features do not align with social expectations or violate boundaries 
of personal preference (Nissenbaum, 2009). Boundaries of personal preference, however, are 
fluid and dynamic – information that would be considered of little value or importance in one 
context may be the very information valued and concealed in another. Communication privacy 
management (CPM) theory assumes people make choices regarding disclosure of personal 
information based on a “mental calculus” to determine whether to share or withhold information 
(Petronio, 2013), guiding their participation in shopper’s cards, online and credit card 
transactions, and web browsing. To make these determinations, CPM posits two rules or guides 
that aid in decision-making: contextual factors and risk-benefit ratio criteria. Contextual factors 
include prior experiences and traumatic events. The risk-benefit ratio criteria include individual 
assessments of type and level of risk when deciding to disclose information—which include 
relational risks, stigma, reputation and security. In further research on Communication Privacy 
Management,  privacy boundaries were found to be influenced by the “mission-relatedness of the 
request for information”—or the extent to which the information requested aids a fair, 
identifiable mission (Stanton & Stam, 2002). However, both of these approaches to privacy 
management, identification of fairness and risk-benefit analysis, require complete information to 
determine. Surveys show that despite concerns about the privacy of their personal information, 
individuals will continue to share their personal data in exchange for monetary benefit or 
convenience, also known as the “privacy paradox”, named for the systematic inconsistencies in 
what people what people say their privacy preferences are and what they do (share information 
widely).  
 
One explanation for the privacy paradox is the theory of incomplete information. The 
theory of incomplete information (TII) emerged from John Harsanyi’s work on game theory, and 
assumes that all parties involved in a transaction are not equally informed, which thus impedes 
the ability of consumers to rationally calculate risks and benefits of engaging in a transaction 
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(Bandara et al., 2017). All users participating in online transactions are engaged in unavoidable 
information asymmetry as personal information that is provided in a transaction then multiplies 
in the course of information intake and processing, propagates as the information is analyzed and 
shared, and persists for an unpredictable span of time—placing the individual in a position of 
information asymmetry with respect to the party they are completing the transaction with. The 
negative utility that may come from future misuses of that information (credit card or personal 
information breaches, for example) is then impossible to calculate (Acquisti, 2004). In general, 
data subjects know less than the data holders about the magnitude of data collection and use of 
shared or collected personal data, or about the associated consequences. Because users lack 
critical information about true risks and benefits of information sharing and privacy, the 
immediate benefits of transacting overwhelm the privacy calculus, resulting in the privacy 
paradox (Bandara et al., 2017).  
 
Six major categories of “unknowns” have been determined to exacerbate this information 
asymmetry: 1) a user often only has vague and limited knowledge of the actions she can take to 
protect her personal information, and she has limited knowledge of the actual or possible actions 
being taken by data gatherers to collect her information; 2) the decision to protect or trade 
information has unpredictable consequences; 3) the rapid rate of technological developments 
make true assessment unknowable; 4) desired actions may not be available—specifically, the 
user cannot regain control over information that has been shared with a third party; 5) users are 
in a daily negotiation of the effort necessary to evaluate everyday privacy decisions, and 6) 
privacy protection and invasion is often a by-product of other desired goods—the convenience of 
online shopping or cost-savings from participation in shoppers clubs interfere with privacy 
determinations, making it difficult to make true privacy valuations (Grossklags & Acquisti, 
2007). However, in one of the few empirical studies on information giving and transaction 
behavior, Tsai et al. found that when the privacy information of a website is made easier to 
identify and understand, consumers were more willing to pay a “privacy premium” to conduct 
business with those websites that offered greater privacy protection (Tsai et al., 2011). The 
willingness to pay a premium indicates that resolving information asymmetry in transactions can 
resolve some of the paradoxical behaviors and concerns regarding privacy.  
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Examination of the role of trust and privacy concerns in comfort with sharing health data 
with third-party commercial companies allows us to begin disentangling these relationships in 
pursuit of actionable recommendations to assuage and mitigate patient concerns about the use of 
health data and close this asymmetrical relationship.  
 
1.5 Conceptual Model 
The conceptual model for this dissertation builds on Anderson and Agarwal’s Model of 
Consumer Digitized PHI Concerns (Anderson & Agarwal, 2011). Anderson’s model, based on 
the Communication Privacy Management (CPM) theory previously discussed, explores under 
what circumstances individuals are willing to disclose identified health information, and what 
effect information type, requestor, purpose, trust, altruism have on willingness to disclose. 
Although Anderson and Agarwal hypothesized that the type of information provided and trust in 
the electronic medium would influence willingness to provide access to personal health 
information (PHI), in their analysis they concluded that 1) intended purpose, 2) requesting 
stakeholder, 3) the individuals health status emotion, and 4) altruism or empathy were the actual, 
final factors associated with willingness to provide access to personal health information.  
 
In my dissertation I expand the Anderson and Agarwal model by exploring the public’s 
comfort with sharing health data with third-party commercial companies for patient purposes 
versus business purposes (Figure 1.1), again, interrogating the public’s comfort with sharing 
healthcare data with third-party companies when data sharing is expressed in terms of patient 
purposes, i.e., to improve care, diagnosis, or treatment, versus comfort when data is expressed in 
terms of business purposes, i.e., the sale of de-identified data for artificial intelligence efforts, 
with the goal of better understanding how presentation of third-party commercial partnerships 
affect comfort with sharing health data.. In the first analytical paper of this dissertation (Chapter 
2) I examine how comfort with sharing health data with third-party commercial companies is 
related to demographic characteristics, self-reported health status, perceived healthcare access, 
and privacy concerns (Blue Arrows in Figure 1). In the second analytical paper of this 
dissertation (Chapter 3) I examine how comfort with third-party commercial companies is related 
to trust in the health system, trust in healthcare providers, altruism, experience of a past data 
breach, and concern about recent data breaches and data misuse events (Red Arrows in Figure 1). 
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In the final paper of this dissertation (Chapter 4) I provide a full model that includes the variables 
examined in the first and second analytical paper, and add in this third paper an examination of 
how comfort with third-party commercial companies is related to 1) comfort with researchers, 
quality analysts, commercial companies, and law enforcement; 2) the public’s confidence in 
existing health data laws and policies; and, finally, 3) the desire for either more control over 
health data sharing or the desire for notification of data use (Purple Arrows in Figure 1).  
 
In the following sections I provide a short review of each of these concepts as they relate 
to comfort with data sharing.  
 
Conceptual Model 
 
Figure 1-1 Conceptual Model of Dissertation Research 
 
Table 1-1 Independent and dependent variables by chapter 
 Ch 2 Ch 3 Ch 4 
Dependent Variables    
Comfort with sharing health data with third-party commercial 
companies for patient and business purposes 
X X X 
Independent Variables    
Demographic characteristics X X X 
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Self-reported health status X X X 
Perceived healthcare access X X X 
Privacy Concerns X X X 
Trust in Health System  X X 
Trust in Providers  X X 
Altruism  X X 
Experience of a Past Data Breach  X X 
Concern about recent data breach events  X X 
Comfort with data stakeholders   X 
Confidence in existing laws   X 
Desire for control over health data   X 
Desire for notification of health data use   X 
 
 
Sharing data for patient versus business purposes 
In this dissertation I examine the public’s comfort sharing health data with third-party 
commercial companies, distinguishing comfort when data is shared for patient purposes, i.e., to 
improve care, diagnosis, or treatment for themselves or for others, versus comfort when data is 
shared for business purposes such as selling de-identified data (outcome variables). This division 
allows for the examination of the effect of stated purpose on comfort with sharing health data 
with third-party commercial companies and is consistent with existing models of consumer 
willingness to provide access to PHI.  
 
Previous research indicates patients desire more control if their health data will be used 
for profit-generating activities (Willison et al., 2009), and are more willing to or comfortable 
with providing access to their health information if the potential health benefits to patients are 
clear (Anderson & Agarwal, 2011). In a study of US veterans, participants expressed to the study 
team that research studies must have “high value with an ‘overall impact on society’ and not be 
‘an academic exercise’ and should consider whether ‘just a few hundred [people] or several 
thousands’ would benefit” (Damschroder et al., 2007). This separation of patient-focused 
purposes from more general business purposes that employed in this dissertation allows for the 
examination of the impact of stated use on comfort with third-party commercial companies. 
Although business purposes and patient purposes are closely related, this distinction may not be 
readily made by patients or by the public. Based on previous research, one would expect greater 
comfort with third-party commercial use of health information when used for purposes that 
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clearly state benefits for patients and for healthcare provision, and less comfort when used for 
business purposes or those purposes that may be more abstract from improvements to patient 
health. Given that health information is currently used for both patient and business purposes, it 
is important to understand how factors such as concerns about privacy, healthcare access, and 
demographic characteristics, are associated with greater or lesser comfort. 
 
In the following section I discuss the component independent variables of the conceptual 
model and revisit some of the attitudinal variables previously discussed (trust and privacy).  
 
Demographic Characteristics 
Although individual privacy attitudes are the result of individual experience and 
motivations (Petronio, 2013), differences in privacy concerns and willingness to share personal 
information have been found between men and women, with women evidencing greater privacy 
concerns and decreased comfort sharing personal information (Sheehan, 1999; Tifferet, 2019). 
Differences in privacy concerns have also been examined among age groups (Zhou & Salvendy, 
2017), with studies showing privacy concerns decrease with increased internet experience (Lohse 
et al., 2000; Zhou & Salvendy, 2017). Younger adults spend more time online compared to their 
older counterparts, and 90% of US emerging adults aged 18-29 reporting using social media 
every day (Scott et al., 2017), leading to the hypothesis that younger people are more 
comfortable sharing their health information. Differences in willingness to share personal 
information has also been found according to educational attainment (Blank et al., 2014; J. Kim 
et al., 2019; Sheehan, 1999) and income (H. Lee et al., 2016; O’Neil, 2001), which find that as 
educational attainment and income increases, privacy concern also increases while willingness to 
share information decreases.  
 
Perceived Healthcare Access and Health Status 
Anderson and Agarwal introduce a conceptual model examining the role of emotions on 
willingness to disclose personal health information. In their research they found that highly 
negative emotions about health status (personal experience with a past or present cancer 
diagnosis) was associated with increased willingness to share PHI with pharmaceutical 
companies for clinical trial research. They hypothesize that this effect is due to the participant’s 
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ability to recall what their cancer diagnosis felt like and are subsequently better able to envision 
the research benefits of sharing their health information as compared to individuals who have 
never received a cancer diagnosis (Anderson & Agarwal, 2011). Studies on the effect of health 
status broadly on participant willingness to share health information, however, have been 
contradictory—in one study, patients with self-rated fair or poor health were less willing to share 
their health information (Weitzman et al., 2010). In a study involving HIV patients, perceived 
healthcare access, or the patient’s satisfaction with their ability to access necessary healthcare, 
was associated with increased willingness to share personal health information (Teixeira et al., 
2011).  
 
Privacy Concerns 
Surveys of the public have routinely found that people are concerned about their personal 
privacy, but have also found that if individuals value the benefits of information disclosure 
enough, privacy concerns are outweighed. In the consumer sector, loyalty points, shopper 
discount cards, and customer accounts are reliant on this suspension of privacy concerns in 
exchange for monetary benefits or for convenience. Patients also appear willing to share health 
information in the research context if the benefit to other patients is clear (Damschroder et al., 
2007). However, overall willingness to share information is modified by privacy concerns-- 
individuals with greater privacy concerns express greater reluctance to share data even for 
patient purposes than those with less privacy concerns (Anderson & Agarwal, 2011). Empirical 
examination of the strength of the specific relationship between privacy concerns and comfort 
sharing health data with third-party commercial companies has not been provided in previous 
literature.  
 
Trust in the Health System and Trust in Providers 
Trust, or the willingness to accept vulnerability to the actions of others (Richards & 
Hartzog, 2015), has been shown to increase the likelihood patients will participate in research 
(K. K. Kim et al., 2017) and is a strong predictor of attitudes and behaviors in other areas such as 
online shopping (Wang & Tseng, 2011), customer loyalty (Kantsperger & Kunz, 2010), and self-
disclosure on social media (Fogel & Nehmad, 2009; Taddei & Contena, 2013). While there are a 
number of approaches to defining and examining trust, four high level categories have been most 
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frequently used to capture the dimensions of trust: benevolence, integrity, competency, and 
predictability or fidelity (McKnight & Chervany, 2001). Benevolence means “caring and being 
motivated to act in one’s interest rather than acting opportunistically”; integrity means “making 
good faith agreements, telling the truth, and fulfilling promises”; competence means “having the 
ability or power to do for one what needs to be done”; and predictability means “trustee actions 
that are consistent enough to be forecasted” (McKnight & Chervany, 2001). Existing research on 
trust, privacy, and control of information have differed in their results on the mediating or 
moderating relationship between each. Some have found that trust is the commanding variable, 
reducing privacy concerns and increasing willingness to share personal information overall 
(Fogel & Nehmad, 2009), while others have found that privacy is actually the commanding 
variable, increasing trust and leading to greater disclosure of personal information (Krasnova et 
al., 2010).  
 
Altruism 
Altruism is the prioritization of the needs of others even though no direct benefit may be 
conferred onto the individual. Individuals who consider themselves altruistic place high value on 
how their efforts may contribute to the well-being of others. As was stated earlier, studies on 
patient willingness to participate in healthcare research find that individuals are more willing to 
participate in research studies if their participation would help a friend or relative or has the 
potential to benefit society (Doukas & Hardwig, 2014; Reynolds & Nelson, 2007; Shavers et al., 
2001).  
 
Impact of Data Breaches and Concern about Recent Events 
In a study of healthcare data breaches, healthcare systems lost a reported average of $408 
per record due to detection efforts, notification, legal expenditures and fines, and lost business 
(Ponemon Institute, 2018). This same study found that healthcare organizations worldwide lost 
customers as a result of data breaches. Studies of data breaches in other sectors have found 
similar effects. Research on online shopping behavior found that in the wake of a data breach, 
customers engage in protective behaviors that include avoiding the online store entirely or 
doubling-down on protective monitoring efforts to mitigate any issues that might arise due to 
compromised personal information (M. Lee & Lee, 2012). Similar patterns of decreased 
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customer retention were also identified in a 2002 examination of hotel data breaches – a data 
breach event resulted in changes to the offline behavior of customers who reported being less 
willing to revisit and recommend that hotel (Belanger et al., 2002). Yet another study on the 
effect of data breaches found a negative and statistically significant impact on the market value 
of the breached companies (Acquisto et al., 2006).  
 
Comfort with Researchers, Quality Analysts, Commercial Companies 
Multiple studies have shown that on the whole, patients are willing to share their health 
data with researchers (Damschroder et al., 2007; Karampela et al., 2019; Seltzer et al., 2019; 
Spencer et al., 2016; Teixeira et al., 2011). Despite dissatisfaction about how the results of 
research studies were communicated back to participants, patients were also willing to share data 
beyond their personal health information for the purposes of research, including tax records and 
credit card histories (Seltzer et al., 2019). This willingness to share health information is, 
however, largely confined to only to efforts characterized as “research”. As an example of 
willingness to share health data with third-party commercial companies, a 2019 survey 
conducted by the Chicago Booth/Kellogg School Financial Trust found that 93% of survey 
participants were unwilling to share their health data with Facebook (Promarket, 2020).  
 
Comfort with Law Enforcement 
Third-party access to health data also includes police. A 2019 survey conducted by the 
Pew Research Center found that 48% of Americans consider it acceptable for DNA testing 
companies (23andMe, Ancestry.com) to share their customers’ data with law enforcement, while 
one-third (34%) of respondents said sharing with law enforcement was unacceptable, and 18% 
were unsure whether the practice was acceptable or unacceptable (Perrin, 2020). As third-party 
companies seek greater access to health data as well as data that can be considered health data 
(web histories, fitness applications), law enforcement also gains an increasingly robust data set 
with which to conduct investigations. In 2019, a Florida judge granted a warrant that allowed the 
police to search the complete genetic database of GEDMatch. The terms of the warrant included 
all customers of GEDMatch, including those who didn’t opt-in to any data sharing agreement. 
Following this event, GEDMatch updated their terms of agreement and added a form asking 
users to consent to future searches. Notably, as of November 2019, only 185,000 of the 
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company’s total population of 1.3 million users, a mere 7% of the total user population, have 
provided this consent (Tiller, 2019).  
 
Confidence in existing laws and policies 
As healthcare breaches increase year after year, patient confidence in the ability of the 
health system to control and prevent unauthorized access to their personal health information is 
decreasing (HIPAA Journal, 2017). In a 2016 survey, 89% of healthcare consumers reported 
withholding health information during their visit because of privacy and security concerns (Black 
Book Market Research, 2017). Research shows patients desire clear and consistent consequences 
for anyone who violates patient privacy, and for researchers to be held accountable for 
maintaining confidentiality (Damschroder et al., 2007), but changes to regulations governing 
information sharing have not yet occurred. In 2007, only 25% of participants were aware that 
researchers could use their medical records without explicit permission from the patient 
(Damschroder et al., 2007). In 2016, 81% of respondents to a Black Book Market Research 
survey (Black Book Market Research, 2017) reported concern that their chronic condition data 
was being shared with retailers, employers, or the government without their knowledge (Gooch, 
2017).  
 
Desire for control and notification 
Research on willingness to allow for personal health data to be used for research have 
found that in general, 96% of patients were willing to provide their data for research, yet 78% 
also indicated their desire for more control over how their information was used (Damschroder et 
al., 2007). Patients have consistently reported wanting to know how their health data may have 
contributed to helping others, and who was using their medical records for what purpose 
(Damschroder et al., 2007; J. Kim et al., 2019; Weitzman et al., 2010). Desire for notification 
persists even when there is high institutional trust (Damschroder et al., 2007). 
 
1.6 Conclusion 
 Health systems must navigate patient privacy and innovation carefully as big data efforts 
in healthcare proliferate and the healthcare marketplace is inundated with new commercial 
entrants. Examination of the public’s comfort with sharing health data with third-party 
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commercial companies is critical to mitigate public backlash and protect public and patient trust. 
In this dissertation, I consider a number of factors that may be associated with this comfort to 
inform future studies, health systems, and designers who can help bridge the gap between 
patients and the systems that serve them to ensure both privacy and trust.    
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Chapter 2 The Public’s Comfort with Sharing Health Data with Third-Party Commercial 
Companies 
 
2.1 Abstract 
Background: Healthcare systems are using big data-driven methods to realize the vision of 
learning health systems and improve care quality.  In so doing, many are partnering with third-
party commercial companies to provide novel data processing and analysis capabilities while 
also providing personal health information to a for-profit industry that may store and sell data.  
  
Objective: To describe the public’s comfort with sharing health data with third-party 
commercial companies for patient and business purposes and how this comfort is associated with 
demographic factors (sex, age, race/ethnicity, education, employment, income, insurance status, 
and self-reported health status), perceived healthcare access, and concerns about privacy.  
  
Methods: We surveyed the US public (n = 1841) to assess comfort with sharing health data with 
third-party commercial companies for patient or business purposes. We examined whether there 
was a difference between comfort with data sharing for patient or business purposes and then 
used univariate and stepwise regression modeling to estimate the relationship between comfort 
with third-party commercial companies for patient and business purposes (outcomes) and 
demographic factors, self-reported health status, perceived healthcare access, and privacy 
concerns. 
  
Findings: The public is more comfortable sharing health data with third party commercial 
companies for patient purposes as compared to business purposes (paired 𝑡 = 39.84, p < 0.001). 
Higher education was associated with greater comfort with sharing health data for patient 
purposes (𝛽 =	0.205, p< 0.001) and decreased comfort with sharing health data for business 
purposes (𝛽 =	-0.145, 𝑝 = 0.079). There was an inverse relationship between privacy concerns 
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and comfort with sharing health data for both patient (𝛽 =	-0.223, 𝑝 < 0.001) and business 
purposes (𝛽 =	-0.246, 𝑝 < 0.001). Participants ages 45-59 were less comfortable sharing health 
data with third party commercial companies for patient purposes (𝛽 =	-0.154, 𝑝 = 0.0012) than 
other age groups.  
  
Implications: Proactive acknowledgment of privacy concerns and better communication of the 
steps being taken to protect the privacy of health data can increase patient comfort. Healthcare 
systems may be able to increase public and patient comfort with sharing health data with third-
party commercial companies by emphasizing the patient-centered benefits of these partnerships.  
 
2.2 Introduction 
2.2.1 Background 
In the fall of 2019, Google and Ascension announced a data partnership called 
“Nightingale”. As part of the effort, Ascension, the largest non-profit healthcare system in the 
United States, moved identifiable patient records onto Google’s cloud servers to begin data 
analysis on a subset of Ascension’s patient population of 50 million people (Copeland & 
Needleman, 2019).  News coverage of the partnership included language such as “secretly 
gathering personal health records (Griggs, 2019)” and “Google: You can trust us with the 
medical data you didn’t know we already had (Brodkin, 2019)”. What likely began as an exciting 
data-discovery partnership has since devolved into a full investigation by the Office for Civil 
Rights in the Department of Health and Human Services (Brodkin, 2019). This response by the 
public, however, was not unprecedented. At the time of the announcement in November 2019, 
Google and the University of Chicago were being sued for the use of identifiable patient records 
without consent (Wakabayashi, 2019), and in Fall 2018, news coverage revealing the details of 
Sloan Kettering’s external startup venture known as Paige.AI resulted in an internal, system-
wide review of all third-party commercial company data sharing agreements and a breakdown in 
community trust (Singer & Wakabayashi, 2019; Vincent, 2019).  However poorly received they 
may have been, partnerships and electronic personal health information (ePHI) data sharing 
agreements like these are key to realizing the potential of big data efforts in healthcare: 
personalized medicine, better understanding of rare diseases, and reduction of prescription errors, 
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among other efforts. Third-party commercial companies have been routinely used by healthcare 
systems to extend the often-limited in-house capabilities of diagnostic testing and image 
analysis. But as healthcare systems increasingly participate in various data and technology 
ventures and third-party partnerships, the ethics of these partnerships and the responsibility of the 
healthcare system to the patient are being questioned.  
 
Healthcare systems in partnership with third-party commercial companies, Ascension, 
University of Chicago, and Sloan Kettering included, are doing so in compliance with existing 
HIPAA regulations and approval from Institutional Review Boards as required (Ornstein & 
Thomas, 2018). The accompanying media coverage, however, strongly suggests that compliance 
with existing laws is insufficient for patients and for the public (Landi, 2020). Previous research 
on patient willingness or comfort with sharing healthcare data indicate reservations about the use 
of healthcare data outside of those services needed to provide direct care (J. Kim et al., 2019) and 
concern about the motivations behind the use of health data (Stockdale et al., 2019). Despite 
these reservations, patients are largely supportive of research efforts and generally look forward 
to the potential healthcare insights offered by large patient data sets (Doukas & Hardwig, 2014; 
Reynolds & Nelson, 2007; Shavers et al., 2001). The challenge for healthcare systems and their 
third-party commercial partnerships is to reconcile patient privacy concerns with the patient’s 
desire to contribute to the potential of big data to improve care outcomes, quality, and healthcare 
efficiency as healthcare systems grow increasingly reliant on third-party commercial companies 
to realize big data goals. Examination of the public’s comfort with sharing healthcare data with 
third-party commercial companies and their privacy concerns is needed to guide the manner in 
which future healthcare system partnerships with third-party commercial companies are planned 
and communicated, so that healthcare organizations can mitigate the possibility of public 
surprise and backlash.  
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2.2.2 Conceptual Model 
 
Figure 2-1 Conceptual Model of Dissertation Research – this analysis is focused on  individual characteristics, perceived 
healthcare access and health status, and privacy concerns 
 
Difference between business v. patient purposes 
Healthcare systems do indeed blur the use of patient and commercial use and benefit, 
however, there may be an underlying assumption that the patient is aware of how business uses 
of patient data improve patient care. In the case of Sloan Kettering, healthcare organizations may 
emphasize the innovative nature of the partnership and the benefits accrued to the health system 
instead of tangible improvements to patient care (CooperKatz, 2018). We dichotomize patient 
uses and business uses, even though these two concepts are intertwined, interrogating comfort 
when data is shared for patient purposes, i.e., to improve care, diagnosis, or treatment, versus 
comfort when data is shared for business purposes, i.e., the sale of de-identified data for artificial 
intelligence efforts, allows for examination of the effect of communicated purpose of use on 
comfort with sharing health data with third-party commercial companies. Comfort can also be 
understood as “acceptance”, “openness”, or “willingness” to share health data.  
 
The division we employ is consistent with existing models of consumer willingness to 
provide access to PHI. Previous research indicates patients desire more control if their health 
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data will be used for profit-generating research (Willison et al., 2009), and are more willing to 
provide access to their health information if the potential health benefits to the public are clear 
(Anderson & Agarwal, 2011; Castell & Evans, 2016). The public has been found to be less 
accepting of data sharing partnerships not only when the public health benefits of the partnership 
are not made clear, but also if the data sharing relationship was determined to be of only private 
benefit (Castell & Evans, 2016). In a study of US veterans, participants expressed to the study 
team that research studies must have “high value with an ‘overall impact on society’ and not be 
‘an academic exercise’ and should consider whether ‘just a few hundred [people] or several 
thousands’ would benefit” (Damschroder et al., 2007). Given that health information is currently 
used for both patient and business purposes, it is worthwhile to examine how stated intent 
impacts comfort with third-party commercial companies and the relationship of this comfort with 
concerns about privacy, healthcare access, and demographic factors. 
 
To further characterize comfort with sharing health data with third-party commercial 
companies, we explore the impact of privacy concerns, perceived healthcare access, and 
demographic characteristics on comfort with sharing health data with third-party commercial 
companies.  
 
Privacy Concerns 
Overall willingness to share information is modified by privacy concerns-- individuals 
with greater privacy concerns express greater reluctance to share data even for patient purposes 
than those with less privacy concerns (Anderson & Agarwal, 2011). However, empirical 
examination of the strength of the relationship between privacy concerns and comfort with 
sharing health data with third-party commercial companies has not been provided in previous 
literature.  
 
Perceived Healthcare Access and Health Status 
Highly negative emotions about health status (personal experience with a past or present 
cancer diagnosis) is associated with an increased willingness to share personal health information 
(PHI) with pharmaceutical companies for clinical trial research (Anderson & Agarwal, 2011). 
However, studies on the effect of health status broadly on participant willingness to share health 
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information have been contradictory—in one study, patients with self-rated fair or poor health 
were less willing to share their health information (Weitzman et al., 2010). In a study involving 
HIV patients, perceived healthcare access, or the patient’s satisfaction with their ability to access 
necessary healthcare, was associated with increased willingness to share personal health 
information (Teixeira et al., 2011).  
 
Demographics 
Differences in willingness to share personal information has also been found according to 
educational attainment (Blank et al., 2014; J. Kim et al., 2019; Sheehan, 1999) and income (Lee 
et al., 2016; O’Neil, 2001). These studies have found that as educational attainment and income 
increases, willingness to share information decreases.  
 
2.2.3 Study Objective 
The aim of this study is to interrogate the public’s comfort with sharing healthcare data 
with third-party companies when data sharing is expressed in terms of patient purposes, i.e., to 
improve care, diagnosis, or treatment, versus comfort when data is expressed in terms of 
business purposes, i.e., the sale of de-identified data for artificial intelligence efforts, with the 
goal of better understanding how presentation of third-party commercial partnerships affect 
comfort with sharing health data. We specifically examine how privacy concerns, perceived 
healthcare access, and demographic factors including self-reported health status are associated 
with both types of comfort with data sharing in order to provide insight on how healthcare 
systems and policy makers may navigate future data partnerships. 
 
2.3 Methods 
Respondent comfort with sharing health data with third-party commercial companies was 
captured using a 20-minute online survey of US adults. In the following section we explain how 
the concepts described above are operationalized in this survey, followed by an explanation of 
the statistical methods used to analyze this data.  
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2.3.1 Participants 
Respondents were surveyed using the National Opinion Research Center’s (NORC) 
probability-based, nationally representative sample of US adults, based on 2010 Census 
Information. NORC’s national sample frame employs a two-stage probability sample design to 
select a representative sample of households in the United States, oversampling African 
American, Hispanic populations, as well as households 200% below the federal poverty level. 
Survey recruitment and deployment was done in May 2019. Data collection was completed by 
June 2019. Eligible participants (at least 21 years old and able to read and write in English) were 
contacted via email to participate in the online survey, resulting in a total of 2,157 participants 
(66% response rate). The first component of the survey was a short (90 seconds) animated video 
describing how health data of a fictional patient is shared through the duration of care—to 
insurers, billers, and analysts learning from the outcomes of treatment. Definitions of important 
terms such as “healthcare system”, “healthcare providers”, “electronic health record”, “de-
identified health information [or biospecimens]”, and “commercial companies” were provided to 
survey participants wherever those terms appeared. “Commercial companies” was defined for 
respondents to this survey as “third-party companies that are not part of a hospital. For example, 
a third-party commercial company may conduct genetic tests and analyze information for a 
hospital or healthcare provider for a fee when a hospital is not able to conduct the test on their 
own.”  “De-identified [health information or biospecimens]” was defined for respondents in the 
following manner: “de-identified means that “identifying information” about you is removed 
from your health information. Identifying information includes things like your name, address, 
date of birth, etc.”  
 
NORC calculated post-stratification weights according to US Census demographic 
benchmarks for age, sex, household income, education, as well as race and ethnicity to reduce 
sampling bias. For the purposes of this paper, records with missing responses to one or more of 
the questions used in this analysis were not included, resulting in a final analyzed sample of 
1,841 responses. This study protocol was approved by the University of Michigan Health 
Sciences Institutional Review Board.  
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2.3.2 Survey Design 
Variables used in this study were derived from a 20-minute, 164-item survey created to 
examine knowledge, attitudes, and beliefs about data sharing. Privacy measures were adapted 
from Anderson’s work on consumer willingness to disclose personal health data and the 
California Health Foundation’s 2005 National Consumer Health Privacy survey (Anderson & 
Agarwal, 2011; Bishop et al., 2005). Privacy measures also include questions about deception 
and medical mistrust (Boulware et al., 2003; LaVeist et al., 2009) and have been used in previous 
studies (Platt et al., 2018).  
 
2.3.3 Measurements used in this study 
Public Comfort with Sharing Health Data with Third-Party Commercial Companies for 
Patient and Business Purposes 
To explore public comfort with sharing health data with third-party commercial 
companies for patient purposes, respondents answered questions about “how comfortable” they 
were with three statements regarding data sharing with third-party commercial companies, each 
along a 4-point Likert scale. Participants were asked “How comfortable are you with a third-
party commercial company using your DNA and health information to improve the diagnosis 
and treatment of cancer in other patients?” and “How comfortable are you with a third-party 
commercial company developing predictions about how you will respond to a particular cancer 
treatment?: “not at all comfortable” (1), “somewhat comfortable” (2), “fairly comfortable” (3), 
and “very comfortable” (4). Participants were also asked “how true” it was that “The 
organizations that have my health information and share it can use large amounts of data to 
improve patient care”: “not true” (1), “somewhat true” (2), “fairly true” (3), and “very true” (4).  
 
To examine participant comfort with sharing health data with third-party commercial 
companies for business purposes, participants were asked “How comfortable are you with a 
third-party commercial company storing your DNA and health information?”; “How comfortable 
are you with a third-party commercial company sharing predictions about how you will respond 
to cancer treatment with insurance companies?”; and “How comfortable are you with a third-
party commercial company selling de-identified health information to a pharmaceutical 
company?”. “Business purpose” in this research is understood as storage of health data beyond 
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the purposes of clinical care and sharing information with third-party commercial companies to 
improve their own business processes without explicitly stated direct benefit to patients. 
Respondents were provided with the options “not at all comfortable” (1), “somewhat 
comfortable” (2), “fairly comfortable” (3), and “very comfortable” (4). Indices for data use for 
patient purposes and business purposes were then calculated as the sum of participant responses 
to the three questions in each index divided by the number of questions.  
 
The Cronbach’s alpha for these questions was 0.766 for comfort with sharing health data 
with third-party commercial companies for patient purposes and 0.786 for comfort with sharing 
health data for business purposes. 
 
Demographics 
Demographic factors reported in this study include sex, age, race and ethnicity, 
education, income, and employment. The survey fielded by NORC provided with only two 
options for sex, male and female. Age was divided into four groups: 18-29, 30-44, 45-59, and 
60+. Categories for race and ethnicity include “white, non-Hispanic”, “black, non-Hispanic”, 
“other, non-Hispanic”, “Hispanic”, “multiracial, non-Hispanic”, and “Asian, non-Hispanic”. 
Education was divided into four groups: less than high school, high school graduate, some 
college, or bachelor’s degree or above. Employment was grouped into four categories: 
employed, not-employed, retired, or not working due to disability or other reasons.  
 
Health variables 
In addition to demographic information, we examine the effect of respondent’s insurance 
status (“Are you now covered by any form of health insurance or health plan? Yes (1) or No 
(2)”), self-reported health status (“Would you say that in general your health is… “poor” (1), 
“fair” (2), “good” (3), “very good” (4), “excellent” (5)), and examine participant’s perceived 
ability to access healthcare services at a satisfactory level via the perceived healthcare access 
index. The index is based on various aspects of the healthcare experience and is evaluated here 
using a five-item index, asking “how true” ( “not true”, “somewhat true”, “fairly true”, or “very 
true”) the following statements were for participants: 1) “The healthcare system in this country is 
easy to use”; 2) “I can get the healthcare I need when I need it”; 3) “I get all the information I 
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need about my health from my healthcare provider”; 4) “I could access my electronic health 
record if I wanted to”; 5) “In general, I am satisfied with the treatment I receive from my 
healthcare provider”. The perceived healthcare access index was then calculated as the sum of 
participant responses to these five items and then divided by the number of questions. The 
Cronbach’s alpha was 0.820 for the perceived healthcare access index.  
 
Privacy Concerns 
To measure individual privacy concerns, respondent privacy attitudes were evaluated 
using a 4-item index, assessing their belief in the privacy protections of their healthcare system 
and whether they have concern information about themselves is being misused or could be used 
in a way that is harmful to the respondent. The component questions for the privacy index are: 
“1) My healthcare system respects my privacy; 2) I worry that private information about my 
health could be used against me; 3) I worry my health information is available to people who 
have no business seeing it; 4) There are some things I would not tell my healthcare providers 
because I can’t trust them with the information”. Each item asks respondents to rate “how true” 
each was for themselves on a Likert-type scale ranging from 1 (not true) to 4 (very true). The 
final privacy index score reflects the average of each participant’s response to these four 
questions. The first component question of the privacy index, “my healthcare system respects my 
privacy”, has been reversed-scored for inclusion in this index. The Cronbach’s alpha was 0.771 
for the questions used in this index.  
 
2.3.4 Data Analysis 
Descriptive statistics were estimated on all variables and are used to describe the 
demographic characteristics, perceived healthcare access, and privacy concerns of participants. A 
paired t-test examining the difference between comfort with sharing health data with commercial 
companies for patient purposes and comfort with sharing health data with commercial companies 
for business purposes was conducted to determine whether the difference between the two means 
is statistically significant. 
 
Weighted Ordinary Least Squares (OLS) Regression analysis was used to estimate the 
linear relationship between comfort with third-party commercial companies for patient and 
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business purposes and each demographic and health variable separately. We then estimated a 
multivariable model with all demographic and health variables and conducted a stepwise 
regression model to identify a parsimonious set of variables that explained the greatest amount of 
variability in the two outcomes – comfort with sharing data with commercial companies for 
business or patient purposes.  For the stepwise regression model, we set statistical significance at 
a=0.05 (p<0.002) for inclusion and a=0.01 for exclusion, applying a Bonferroni correction to 
minimize Type I error. To enable comparison of effect sizes, regression coefficients were 
normalized (mean = 0, SD = 1).  
 
2.4 Results 
2.4.1 Sample Demographics 
The resulting weighted sample of 1,841 participants shows a near even split between 
male and female participants (49% male). Approximately 12% of participants were under the age 
of 29, and 31% of participants were over the age of 60. Nearly 60% of participants identified as 
white non-Hispanic, 15% as black, non-Hispanic, 19% as Hispanic, 3% as Asian, non-Hispanic, 
2% of participants identified race and ethnicity as “other”, and 3% identified as multiethnic, 
consistent with 2016 data from the US Census Bureau (12% of the US population identifies as 
black or African-American, non-Hispanic). Nearly half of participants completed some college 
(46%), and 33% of participants have a bachelor’s degree. While the proportion of participants 
with a bachelor’s degree is consistent with national percentages (30%, 2016 census data), the 
proportion of participants with some college, no degree is much higher in this study than national 
percentages (21%, 2016 census data). Just over half of participants (59%) made an income less 
than $60,000, consistent with the median household income for 2018 (Guzman, 2019). Over half 
of participants (60%) had employment. Of the health questions included in this analysis, 89% of 
study participants reported having health insurance of some type, which is slightly lower than 
reported national percentages - 92% of the US population according to the 2018 US Census (US 
Census Bureau, 2019). The mean self-reported health score of participants was 3.08, suggesting 
that on average, the respondents were of “good” health.  
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Table 2-1 Demographic descriptive statistics 
Table 2.1 Demographic descriptive statistics (N = 1841)  
  
N 
Frequency 
(weighted) 
Sex   
 Male 903 49.05%  
 Female 938 50.95% 
Age   
 18-29 227 12.33% 
 30-44 554 30.09% 
 45-59 483 26.24% 
 60+ 577 31.34% 
Race/Ethnicity   
 White 1086 58.99% 
 Black, NH 273 14.83% 
 Other, NH 30 1.63% 
 Hispanic 358 19.45% 
 Multiracial, NH 47 2.55% 
 Asian, NH 47 2.55% 
Education   
 Less than High School 73 3.97% 
 High School 317 17.22% 
 Some college 841 45.68% 
 BA or above 610 33.13% 
Income   
 Less than $60,000 1082 58.77% 
 $60,000 or greater 759 41.23% 
Employment   
 Employed 1112 60.40% 
 Not employed 87 4.73% 
 Retired 373 20.26% 
 Disabled/Other 269 14.61 
Insured   
 Is insured 1638 88.97% 
 Is not insured 203 11.03% 
Self-reported health   
 Range: 1 (Poor) to 5 (Excellent)  Mean: 3.08 
(SD=0.92) 
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2.4.2 Public Comfort with Sharing Healthcare Data with Third-party Commercial 
Companies 
Public comfort with sharing health data with third-party commercial companies was 
evaluated using two three-item indices: 1) comfort with sharing health data with third-party 
commercial companies for patient purposes (for themselves and for others), and 2) comfort with 
sharing health data with third-party commercial companies for business purposes (Table 1.2). 
The resulting mean of comfort with sharing data with third-party commercial companies for 
patient purposes was 2.54 (SD = 0.81) or between “somewhat comfortable” and “fairly 
comfortable”. Roughly half of participants indicated that they were either fairly for very 
comfortable sharing data with third-party commercial companies for patient purposes (53.39% 
are comfortable with a third-party commercial company using their DNA and health information 
to improve the diagnosis and treatment of cancer in other patients, 49.16% are comfortable with 
third-party commercial companies developing predictions about how they will respond to a 
particular cancer treatment, and 47.80% believe that the organizations that have their health 
information and share it can use large amounts of data to improve patient care). Comfort with 
sharing health data with third-party commercial companies for business purposes had a resulting 
mean of 1.93 (SD = 0.85) or “somewhat comfortable”. One quarter to one third of participants 
indicated they were either fairly or very comfortable with each of the component questions in 
comfort with sharing health data third-party commercial companies for business purposes 
(29.90% are comfortable with a third-party commercial company storing their DNA and health 
information, 31.02% are comfortable with a third-party commercial company sharing predictions 
about how they will respond to cancer treatment with insurance companies, and 24.39% are 
comfortable with a third-party commercial company selling de-identified health information to a 
pharmaceutical company). Figure 1 shows the distributions of the two indices. 
 
A paired t-test was conducted on both comfort indices, the results of which show that 
there is a statistically significant difference between comfort with sharing health data with third-
party commercial companies for patient purposes and comfort with sharing health data with 
third-party commercial companies for business purposes only, paired 𝑡 = 39.84,𝑝 < 0.001.  
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Figure 2-2 boxplot of public comfort sharing health data with third-party commercial companies for patient purposes (blue) and 
for business purposes (red) 
 
Table 2-2 Descriptive statistics for survey questions used in indices measuring comfort with sharing health data with third-party 
commercial companies for patient purposes and business purposes 
Table 2.2 Descriptive statistics for survey questions used in indices measuring comfort with sharing 
health data with third-party commercial companies for patient purposes and comfort with sharing 
health data with third-party commercial companies for business purposes. (N = 1841) 
 
 
 
 
Frequency 
(% fairly or very 
comfortable/ fairly 
or very true) 
 
 
 
Mean (SD) 
Comfort with Sharing Health Data with Third-Party 
Commercial Companies for Patient Purposes 
  
How comfortable are you with a third-party commercial 
company using your DNA and health information to improve 
the diagnosis and treatment of cancer in other patients?  
53.39% 2.58 (1.05) 
How comfortable are you with a third-party commercial 
company developing predictions about how you will respond to 
a particular cancer treatment? 
49.16% 2.48 (1.02) 
The organizations that have my health information and share it 
can use large amounts of data to improve patient care  
47.80% 2.56 (0.86) 
Comfort with sharing health data with third-party commercial 
companies for patient purposes index (Cronbach’s a=0.769) 
Median: 2.67 2.54 (0.81) 
Comfort with Sharing Health Data with Third-Party 
Commercial Companies for Business Purposes 
  
How comfortable are you with a third-party commercial 
company storing your DNA and health information?  
28.90% 1.98 (1.01) 
How comfortable are you with a third-party commercial 
company sharing predictions about how you will respond to 
cancer treatment with insurance companies?  
31.02% 2.00 (1.04) 
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How comfortable are you with a third-party commercial 
company selling de-identified health information to a 
pharmaceutical company?  
24.39% 1.81 (1.01) 
Comfort with sharing health data with third-party commercial 
companies for business purposes index (Cronbach’s a=0.786) 
Median: 1.67 1.93 (0.85) 
* Range of indices: 1 = not comfortable sharing health data with third-party commercial companies; 2 = 
somewhat comfortable sharing health data with third-party commercial companies; 3 = fairly 
comfortable sharing health data with third-party commercial companies; 4 = very comfortable sharing 
data with third-party commercial companies 
 
2.4.3 Perceived Healthcare Access 
The resulting mean index score for the perceived healthcare access index was 2.82 
(SD=0.75), which corresponds to “fairly true” for these questions, indicating fairly high 
confidence in participants’ ability to access healthcare services at a satisfactory level. One-third 
(37.48%) of participants responded that it was fairly or very true that the healthcare system in the 
United States is easy to use, 70.23% responded that it was fairly or very true that they could get 
the healthcare they needed when they needed it, 62.42% responded that it was fairly or very true 
that they get all the information they needed about their health from their healthcare provider, 
67.19% of participants responded that it was fairly or very true that they could access their 
electronic health record if they wanted to, and 73.01% of participants responded that it was either 
fairly or very true that they were satisfied with the treatment they received from their healthcare 
provider.  
 
Table 2-3 Descriptive statistics for survey questions used in indices measuring Perceived Healthcare Access 
Table 2.3 Descriptive statistics for survey questions used in indices measuring Perceived Healthcare 
Access (N=1841)   
 Frequency 
(% fairly or very 
true) 
 
 
Mean (SD) 
Perceived Healthcare Access Index   
The healthcare system in this country is easy to use 37.48% 2.22 (0.98) 
I can get the healthcare I need when I need it 70.23% 3.02 (0.95) 
I get all the information I need about my health from my 
healthcare provider 
62.42% 2.82 (0.97) 
I could access my electronic health record if I wanted to  67.19% 2.99 (1.06) 
In general, I am satisfied with the treatment I receive from my 
healthcare provider 
73.01% 3.04 (0.92) 
Healthcare Access index (Cronbach’s a=0.820) Median: 2.8 2.82 (0.75) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
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2.4.4 Privacy Concerns 
Participant attitudes toward privacy were assessed using a four-item index (Table 1.3) 
examining various facets of privacy in healthcare. Just over half of participants (52.69%) 
responded that it was fairly or very true that their healthcare system respected their privacy, 
35.58% responded that it was fairly or very true that they were worried health information could 
be used against them, 40.96% of participants indicated that it was fairly or very true that they 
worried their health information is being inappropriately accessed, and 24.12% responded that it 
was fairly or very true that they would withhold certain types of information from their care 
providers because of a lack of trust. One item in the index, “my healthcare system respects my 
privacy” was reversed so that higher Privacy Index scores consistently indicated greater privacy 
concerns. The resulting mean privacy attitudes index score was 2.22 (SD=0.78), or a privacy 
confidence of “somewhat true”.  
 
Table 2-4 Descriptive statistics for survey questions measuring privacy concerns 
Table 2.4 Descriptive statistics for survey questions measuring privacy concerns (N=1841)  
 
 
 
Frequency 
(% fairly or very 
true) 
 
 
 
Mean (SD) 
Privacy Index*   
My healthcare system respects my privacy**  52.69% 2.63 (0.91) 
I worry that private information about my health could be used 
against me 
35.58% 2.22 (1.07) 
I worry my health information is available to people who have 
no business seeing it 
40.96% 2.38 (1.05) 
There are some things I would not tell my healthcare providers 
because I can’t trust them with the information 
24.12% 1.89 (1.00) 
Privacy index (Cronbach’s a=0.771) Median: 2.25 2.22 (0.78) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
** This question has been reversed-scored for inclusion in this index 
 
2.4.5 Univariate Model 
Examination of comfort with sharing health data with commercial companies for patient 
and business purposes by demographic variables and privacy attitudes display slight increases 
and statistically significant differences in comfort with sharing health data with commercial 
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companies according to age, with participants between the ages of 45-59 indicating decreased 
comfort with sharing health data with third-party commercial companies for patient purposes 
compared to other age groups (𝑏∗ = −0.102,𝑝 = 0.032). Education displayed a small trend, 
with comfort with sharing health data with third-party commercial companies for patient 
purposes increasing as education increased (possession of a bachelor’s degree: 𝑏∗ = 0.197,𝑝 =0.002). Examination of privacy attitudes and comfort with sharing health data with third-party 
commercial companies reveals that as privacy concerns increase, comfort with sharing health 
data with third-party commercial companies for both patient (𝑏∗ = −0.260,𝑝 = 1.9 ∗ 1089:) 
and business purposes (𝑏∗ = −0.264,𝑝 = 5.7 ∗ 1089:) decreases.  
 
Table 2-5 Univariate associations for demographic factors, perceived healthcare access, and privacy concerns with comfort with 
sharing health data with third-party commercial companies for patient and business purposes 
Table 2.5 Univariate associations for demographic factors, perceived healthcare access, and privacy 
concerns with comfort with sharing health data with third-party commercial companies for patient purposes 
and business purposes (N=1841) 
 Patient Purposes 
(univariate) 
Business Purposes 
(univariate) 
 b* p-value 𝑅< b* p-value 𝑅< 
Demographics       
Sex        
 Male ref   ref   
 Female -0.037 0.25 0.001 -0.042 0.20 0.002 
Age       
 18-29 ref   ref   
 30-44 -0.078 0.085 0.007 -0.035 0.49 0.005 
 45-59 -0.102 0.032  -0.091 0.087  
 60+ -0.029 0.53  -0.027 0.61  
Race/Ethnicity       
 White ref   ref   
 Black, NH -0.028 0.37 0.005 0.034 0.31 0.005 
 Other, NH -0.029 0.38  -0.014 0.64  
 Hispanic -0.062 0.067  0.021 0.55  
 Multiracial, NH -0.031 0.29  -0.039 0.15  
 Asian, NH 0.004 0.90  0.039 0.28  
Education       
 Less than High School ref   ref   
 High School 0.098 0.14 0.014 0.001 0.99 0.011 
 Some college 0.126 0.034  -0.045 0.55  
 BA or above 0.197 0.002  -0.117 0.14  
Income       
 Less than $60,000 ref   ref   
 $60,000 or greater 0.059 0.069 0.003 -0.028 0.41 0.001 
Employment       
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 Employed ref   ref   
 Not employed 0.032 0.32 0.003 0.087 0.13 0.009 
 Retired 0.022 0.44  0.014 0.63  
 Disabled/Other -0.037 0.29  -0.034 0.28  
Insured       
 Has insurance ref   ref   
 Does not have insurance -0.060 0.057 0.004 0.021 0.46 0.001 
Self-reported health       
 Poor ref   ref   
 Fair 0.013 0.84 0.012 0.010 0.88 0.003 
 Good 0.043 0.57  0.062 0.38  
 Very Good 0.073 0.29  0.010 0.88  
 Excellent 0.119 0.021  0.022 0.67  
Perceived Healthcare Access Index       
 Perceived Healthcare Access 0.204 6.0*10-10 0.041 0.154 3.8*10-06 0.024 
Privacy Concerns       
 Privacy Concerns -0.260 1.9*10-14 0.068 -0.264 5.7*10-14 0.070 
        
b* = standardized beta 
 
2.4.6 Stepwise regression models 
Demographic predictors of comfort with sharing health data with third-party commercial 
companies for patient purposes show that in the multivariable model, 11% of the variability can 
be explained by demographic differences, perceived healthcare access, and attitudes towards 
privacy in the Bonferroni-corrected stepwise regression model. Five variables remained in the 
final regression model for comfort with sharing health data with third-party commercial 
companies for patient purposes: sex, age, education, perceived healthcare access, and privacy 
concerns. Possession of a bachelor’s degree was the strongest demographic predictor of 
increased comfort with sharing health data with third-party commercial companies for patient 
purposes (b*=0.205, p=0.0009). Examination of demographic predictors of public comfort with 
sharing health data with third-party commercial companies for business purposes show that in 
the multivariable model, 10% of variability can be explained by demographic differences, 
perceived healthcare access, and attitudes towards privacy. In the Bonferroni-corrected stepwise 
regression model, five variables remained in the final business purpose model: sex, education, 
employment, perceived healthcare access, and privacy concerns, which displayed the strongest 
association with comfort with sharing health data with third-party commercial companies for 
business purposes. As privacy concerns decreased, comfort with sharing health data with third-
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party commercial companies increased for both patient purposes (b*=-0.223, p=6.9 ∗ 1089=) and 
business purposes (b*=-0.246, p=4.5 ∗ 1089<).  
 
Table 2-6 Stepwise regression modeling of predictors of comfort with sharing health data with third-party commercial companies 
for patient and business purposes 
Table 2.6 Stepwise regression modeling of predictors of comfort with sharing health data with 
third-party commercial companies for patient purposes and comfort with sharing health data with 
third-party commercial companies for business purposes (N=1841) 
 Patient Purposes 
Multivariable stepwise  
Bonferroni corrected  
(𝛼 =	0.002) 
 Business Purposes 
Multivariable stepwise  
Bonferroni corrected  
(𝛼 =	0.002) 
 Model 𝑅< 0.1117  Model 𝑅< 0.0978 
      
 b* p-value  b* p-value 
Sex      
Male ref   ref  
Female -0.056 0.062  -0.064 0.037 
Age      
18-29 ref     
30-44 -0.104 0.02    
45-59 -0.154 0.0012    
60+ -0.117 0.012    
Education      
Less than High School ref   ref  
High School 0.089 0.16  -0.040 0.62 
Some college 0.133 0.021  -0.069 0.37 
BA or above 0.205 9.0*10-4  -0.145 0.079 
Employment      
Employed    ref  
Not employed    0.071 0.034 
Retired    -0.037 0.22 
Disabled/Other    -0.060 0.053 
Perceived Healthcare Access 
Index 
     
Perceived Healthcare Access 0.140 5.4*10-5  0.070 0.051 
Privacy Concerns Index      
Privacy Concerns -0.223 6.9*10-10  -0.246 4.5*10-12 
      
b* = standardized beta 
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2.5 Discussion 
To better understand the public’s comfort with sharing health data with third-party 
commercial companies, this study sought to examine differences in comfort with sharing health 
data for patient purposes and comfort with sharing health data for business purposes, and identify 
the demographic variables that contribute to increased or decreased public comfort with sharing 
health data with third-party commercial companies. We also examined the relationship between 
privacy attitudes and comfort with sharing health data with commercial companies. Survey 
results revealed significantly less comfort with sharing health data with commercial companies 
for business purposes than patient purposes.  
 
Although demographic factors had a modest effect on the public’s comfort with sharing 
health data with third-party commercial companies; sex, age, education, and employment 
emerged as significant demographic variables when modeled using stepwise regression. Notably, 
self-reported health status  did not persist in the final model presented here, despite the 
significance of healthcare status in other studies (K. K. Kim et al., 2017; Tikoo, 2014; Weitzman 
et al., 2010). One of the most significant findings of this study is that comfort with sharing health 
data with commercial companies for patient purposes increased with educational attainment, and 
that comfort with sharing health data with commercial companies for business purposes 
decreased with educational attainment. Although previous studies have identified an inverse 
relationship between willingness to share information and education, this study reveals that 
communicating the patient-centered motives for sharing health information with third-party 
commercial companies may reverse that trend. Perceived healthcare access was strongly 
associated with comfort with sharing health data with third-party commercial companies for 
patient purposes, likely indicating that ease of access, and the overall sense that one’s own needs 
are being adequately met, increases personal motivation to extend that care to others as well. It is 
also likely that individuals with high healthcare satisfaction are more empowered consumers of 
healthcare resources and feel a greater sense of agency and control over their health data and 
healthcare experience.  
 
Decreased privacy concerns or decreased worry about how healthcare data is used was 
associated with increased comfort with sharing health data with third-party commercial 
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companies and remained in the final stepwise regression model. In the privacy concerns index, 
we asked patients whether it was very or not true that the healthcare system respected [their] 
privacy. Interestingly, only half of participants indicated that it was either fairly or very true that 
the healthcare system respected [their] privacy. Patient privacy is of paramount importance in 
healthcare, with HIPAA representing one of the few examples of comprehensive privacy law 
worldwide. That only 52.69% participants feel respected in this way indicates the gap between 
what we have been able to provide patients with regard to their privacy and what they require 
now amidst this rapidly developing computing and big data environment. One third of 
participants (35.58%) indicated their concern that private information about their health could be 
used against them, and 40.96% of participants indicated concern that their health information 
was available to people who had no business seeing it. Alleviation of these fears of abuse can 
decrease privacy concerns and increase comfort with sharing health data with third-party 
commercial companies. 
 
2.5.1 Implications for research 
Healthcare research is rapidly becoming dependent on the large data sets provided by 
electronic personal health information (ePHI). Data partnerships with companies like Google are 
increasingly being sought in order to expand the data processing and research capabilities of 
healthcare systems. At a minimum, this research indicates the importance of promoting the 
patient-centered benefits of these partnerships at not only their announcement, but at their 
inception. Although healthcare systems anticipate tremendous benefits to their patients in the 
creation of these partnerships, it should not be assumed that the public automatically perceives 
these partnerships to be beneficial. While improvements to business efficiency and processes 
will in turn likely benefit patient care, this research indicates that these connections are too 
abstract for patients and should be made more explicit. The large difference between comfort 
with sharing data with commercial companies for business versus patient purposes suggests a 
need for further interrogation of the different predictors of these variables and deeper 
examination of the meaning the public has ascribed to commercial companies.  
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2.5.2 Implications for policy and practice 
In this research we found that a little over half of respondents (52.69%) felt that “[their] 
healthcare system respects [their] privacy”, and that the total privacy concerns index accounted 
for just over 20% of public comfort with sharing health data with third-party commercial 
companies for both patient and business purposes in the stepwise regression model presented in 
this analysis. That the public feels so inadequately protected signals an urgent need to reassess 
the privacy laws and regulations of healthcare, and to take quick steps to differentiate the manner 
in which healthcare systems use personal health information from the manner in which personal 
data is used in other industries. One possibility is to consider nationwide adoption of the Texas 
Medical Privacy Act, which is one of the broadest and most strict medical privacy laws in the 
United States. Under the Texas Medical Privacy Act, 1) any organization that assembles, 
collects, stores, or transmits PHI, or 2) comes into possession of PHI, is subject to HIPAA 
(Solove & Schwartz, 2019). Texas adds the additional prohibition of re-identifying de-identified 
data under any circumstance (Luna, 2011). As third-party partnerships proliferate, application of 
HIPAA to only covered entities requires reexamination.  
 
2.5.3 Limitations 
As with any survey, this study is merely a snapshot of patient beliefs and preferences, 
limited due to the nature of survey questions – other aspects of patient and public privacy 
concerns, perceived healthcare access, and health that may provide a more complete portrait of 
the public’s comfort with sharing health data with third-party commercial companies may not be 
captured here. Additionally, a stepwise regression model is a conservative model that eliminates 
factors that might be important to understanding patient and public comfort with sharing health 
data with third-party commercial companies.  
 
The circumstances of data sharing and the privacy context in which that sharing will 
occur will continue to evolve as laws, expectations, and experiences of healthcare data sharing 
change. Longitudinal studies that evaluate changes in comfort with sharing health data with 
third-party commercial companies would be superior, especially in light of changing media 
coverage of these partnerships. In subsequent research, we will examine a sampling of media 
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events and their potential effect on comfort with sharing health data with third-party commercial 
companies.  
 
2.5.4 Conclusion 
This study revealed that educational attainment is associated with increased comfort with 
sharing health data with third-party commercial companies for patient purposes and decreased 
comfort with sharing health data with third-party commercial companies for business purposes, 
and privacy concern is strongly associated with less comfort with sharing health data with third-
party commercial companies for both patient and business purposes. This study also revealed 
differences in comfort with sharing health data with third-party commercial companies explicitly 
patient centered purposes versus business purposes with no explicitly stated patient benefit. 
Healthcare systems embarking on new third-party data partnerships to expand their ability to 
process and analyze health data can benefit from early identification and communication of the 
patient-centered benefits that will result from their third-party commercial partnerships. 
Healthcare systems can do more to provide reassurances that healthcare privacy will be 
protected, for example: communicating data protection efforts to the public at the time a new 
third-party partnership is announced, proactive acknowledgement of privacy concerns as privacy 
breaches unfold, and frequent communication of what healthcare systems are doing to mitigate 
privacy risks. More research is needed on attitudinal dimensions related to privacy (trust, 
comfort with researchers, quality analysts, and commercial companies, protections and 
notification of data access) to better understand comfort with sharing health data with third-party 
commercial companies for patient and business purposes.   
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Chapter 3 Trust in the Health System, Privacy Concerns, and The Public’s Comfort with 
Sharing Health Data with Third-Party Commercial Companies 
 
3.1 Abstract 
Background:  Healthcare systems are partnering with third-party commercial companies to 
provide novel data processing and analysis capabilities that are critical to realizing the goals of 
learning health systems. These partnerships, however, provide personal health information to a 
for-profit industry that may store and sell data and the public may not be comfortable with such 
transactions.  
  
Objective: To describe the public’s comfort sharing health data with third-party commercial 
companies for patient purposes versus sharing of health data with third-party commercial 
companies for business purposes, and how comfort with both purposes is associated with 
attitudes towards trust in the health system, trust in healthcare providers, altruism, privacy 
concerns, past experience with a data breach, and concern about recent events involving 
data breaches or third-party data partnerships in healthcare. 
  
Methods: We analyzed the results of a nationally representative sample of US residents 
responding to a survey (n = 1841) containing questions about their comfort sharing health data 
with third-party commercial companies for patient or business purposes. We assessed whether 
there was a difference between comfort with these two types of health data sharing and then used 
univariable and stepwise regression modeling to estimate the relationship between comfort with 
third-party commercial companies for patient and business purposes (outcomes) and trust in the 
health system, trust in providers, altruism, privacy, personal experience regarding a data breach, 
and concern about recent news events (independent variables). Also included are demographic 
factors, perceived healthcare access, and self-reported health status.  
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Results: Trust in the health system exhibited the strongest association with comfort sharing 
health data with third-party commercial companies for both patient purposes (𝑏∗ = 0.367, 𝑝 =4.6 ∗ 108<=) and business purposes ( 𝑏∗ = 0.326, 𝑝 = 4.7 ∗ 1089?), followed by trust in 
providers (patient purposes: 𝑏∗ = 0.139,𝑝 = 1.6 ∗ 108:); business purposes: 𝑏∗ = 0.218, 𝑝 =6.4 ∗ 108@) and privacy concerns (patient purposes: 𝑏∗ = −0.110,𝑝 = 0.002); business 
purposes: 𝑏∗ = −0.115, 𝑝 = 0.001). Education was strongly associated with comfort sharing 
health care data with third party commercial companies for patient purposes only (possession of 
college degree: 𝑏∗ = 0.298, 𝑝 = 2.6 ∗ 108A). Among our experience variables and concerns 
about recent events, past experience with a data breach was not associated with either comfort 
sharing data with third-party commercial companies for patient or business purposes. Concern 
about the Memorial Sloan Kettering Cancer Center start up, Paige.AI, however, was negatively 
associated with comfort sharing health data with third-party commercial companies for business 
purposes (𝑏∗ = −0.139, 𝑝 = 5.4 ∗ 108A).  
 
Conclusions: For both patient and business purposes, trust in the health system was the strongest 
predictor of comfort with sharing health data with third-party commercial companies. This 
finding suggests that regardless of the privacy controls and assurances put in place, if the health 
system at large is not trusted by the patient, increased comfort with and widespread support of 
third-party commercial company partnerships will not be forthcoming.  
 
3.2 Introduction 
3.2.1 Background 
The healthcare transition to electronic health records (EHRs) and health information 
exchanges (HIE) has opened the possibility of big data insights into health outcomes and rare 
diseases that were not before conceivable. To accelerate the progress of data-driven discoveries, 
health systems are increasingly turning to third-party commercial companies to expand on 
limited in-house data analysis capabilities and take advantage of the expertise and processing 
power of large, established data companies like Amazon and Google. These partnerships, 
however, have been met by the general public with reluctance to participate (Huang, 2018) and 
concerns about health data privacy (Griggs, 2019).  
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In September 2018, Memorial Sloan Kettering Cancer Center encountered public and 
media opposition when their health data startup partnership, Paige.AI, was announced to the 
public (Ornstein & Thomas, 2018). A former Sloan Kettering patient wrote an open letter in 
response, expressing the “betrayal of trust” and unease that patient tissue was “being 
commercialized without our consent” (Petrow, 2018). One year later, in November 2019, Google 
announced “Project Nightingale”—a large scale data partnership with Ascension, one of the 
largest healthcare systems in the United States (Singer & Wakabayashi, 2019). As of this 
writing, Project Nightingale has been stymied by bi-partisan senatorial demands for the details of 
their data sharing partnership and an investigation by the Health and Human Services’ (HHS) 
Office for Civil Rights (OCR) to examine the “mass collection of individuals’ medical records 
with respect to the implications for patient privacy under HIPAA” (Cohen, 2019).  
 
Both of these health data partnerships were done in compliance with existing HIPAA 
regulations – both healthcare systems submitted their projects to their respective Institutional 
Review Boards, and both were approved (Ornstein & Thomas, 2018; Shaukat, 2019). At the time 
the Ascension partnership was announced, Google was already in the midst of a lawsuit brought 
by a University of Chicago medical student for the use of patient data that was allegedly not de-
identified (Moon, 2019) and was grappling with the growing perception that the company cared 
little about people’s privacy (Porter, 2019; Turow, 2017). However, large healthcare data 
projects such as these are neither unusual nor novel. HIPAA has long permitted healthcare 
systems and EHR vendors to share and sell de-identified data to third-party commercial 
companies. Microsoft holds established data partnerships with healthcare systems and insurers 
including the University of Pittsburgh Medical Center and Premera Blue Cross intended to 
advance artificial intelligence (AI) healthcare initiatives for cancer care (P. Lee, 2017; Roach, 
2019; Vincent, 2016). Since 2012, IBM has had access to 1.5 million Sloan Kettering patient 
records to explore better cancer treatments (Chen, 2018; Memorial Sloan Kettering Cancer 
Center, 2014; Vincent, 2016). These partnerships were not subjected to the same scrutinizing 
media response as was Project Nightingale or Paige.AI—news coverage and presentation of 
these projects expressed hope for progress and discovery as opposed to concerns about data 
security and violations of patient data use.  
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The backlash endured by Google, Sloan Kettering, and Ascension Healthcare follow on 
the heels of data breaches in other sectors – in the years preceding Google and Ascension’s 
partnership announcement, the Equifax data breach in 2017 compromised personal and financial 
data of 143 million people (Fruhlinger, 2020); the Marriot data breach compromised the data of 
500 million people (Gressin, 2018); and Facebook was in the midst of the Cambridge Analytica 
scandal in which the data of 87 million people was used for enhanced political profiling without 
their consent (Chang, 2018). These events may have fundamentally shifted the public’s privacy 
concerns, in turn affecting patient attitudes toward data sharing with third-party commercial 
companies beyond the purposes of direct clinical care.  
 
Third-party commercial companies are those companies that fall outside of usual 
“covered entities”, covered entities being healthcare systems or providers who transmit any 
health information, health care plans, and health care clearinghouses (billing services, 
community health information systems, etc.) (Office for Civil Rights (OCR), 2013). 
Traditionally, “third-party” referred to administrators or payors of healthcare expenses—
intermediaries that network with other providers and systems to fairly price medical billing 
claims or facilitate in some other capacity tasks critical to the administration of a health system. 
More recently, however, “third-party” has also come to refer to companies that purchase de-
identified health data from providers, payors, and pharmacies in order to gain market strategy 
insights (Arndt, 2018). The business of third-party medical data trading has exploded, with some 
companies leading this field making over $2 billion in revenue in one year alone (Tanner, 2016). 
Once a data transaction is completed between a covered entity and a third-party commercial 
company, that company is then able to re-sell this de-identified information on the secondary 
data market. The chosen partners of these healthcare systems may simply the least trusted of all 
and will continue to endure criticism and greater concern. Media coverage of Amazon, 
Facebook, and Google and the general public’s trust or mistrust of these companies have 
included variations on “tax-avoiding, soul-sucking machine[s]” (Galloway, 2018), evidencing 
growing fissures in the public’s trust towards these companies and possibly the healthcare 
systems that partner with them.  
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3.2.2 Problem Statement 
The consequences of violating or being perceived to violate patient privacy can include 
decreased organizational trust, decreased customer loyalty, and decreased patient candor with 
their provider (Agaku et al., 2014; Shen et al., 2019). Research in pursuit of privacy approaches 
that assuage or meet the concerns of patients has not resulted in conclusive recommendations 
about how to manage data privacy expectations in healthcare. Studies have found that patients 
and the public are generally of two minds: there is widespread willingness to share health data 
for the benefit of others, yet concerns persist about the security of health data that is used for 
research and further, that the data will be used for profit-driven motives instead of patient care 
(Stockdale et al., 2019). Deeper exploration of the public’s comfort with sharing health data with 
third-party companies and the relationship of this comfort with the public attitudes - privacy, 
trust, altruism - and the impact on recent events (data breach, concern about recent events) is 
needed to better understand how healthcare systems can mitigate, manage, or prevent negative 
reactions towards existing or future data partnerships.  
 
3.2.3 Conceptual Model 
 
Figure 3-1 Conceptual Model of Dissertation Research – this analysis is focused on attitude measures and impact of recent 
events 
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Outcomes of interest: comfort with sharing data with commercial companies for business and 
patient purposes 
In this analysis we examine the public’s comfort with sharing health data with third-party 
commercial companies, investigating comfort when data is shared for patient purposes, i.e., to 
improve care, diagnosis, or treatment, versus comfort when data is shared for business purposes 
such as selling de-identified data. This division of patient-focused versus business-focused health 
data sharing allows for examination of the effect of stated purpose on the public’s comfort with 
sharing health data with third-party commercial companies. Previous research indicates patients 
are more willing to provide access to their health information if the potential health benefits are 
clear (Anderson & Agarwal, 2011), and are less willing to provide access if their health data will 
be used for profit-generating research (Willison et al., 2009). In a study of US veterans, 
participants expressed to the study team that research studies must have “high value with an 
‘overall impact on society’ and not be ‘an academic exercise’” (Damschroder et al., 2007). We 
thus separate sharing of health data with third-party companies for patient-focused purposes from 
more general business purposes to examine and then compare participant’s comfort sharing 
health data with third-party commercial companies.  
In this paper, we consider the attitudes (trust, altruism, privacy concerns) and experiences 
(e.g., previous data breach) that may be associated with comfort sharing health data with third-
party commercial companies.  
 
Attitudes: Trust in the Health System and Trust in Providers 
Trust, or the willingness to accept vulnerability to the actions of others (Richards & 
Hartzog, 2015), has been shown to increase the likelihood patients will participate in research 
(Kim et al., 2017) and is a strong predictor of attitudes and behaviors in other areas such as 
online shopping (Wang & Tseng, 2011), customer loyalty (Kantsperger & Kunz, 2010), and self-
disclosure on social media (Fogel & Nehmad, 2009; Taddei & Contena, 2013). While there are a 
number of approaches to defining and examining trust, four high level categories have been most 
frequently used to capture the dimensions of trust: benevolence, integrity, competency, and 
predictability or fidelity (McKnight & Chervany, 2001). Benevolence means “caring and being 
motivated to act in one’s interest rather than acting opportunistically”; integrity means “making 
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good faith agreements, telling the truth, and fulfilling promises”; competence means “having the 
ability or power to do for one what needs to be done”; and predictability means “trustee actions 
that are consistent enough to be forecasted” (McKnight & Chervany, 2001). Existing research on 
trust, privacy, and control of information have differed in their results on the mediating or 
moderating relationship between each. Some have found that trust is the commanding variable, 
reducing privacy concerns and increasing willingness to share personal information overall 
(Fogel & Nehmad, 2009), while others have found that privacy is actually the commanding 
variable, increasing trust and leading to greater disclosure of personal information (Krasnova et 
al., 2010).  
 
Attitudes: Privacy Concerns 
Surveys of the public’s general attitude toward privacy have consistently found that 
people are concerned about their personal privacy. Many of these same studies have also found, 
however, that if the stated benefits of disclosure are attractive enough, individuals are willing to 
suspend privacy concerns for the benefits promised in exchange for disclosure. In the consumer 
sector, loyalty points, shopper discount cards, and customer accounts are reliant on this 
suspension of privacy concerns in exchange for monetary benefits or for convenience. This 
tradeoff calculus has also been shown in healthcare. While privacy is of paramount concern in 
healthcare, patients are more willing to share health information for research purposes if the 
benefits of participation for themselves or for the greater good are clear (Damschroder et al., 
2007). This willingness to share health information is, however, still modified by general privacy 
concerns; even when the patient benefits are clear, individuals with greater privacy concerns 
express greater reluctance to share data than those with less privacy concerns (Anderson & 
Agarwal, 2011).  
 
Attitudes: Altruism 
Altruism is the prioritization of the needs of others even though no direct benefit may be 
conferred onto the individual. Individuals who consider themselves altruistic place high value on 
how their efforts may contribute to the well-being of others. As was stated earlier, studies on 
patient willingness to participate in healthcare research find that individuals are more willing to 
participate in research studies if their participation would help a friend or relative or has the 
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potential to benefit society (Doukas & Hardwig, 2014; Reynolds & Nelson, 2007; Shavers et al., 
2001).  
 
Impact of Data Breaches and Concern about Recent Events 
In a study of healthcare data breaches, healthcare systems lost a reported average of $408 
per record due to detection efforts, notification, legal expenditures and fines, and lost business 
(Ponemon Institute, 2018). This same study found that healthcare organizations worldwide lost 
customers as a result of data breaches. Studies of data breaches in other sectors have found 
similar effects. Research on online shopping behavior found that in the wake of a data breach, 
customers engage in protective behaviors that include avoiding the online store entirely or 
doubling-down on protective monitoring efforts to mitigate any issues that might arise due to 
compromised personal information (M. Lee & Lee, 2012). Similar patterns of decreased 
customer retention were also identified in a 2002 examination of hotel data breaches – a data 
breach event resulted in changes to the offline behavior of customers who reported being less 
willing to revisit and recommend that hotel (Belanger et al., 2002). Yet another study on the 
effect of data breaches found a negative and statistically significant impact on the market value 
of the breached companies (Acquisto et al., 2006). Research examining the effects of data breach 
events on comfort with sharing data with third-party commercial companies specifically has not 
yet been conducted to our knowledge.  
 
3.2.4 Study Objective 
The aims of this study are to examine the relationship between the public’s comfort with 
sharing health data with third-party commercial companies and the public’s attitudes regarding 
trust in the health system, trust in providers, privacy concerns, altruism, past experience with a 
data breach, as well as concern about recent data breaches or third-party data partnerships in 
healthcare. 
 
3.3 Methods 
Respondent comfort with sharing health data with third-party commercial companies was 
captured using a 20-minute online survey of US adults. In this section I explain how the concepts 
 77 
described above are operationalized in this survey, followed by an explanation of the statistical 
methods used to analyze this data.  
 
3.3.1 Participants 
Respondents were surveyed using the National Opinion Research Center’s (NORC) 
probability-based, nationally representative sample of US adults, based on 2010 Census 
Information. NORC’s national sample frame employs a two-stage probability sample design to 
select a representative sample of households in the United States, oversampling African 
American, Hispanic populations, as well as households 200% below the federal poverty level. 
Survey recruitment and deployment was done in May 2019. Data collection was completed by 
June 2019. Eligible participants (at least 21 years old and able to read and write in English) were 
contacted via email to participate in the online survey, resulting in a total of 2,157 participants 
(66% response rate). The first component of the survey was a short (90 seconds) animated video 
describing how health data of a fictional patient is shared through the duration of care—to 
insurers, billers, and analysts learning from the outcomes of treatment. Definitions of important 
terms such as “healthcare system”, “healthcare providers”, “electronic health record”, “de-
identified health information [or biospecimens]”, and “commercial companies” were provided to 
survey participants wherever those terms appeared. “Commercial companies” was defined for 
respondents to this survey as “third-party companies that are not part of a hospital. For example, 
a third-party commercial company may conduct genetic tests and analyze information for a 
hospital or healthcare provider for a fee when a hospital is not able to conduct the test on their 
own.”  “De-identified [health information or biospecimens]” was defined for respondents in the 
following manner: “de-identified means that “identifying information” about you is removed 
from your health information. Identifying information includes things like your name, address, 
date of birth, etc.”  
 
NORC calculated post-stratification weights according to US Census demographic 
benchmarks for age, sex, household income, education, as well as race and ethnicity to reduce 
sampling bias. For the purposes of this paper, records with missing responses to one or more of 
the questions used in this analysis were not included, resulting in a final analyzed sample of 
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1,841 responses. This study protocol was approved by the University of Michigan Health 
Sciences Institutional Review Board.  
 
3.3.2 Survey Design 
Variables used in this study were derived from a 20-minute, 164-item survey created to 
examine knowledge, attitudes, and beliefs about data sharing. Trust measures were adapted from 
the work of Mark Hall and colleagues (Hall, Camacho, et al., 2002; Hall et al., 2001; Hall, 
Zheng, et al., 2002). Altruism measures were adapted from the General Social Survey (Smith et 
al., 2019), the National Election Survey (Feldman & Steenbergen, 2001), and the General Self-
Efficacy Scale (Schwarzer & Jerusalem, 1992). Privacy measures were adapted from Anderson’s 
work on consumer willingness to disclose personal health information and the California Health 
Foundation’s 2005 National Consumer Health Privacy survey (Anderson & Agarwal, 2011; 
Bishop et al., 2005). Privacy measures also include questions about deception and medical 
mistrust (Boulware et al., 2003; LaVeist et al., 2009) and have been used in previous studies 
(Platt et al., 2018).  
 
3.3.3 Measures used in this study 
The Public’s Comfort with Sharing Health Data with Third-Party Commercial Companies for 
Patient and Business Purposes 
To explore public comfort with sharing health data with third-party commercial 
companies for patient purposes, respondents answered questions about “how comfortable” they 
were with three statements regarding data sharing with third-party commercial companies, each 
along a 4-point Likert scale. Participants were asked “How comfortable are you with a third-
party commercial company using your DNA and health information to improve the diagnosis 
and treatment of cancer in other patients?” and “How comfortable are you with a third-party 
commercial company developing predictions about how you will respond to a particular cancer 
treatment?: “not at all comfortable” (1), “somewhat comfortable” (2), “fairly comfortable” (3), 
and “very comfortable” (4). Participants were also asked “how true” it was that “The 
organizations that have my health information and share it can use large amounts of data to 
improve patient care”: “not true” (1), “somewhat true” (2), “fairly true” (3), and “very true” (4).  
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To examine participant comfort with sharing health data with third-party commercial 
companies for business purposes, participants were asked “How comfortable are you with a 
third-party commercial company storing your DNA and health information?”; “How comfortable 
are you with a third-party commercial company sharing predictions about how you will respond 
to cancer treatment with insurance companies?”; and “How comfortable are you with a third-
party commercial company selling de-identified health information to a pharmaceutical 
company?”. “Business purpose” in this research is understood as storage of health data beyond 
the purposes of clinical care and sharing information with third-party commercial companies to 
improve their own business processes without explicitly stated direct benefit to patients. 
Respondents were provided with the options “not at all comfortable” (1), “somewhat 
comfortable” (2), “fairly comfortable” (3), and “very comfortable” (4). Indices for data use for 
patient purposes and business purposes were then calculated as the sum of participant responses 
to the three questions in each index divided by the number of questions.  
 
The Cronbach’s alpha for these questions was 0.766 for comfort with sharing health data 
with third-party commercial companies for patient purposes and 0.786 for comfort with sharing 
health data for business purposes. 
 
Privacy Concerns 
To measure individual privacy concerns, respondent privacy attitudes were evaluated 
using a 4-item index. These questions assessed respondent’s beliefs about the privacy measures 
used by their healthcare system and whether they have concerns that personal health information 
about themselves is being misused or could be used in a way that is harmful. The component 
questions for the privacy index are: “a) My healthcare system respects my privacy; b) I worry 
that private information about my health could be used against me; c) I worry my health 
information is available to people who have no business seeing it; d) There are some things I 
would not tell my healthcare providers because I can’t trust them with the information”. Each 
item asked respondents to rate “how true” each was for themselves on a Likert-type scale 
ranging from 1 (not true) to 4 (very true). The final privacy index score reflects the average of 
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each participant’s response to these four questions. The Cronbach’s alpha was 0.771 for the 
questions used in the privacy concerns index.  
 
Trust in the Healthcare System 
Trust in the healthcare system, or system trust, is measured in this study using a modified 
version of the Platt et al. (2018) System Trust Index. The index was originally conceptualized as 
a composite index of three dimensions of system trust – competency, fidelity, and integrity (Platt 
et al., 2018). Component questions for the index asked participants to rate “how true” the 
following statements were “about the organizations that have your health information and share 
it”: “a) …try hard to be fair in dealing with others; b) …would try to hide a serious mistake they 
made; c) …would never mislead me about how my health information is used; d) … have 
specialized capabilities that can promote innovation in health; e) … can be trusted to use my 
health information responsibly; f) … think about what is best for me; and g) …act in an ethical 
manner”. Respondents rated “how true” each statement was for themselves on a Likert-scale 
ranging from 1 (“not true”) to 4 (“very true”). The final system trust index score reflects the 
average of the participant’s responses to each of these seven questions. The Cronbach’s alpha 
was 0.845 for questions contributing to the system trust index.  
 
Provider Trust 
Provider trust is evaluated here using a 4-item index assessing respondent’s trust in their 
healthcare providers. Component questions for this index are: a) “Health care providers care 
most about making money for themselves”; b) “Health care providers do not care about helping 
people like me”; c) “I trust health care providers to use my health information responsibly”; d) 
“All things considered, health care providers in this country can be trusted”. Each item asked 
respondents to rate “how true” each question was for themselves on a Likert scale ranging from 1 
(“not true) to 4 (“very true”). The final provider trust score is the total of each response divided 
by the number of questions for the index (4). The Cronbach’s alpha for the questions 
contributing to the provider trust index is 0.697. Provider trust questions were used in a previous 
study by Platt et al. (2019). 
 
Altruism 
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Respondent altruism is measured in this study using a 4-item index that asks “how true” 
the following questions are for the respondent on a Likert scale ranging from 1 (“not true”) to 4 
(“very true”): a) “I find ways to help others less fortunate than me”; b) “The dignity and well-
being of all should be the most important concern in any society”; c) “One of the problems of 
today’s society is that people are often not kind enough to others”; and, d) “All people who are 
unable to provide for their own needs should be helped by others”. Respondents’ altruism index 
scores are calculated as the average of their responses to these four questions. The Cronbach’s 
alpha is 0.711 for questions contributing to the altruism index.  
 
Experience of a past data breach 
To find out whether respondents had their data compromised in the past, and explore the 
impact this experience might have on the respondent’s comfort with sharing health data with 
third-party commercial companies, respondents were asked “Have you ever experienced 
problems with stolen or misused information?”. Response options to this question were a) “Yes – 
I am currently experiencing problems”; b) “Yes – but all problems have been resolved”; and c) 
“No – I have not experienced any problems within the past five years”. A second question was 
used to capture experience of a data breach: “I believe my financial information has been 
compromised as the result of a data breach or hacking”. For this question respondents could 
answer “yes” or “no”.  
 
Concern about recent events and breaches 
To evaluate the effect of recent data breaches or misuse of health information on comfort 
with sharing health data with third-party commercial companies, we selected a sample of recent 
events varying in industry and scale of impact and asked respondents “how concerned” they 
were about the following selection of events: a) “Concern about Facebook sharing information 
with Cambridge Analytica for political purposes”; b) “Concern about data breach of people’s 
social security numbers and driver’s license numbers at Equifax”; c) “Concern about Memorial 
Sloan Kettering hospital executives using hospital data for their own startup company”; d) 
“Concern about Marriot data breach of passport numbers and credit card numbers.” Respondents 
answered on a Likert-scale from 1 (“not at all concerned”) to 4 (“very concerned”).  
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3.3.4 Data Analysis 
For this analysis we first generated summary descriptive statistics on respondent 
characteristics (demographics), privacy concerns, system trust, provider trust, altruism, 
experience of a data breach and concern about recent events. A paired t-test examining the 
difference between comfort sharing health data with commercial companies for patient purposes 
and comfort sharing health data with commercial companies for business purposes was 
conducted to determine whether the difference between the two means is statistically significant.  
 
Weighted Ordinary Least Squares (OLS) Regression analysis was used to estimate the 
linear relationship between comfort with third-party commercial companies for patient and 
business purposes and each demographic and health variable separately. We then estimated a 
multivariable model with all demographic and health variables and conducted a stepwise 
regression model to identify a parsimonious set of variables that explained the greatest amount of 
variability in the two outcomes – comfort with sharing data with commercial companies for 
business or patient purposes.  For the stepwise regression model, we set statistical significance at 
a=0.05 (p<0.002) for inclusion and a=0.01 for exclusion, applying a Bonferroni correction to 
minimize Type I error. To enable comparison of effect sizes, regression coefficients were 
normalized (mean = 0, SD = 1).  
 
3.4 Results 
To examine predictors of comfort with third-party commercial companies using health 
information for patient and business purposes, we first examined the descriptive statistics for 
each of the independent variables and then conducted univariable and multivariable stepwise 
regression to identify predictors.  Statistical significance was set at the 0.05 level.  
 
3.4.1 Demographic descriptive statistics 
The resulting weighted sample of 1,841 participants shows a near even split between 
male and female participants (49% male). Approximately 12% of participants were under the age 
of 29, and 31% of participants were over the age of 60. Nearly 60% of participants identified as 
white non-Hispanic, 15% as black, non-Hispanic, 19% as Hispanic, 3% as Asian, non-Hispanic, 
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2% of participants identified race and ethnicity as “other”, and 3% identified as multiethnic, 
consistent with 2016 data from the US Census Bureau (12.3% of the US population identifies as 
black or African-American, non-Hispanic). Nearly half of participants completed some college 
(46%), and 33% of participants have a bachelor’s degree. While the proportion of participants 
with a bachelor’s degree is consistent with national percentages (30%, 2016 census data), the 
proportion of participants with some college, no degree is much higher in this study than national 
percentages (21%, 2016 census data). Just over half of participants (59%) made an income less 
than $60,000, consistent with the median household income for 2018 (Guzman, 2019). Over half 
of participants (60%) had employment. Of the health questions included in this analysis, 89% of 
study participants reported having health insurance of some type, which is slightly lower than 
reported national percentages - 92% of the US population according to the 2018 US Census (US 
Census Bureau, 2019). The mean self-reported health score of participants was 3.08, suggesting 
that on average, the respondents were of “good” health.  
 
Table 3-1 Demographic descriptive statistics 
Table 3.1 Demographic descriptive statistics (N = 1841)  
  
N 
 
Frequency 
Sex   
 Male 903 49.05%  
 Female 938 50.95% 
Age   
 18-29 227 12.33% 
 30-44 554 30.09% 
 45-59 483 26.24% 
 60+ 577 31.34% 
Race/Ethnicity   
 White 1086 58.99% 
 Black, NH 273 14.83% 
 Other, NH 30 1.63% 
 Hispanic 358 19.45% 
 Multiracial, NH 47 2.55% 
 Asian, NH 47 2.55% 
Education   
 Less than High School 73 3.97% 
 High School 317 17.22% 
 Some college 841 45.68% 
 BA or above 610 33.13% 
Income   
 Less than $60,000 1082 58.77% 
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 $60,000 or greater 759 41.23% 
Employment   
 Employed 1112 60.40% 
 Not employed 87 4.73% 
 Retired 373 20.26% 
 Disabled/Other 269 14.61 
Insured   
 Is insured 1638 88.97% 
 Is not insured 203 11.03% 
Self-reported health   
 Range: 1 (Poor) to 5 (Excellent)  Mean: 3.08 
(SD=0.92) 
    
 
2.4.2 Public Comfort with Sharing Healthcare Data with Third-party Commercial 
Companies 
Public comfort with sharing health data with third-party commercial companies was 
evaluated using two indices: 1) comfort with sharing health data with third-party commercial 
companies for patient purposes (for themselves and for others), and 2) comfort with sharing 
health data with third-party commercial companies for business purposes (Table 2.2). The 
resulting mean of comfort with sharing data with third-party commercial companies for patient 
purposes was 2.54 (SD = 0.81) or between “somewhat comfortable” and “fairly comfortable”. 
Roughly half of participants indicated that they were either fairly for very comfortable sharing 
data with third-party commercial companies for patient purposes as expressed by the component 
questions of the index: (53.39% are comfortable with a third-party commercial company using 
their DNA and health information to improve the diagnosis and treatment of cancer in other 
patients , 49.16% are comfortable with third-party commercial companies developing predictions 
about how they will respond to a particular cancer treatment, and 47.80%  believe that the 
organizations that have their health information and share it can use large amounts of data to 
improve patient care). Comfort with sharing health data with third-party commercial companies 
for business purposes had a resulting mean of 1.93 (SD = 0.85) or “somewhat comfortable”. One 
quarter to one third of participants indicated they were either fairly or very comfortable with 
each of the component questions in comfort sharing health data third-party commercial 
companies for business purposes (28.90% are comfortable with a third-party commercial 
company storing their DNA and health information, 31.02% are comfortable with a third-party 
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company sharing predictions about how they will respond to cancer treatment with insurance 
companies, and 24.39% are comfortable with a third-party commercial company selling de-
identified health information to a pharmaceutical company). Figure 3.2 shows the distributions of 
the two indices. 
 
A paired t-test was conducted on both comfort indices, the results of which show that 
there is a statistically significant difference between comfort with sharing health data with third-
party commercial companies for patient purposes and comfort with sharing health data with 
third-party commercial companies for business purposes only, paired 𝑡 = 39.84,𝑝 < 0.001.  
 
 
Figure 3-2 Box plot distributions of indices measuring Comfort Sharing Health Data with Third-Party Commercial Companies 
for Patient Purposes and Business Purposes 
 
Table 3-2 Descriptive statistics for survey questions used in indices measuring comfort sharing health data with third-party 
commercial companies for patient and business purposes 
Table 3.2 Descriptive statistics for survey questions used in indices measuring comfort sharing health 
data with third-party commercial companies for patient purposes and comfort sharing health data with 
third-party commercial companies for business purposes. (N = 1841) 
 
 
Frequency 
(% fairly or very 
comfortable/ fairly 
or very true) 
 
 
 
Mean (SD) 
Comfort Sharing Health Data with Third-Party Commercial 
Companies for Patient Purposes 
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How comfortable are you with a third-party commercial 
company using your DNA and health information to improve 
the diagnosis and treatment of cancer in other patients? (q27a) 
53.39% 2.58 (1.05) 
How comfortable are you with a third-party commercial 
company developing predictions about how you will respond to 
a particular cancer treatment? (q27b) 
49.16% 2.48 (1.02) 
The organizations that have my health information and share it 
can use large amounts of data to improve patient care (q35c) 
47.80% 2.56 (0.86) 
Comfort sharing health data with third-party commercial 
companies for patient purposes index (Cronbach’s a=0.769) 
Median: 2.67 2.54 (0.81) 
Comfort Sharing Health Data with Third-Party Commercial 
Companies for Business Purposes 
  
How comfortable are you with a third-party commercial 
company storing your DNA and health information? (q27c) 
28.90% 1.98 (1.01) 
How comfortable are you with a third-party commercial 
company sharing predictions about how you will respond to 
cancer treatment with insurance companies? (q27d) 
31.02% 2.00 (1.04) 
How comfortable are you with a third-party commercial 
company selling de-identified health information to a 
pharmaceutical company? (q27e) 
24.39% 1.81 (1.01) 
Comfort sharing health data with third-party commercial 
companies for business purposes index (Cronbach’s a=0.786) 
Median: 1.67 1.93 (0.85) 
* Range of indices: 1 = not comfortable sharing health data with third-party commercial companies; 2 = 
somewhat comfortable sharing health data with third-party commercial companies; 3 = fairly 
comfortable sharing health data with third-party commercial companies; 4 = very comfortable sharing 
data with third-party commercial companies 
 
3.4.3 Privacy Concerns 
Participant attitudes toward privacy were assessed using a four-item index (Table 1.3) 
examining various facets of privacy in healthcare. Just over half of participants (52.69%) 
responded that it was fairly or very true that their healthcare system respected their privacy, 
35.58% responded that it was fairly or very true that they were worried health information could 
be used against them, 40.96% of participants indicated that it was fairly or very true that they 
worried their health information is being inappropriately accessed, and 24.12% responded that it 
was fairly or very true that they would withhold certain types of information from their care 
providers because of a lack of trust. One item in the index, “my healthcare system respects my 
privacy” was reversed for inclusion in the index so that higher Privacy Index scores consistently 
indicated greater privacy concerns. The resulting privacy attitudes index mean was 2.22 
(SD=0.78), indicating overall privacy concerns of this study sample are “somewhat true” based 
on these questions.  
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Table 3-3 Descriptive statistics for survey questions measuring privacy concerns 
Table 3.3 Descriptive statistics for survey questions measuring privacy concerns (N=1841)  
 
 
 
Frequency 
(% fairly or very 
true) 
 
 
 
Mean (SD) 
Privacy Index*   
My healthcare system respects my privacy (q39d) 52.69% 2.63 (0.91) 
I worry that private information about my health could be used 
against me (q41a) 
35.58% 2.22 (1.07) 
I worry my health information is available to people who have 
no business seeing it (q41b) 
40.96% 2.38 (1.05) 
There are some things I would not tell my healthcare providers 
because I can’t trust them with the information (q41c) 
24.12% 1.89 (1.00) 
Privacy index (Cronbach’s a=0.771) Median: 2.25 2.22 (0.78) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
3.4.4 Trust in The Health System 
Participant trust in their health system (system trust) was assessed using a seven-item 
index examining various aspects of the trustee/trustor relationship. Only 40.14% felt that it was 
fairly or very true that “the organizations that have my health information and share it try to be 
fair in dealing with others”, 42.26% responded that it was fairly or very true that these 
organizations “would try to hide a serious mistake”, and only 36.06% responded that it was fairly 
or very true that these organizations “tell me how my health information is used”. Just over a 
quarter of participants (29.11%) felt that it was fairly or very true that the organizations that have 
their health information and share it “would never mislead me about how my health information 
is used”. Over 40% of respondents (43.24%) thought it was fairly or very true that these same 
organizations “have specialized capabilities that can promote innovation in health”. Only 36.12% 
responded that it was fairly or very true that these organizations “can be trusted to use my health 
information responsibly”, 31.12% felt these organizations “think about what is best for me”, and 
just over 40% (41.12%) responded that the organizations that have their health information and 
share it “act in an ethical manner”. One item in the index, “The organizations that have your 
health information and share it … would try to hide a serious mistake they made” was reversed 
for inclusion in the index so that higher scores would indicate greater system trust. In this study, 
the average system trust index score was 2.30 (SD=0.64), which corresponds to an evaluation by 
 88 
our participants that it is “somewhat true” that the organizations that have their health 
information and share it can be trusted.  
 
Table 3-4 Descriptive statistics for survey questions used in indices measuring trust in the health system (System Trust) 
Table 3.4 Descriptive statistics for survey questions used in indices measuring System Trust (N=1841) 
 
“For you, how true are the following statements about the 
organizations that have your health information and share it?”  
Frequency 
(% fairly or very 
true) 
 
 
Mean (SD) 
System Trust Index   
…Try hard to be fair in dealing with others (q34a) 40.14% 2.37 (0.86) 
…Would try to hide a serious mistake they made (q34b) 42.26% 2.43 (1.05) 
… Tell me how my health information is used (q34c) 36.06% 2.24 (0.98) 
… Would never mislead me about how my health information is 
used (q34d) 
29.11% 2.06 (0.92) 
… Have specialized capabilities that can promote innovation in 
health (q35b) 
43.24% 2.44 (0.85) 
… Can be trusted to use my health information responsibly 
(q36a) 
36.12% 2.25 (0.88) 
… Think about what is best for me (q36b) 31.12% 2.11 (0.93) 
… Act in an ethical manner (q36c) 41.12% 2.37 (0.87) 
System Trust index (Cronbach’s a=0.845) 
q34b has been reverse coded for this index 
Median: 2.25 2.30 (0.64) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
3.4.5 Trust in Healthcare Providers 
Participant’s trust in their healthcare providers (provider trust) was examined using a 
four-item index that examined provider intention and care. Only 38.62% of respondents 
indicated that it was fairly or very true that “health care providers care most about making money 
for themselves”, and 13.63% of respondents believe that it is fairly or very true that “health care 
providers do not care about helping people like me”. These two questions were reverse coded for 
inclusion in the provider trust index so that higher score indicate greater trust in health care 
providers. Just over 40% of participants responded both that it was fairly or very true that they 
“trust health care providers to use my health information responsibly” (44.98%) and that it was 
fairly or very true that, “all things considered, health care providers in this country can be 
trusted” (41.34%). The provider trust index score for this population sample was 2.20 
(SD=0.46), which corresponds to an evaluation that it is “somewhat true” that providers can be 
trusted.  
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Table 3-5 Descriptive statistics for survey questions used in indices measuring trust in healthcare providers (Provider Trust) 
Table 3.5 Descriptive statistics for survey questions used in indices measuring trust in healthcare 
providers (Provider Trust) (N=1841) 
 Frequency 
(% fairly or very 
true) 
 
 
Mean (SD) 
Provider Trust Index   
Health care providers care most about making money for 
themselves (q38a) 
38.62% 2.37 (1.00) 
Health care providers do not care about helping people like me 
(q38b) 
13.63% 1.62 (0.85) 
I trust health care providers to use my health information 
responsibly (q38c) 
44.98% 2.46 (0.92) 
All things considered, health care providers in this country can 
be trusted (q38e) 
41.34% 2.37 (0.81) 
Provider Trust index (Cronbach’s a=0.697) Median: 2.25 2.20 (0.46) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
3.4.6 Altruism 
Participant altruism was evaluated using four questions. Over half of participants 
(59.27%) responded that it is fairly or very true that “I find ways to help others less fortunate 
than me”, and 76.04% responded that it is fairly or very true that “the dignity and well-being of 
all should be the most important concern in any society”. Nearly three-quarters of participants 
(73.06%) responded that it was fairly or very true that “one of the problems of today’s society is 
that people are often not kind enough to other” and over half (55.19%) responded that it is fairly 
or very true that “all people who are unable to provide for their own needs should be helped by 
others”. The resulting altruism index score across participants is 2.96 (SD=0.66), which 
corresponds to an evaluation that it is “fairly true” that this study population is altruistic.  
 
Table 3-6 Descriptive statistics for survey questions used in indices measuring altruism 
Table 3.6 Descriptive statistics for survey questions used in indices measuring altruism (N=1841) 
 Frequency 
(% fairly or very 
true) 
 
 
Mean (SD) 
Altruism Index   
I find ways to help others less fortunate than me (q16a) 59.27% 2.78 (0.86) 
The dignity and well-being of all should be the most important 
concern in any society (q16b) 
76.04% 3.19 (0.90) 
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One of the problems of today’s society is that people are often 
not kind enough to others (q16c) 
73.06% 3.12 (0.91) 
All people who are unable to provide for their own needs should 
be helped by others (q16d) 
55.19% 2.75 (0.94) 
Altruism index (Cronbach’s a=0.711) Median: 3.0 2.96 (0.66) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
3.4.7 Experience of a past data breach 
The majority of participants (67.79%) responded “No-I have not experienced any 
problems [with stolen or misused information] within the past 5 years”. Of the respondents that 
indicated they had experienced problems with stolen or misused information, only 5.11% were 
currently experiencing problems. The remaining 27.10% of participants that had experienced 
problems with stolen or misused information considered those problems resolved. A similar 
majority of participants (65.73%) did not believe their financial information had been 
compromised due to a data breach or hacking.  
 
Table 3-7 Descriptive statistics for personal experience with a data breach 
Table 3.7 Descriptive statistics for personal experience with a data breach (N=1841) 
 n Frequency (%) 
Have you experienced problems with stolen or misused 
information (q53) 
  
 Yes – I am currently experiencing problems 94 5.11% 
 Yes – but all problems have been resolved 499 27.10% 
 No – I have not experienced any problems within the past 
five years 
1248 67.79% 
I believe my financial information has been compromised as the 
result of a data breach or hacking (q54) 
  
 Yes 631 34.27% 
 No 1210 65.73% 
   
 
3.4.8 Concern about recent events and breaches 
For each of the recent data breach or data misuse events selected for this study, at least 
60% of participants indicated that they were either fairly or very concerned. The Marriot data 
breach was the least concerning for respondents, with 62.79% indicating that they were fairly or 
very concerned, and the Equifax data breach was the most concerning, with 76.48% of 
respondents indicating that they were either fairly or very concerned. Facebooks involvement 
with Cambridge Analytica was fairly or very concerning to 69.53% of respondents, and Sloan 
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Kettering’s use of hospital data for a start-up company was fairly or very concerning for 65.07% 
of participants.  
 
Table 3-8 Descriptive statistics for concern about recent events 
Table 3.8 Descriptive statistics for concern about recent events (N=1841) 
 Frequency (% 
fairly or very 
concerned) 
 
 
Mean (SD) 
Concern about Facebook sharing information with 
Cambridge Analytica for political purposes (q55a) 
69.53% 3.08 (1.06) 
Concern about data breach of people’s social security 
numbers and driver’s license numbers at Equifax (q55b) 
76.48% 3.27 (0.94) 
Concern about Sloan Kettering hospital executives using 
hospital data for their own startup company (q55c) 
65.07% 2.95 (1.10) 
Concern about Marriot data breach of passport numbers 
and credit card numbers (q55d) 
62.79% 2.90 (1.13) 
   
* Range: 1 = “not at all concerned”; 2 = “somewhat concerned”; 3 = “fairly concerned”; 4 = “very 
concerned” 
 
3.4.9 Univariate Linear Regression  
Univariate examination of comfort sharing health data with third-party commercial 
companies for patient and business purposes show strong associations with system trust 
(𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.453, 𝑝 = 5.5 ∗ 108:<, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.452, 𝑝 = 4.0 ∗108:J)	and provider trust (𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.234, 𝑝 = 3.7 ∗1089=, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.298,𝑝 = 1.7 ∗ 1089J) as well as privacy concerns 
(𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = −0.260,𝑝 = 1.9 ∗ 1089:, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = −0.264,𝑝 =5.7 ∗ 1089:) for both patient and business data sharing purposes.  
 
Altruism was strongly associated with comfort with third-party commercial companies 
sharing data for patient purposes only (𝑏∗ = 0.141, 𝑝 = 5.5 ∗ 108=K). Belief that financial 
information has been compromised as well as concern about recent events showed significant 
associations with comfort with sharing health data with third-party commercial companies for 
business purposes only: Facebook (𝑏∗ = −0.118, 𝑝 = 8.7 ∗ 108=:), Equifax (𝑏∗ = −0.131,𝑝 =8.0 ∗ 108=K), Sloan Kettering (𝑏∗ = −0.185, 𝑝 = 7.4 ∗ 108=L), and Marriot (𝑏∗ = 0.092,𝑝 =0.0068). Perceived healthcare access was significantly associated with comfort with sharing 
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health data wit third-party commercial companies for business purposes only (𝑏∗ = 0.154,𝑝 =3.8 ∗ 108=A). Amongst the demographic factors examined here, being between the ages of 45 
and 59 (𝑏∗ = −0.102, 𝑝 = 0.032), possessing a college degree (𝑏∗ = 0.197, 𝑝 = 0.002), and a 
self-reported health of “excellent” (𝑏∗ = 0.119,𝑝 = 0.021), showed strong associations with 
comfort with sharing health data with third-party commercial companies for patient purposes 
only .  
 
Table 3-9 Univariate associations for attitudes (provider trust, system trust, privacy concerns, altruism), experience of a data 
breach, concern about recent events, and demographic data with comfort sharing health data with third-party commercial 
companies 
Table 3.9 Univariate associations for attitudes (provider trust, system trust, privacy concerns, altruism), 
experience of a data breach, concern about recent events, and demographic data with comfort sharing health 
data with third-party commercial companies for patient purposes and business purposes (N=1841) 
 Patient Purposes 
(univariate) 
Business Purposes 
(univariate) 
 b* p-value 𝑅< b* p-value 𝑅< 
Attitudes       
Trust       
 System Trust 0.453 5.5*10-42 0.205 0.452 4.0*10-43 0.204 
 Provider Trust 0.234 3.7*10-10 0.055 0.298 1.7 *10-13 0.089 
Altruism Index       
 Altruism Index 0.141 5.5*10-05 0.020 0.054 0.12 0.003 
Privacy Index       
 Privacy Concerns -0.260 1.9*10-14 0.068 -0.264 5.7*10-14 0.070 
Experience of Data Breach       
Have you experienced problems with 
stolen or misused information (q53) 
      
 Yes – I am currently 
experiencing problems 
ref   ref   
 Yes – but all problems have 
been resolved 
0.131 0.026 0.004 -0.015 0.78 0.006 
 No – I have not experienced any 
problems within the past five 
years 
0.131 0.028  0.062 0.23  
I believe my financial information has 
been compromised as the result of a 
data breach or hacking (q54) 
      
 Yes ref   ref   
 No  0.044 0.16 0.002 0.121 7.2e-05 0.015 
Concern about recent events       
 Concern about Facebook sharing 
information with Cambridge 
Analytica for political purposes 
(q55a) 
-0.012 0.75 0.0001 -0.118 8.7e-04 0.014 
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 Concern about data breach of 
people’s social security numbers 
and driver’s license numbers at 
Equifax (q55b) 
-0.018 0.60 0.0003 -0.131 8.0e-05 0.017 
 Concern about Sloan Kettering 
hospital executives using 
hospital data for their own 
startup company (q55c) 
-0.046 0.18 0.002 -0.185 7.4e-08 0.034 
 Concern about Marriot data 
breach of passport numbers and 
credit card numbers (q55d) 
-0.011 0.75 0.0001 -0.092 0.0068 0.008 
Demographics       
Sex        
 Male ref   ref   
 Female -0.037 0.25 0.001 -0.042 0.20 0.002 
Age       
 18-29 ref   ref   
 30-44 -0.078 0.085 0.007 -0.035 0.49 0.005 
 45-59 -0.102 0.032  -0.091 0.087  
 60+ -0.029 0.53  -0.027 0.61  
Race/Ethnicity       
 White ref   ref   
 Black, NH -0.028 0.37 0.005 0.034 0.31 0.005 
 Other, NH -0.029 0.38  -0.014 0.64  
 Hispanic -0.062 0.067  0.021 0.55  
 Multiracial, NH -0.031 0.29  -0.039 0.15  
 Asian, NH 0.004 0.90  0.039 0.28  
Education       
 Less than High School ref   ref   
 High School 0.098 0.14 0.014 0.001 0.99 0.011 
 Some college 0.126 0.034  -0.045 0.55  
 BA or above 0.197 0.002  -0.117 0.14  
Income       
 Less than $60,000 ref   ref   
 $60,000 or greater 0.059 0.069 0.003 -0.028 0.41 0.001 
Employment       
 Employed ref   ref   
 Not employed 0.032 0.32 0.003 0.087 0.13 0.009 
 Retired 0.022 0.44  0.014 0.63  
 Disabled/Other -0.037 0.29  -0.034 0.28  
Insured       
 Has insurance ref   ref   
 Does not have insurance -0.060 0.057 0.004 0.021 0.46 0.001 
Self-reported health       
 Poor ref   ref   
 Fair 0.013 0.84 0.012 0.010 0.88 0.003 
 Good 0.043 0.57  0.062 0.38  
 Very Good 0.073 0.29  0.010 0.88  
 Excellent 0.119 0.021  0.022 0.67  
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Perceived Healthcare Access Index       
 Perceived Healthcare Access 0.204 6.0e-10 0.041 0.154 3.8e-06 0.024 
        
b* = standardized beta 
 
3.4.10 Stepwise regression modeling 
In the Bonferroni-corrected stepwise regression model, 26% of variability of comfort 
with sharing health data with third party commercial companies for patient purposes can be 
explained by trust in the health system (system trust) and trust in healthcare providers (provider 
trust), privacy concerns, and education (𝑅< = 0.257). For the business purposes model, 28% of 
variability in comfort with third-party commercial companies can be explained by system and 
provider trust, privacy concerns, and concern about the Sloan Kettering event only (𝑅< =0.281).. System trust is the most strongly associated variable with comfort sharing health data 
with third-party commercial companies for patient purposes (𝑏∗ = 0.367,𝑝 = 4.6 ∗ 108<=) and 
business purposes ( 𝑏∗ = 0.326, 𝑝 = 4.7 ∗ 1089?). As system trust increased, comfort with 
sharing health data with third-party commercial companies also increased. Provider trust was 
also strongly associated with comfort sharing health data with third-party commercial companies 
for patient purposes (𝑏∗ = 0.139, 𝑝 = 1.6 ∗ 108:) and business purposes (𝑏∗ = 0.218,𝑝 = 6.4 ∗108@). Privacy concerns showed less strong but still significant associations with comfort with 
third-party commercial companies for patient purposes (𝑏∗ = −0.110,𝑝 = 0.002) and business 
purposes (𝑏∗ = −0.115, 𝑝 = 0.001). Having some college or a college degree was significantly 
associated with comfort sharing health data with third-party commercial companies for patient 
purposes only (college educated: 𝑏∗ = 0.298, 𝑝 = 2.6 ∗ 108A). Past experience of a data breach 
did not remain in this final model, nor did concern about Facebook and Cambridge Analytica, 
Equifax, or Marriot. Concern about Sloan Kettering hospital executives using health data for 
their own start up, however, remained in the final model for business purposes only (𝑏∗ =−0.139, 𝑝 = 5.4 ∗ 108A). Greater concern about the Sloan Kettering event was associated with 
less comfort with sharing health data with third-party commercial companies for business 
purposes.  
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Table 3-10 Stepwise regression modeling of predictors of comfort sharing health data with third-party commercial companies for 
patient purposes and comfort sharing health data with third-party commercial companies for business purposes 
Table 3.10 Stepwise regression modeling of predictors of comfort sharing health data with third-
party commercial companies for patient purposes and comfort sharing health data with third-
party commercial companies for business purposes (N=1841) 
 Patient Purposes 
Multivariable stepwise 
Bonferroni corrected  
(𝛼 =	0.002) 
 Business Purposes 
Multivariable stepwise 
Bonferroni corrected 
(𝛼 =	0.002) 
 Model 𝑅< 0.257  Model 𝑅< 0.281 
 b* p-value  b* p-value 
Attitudes      
System Trust 0.367 4.6e-20  0.326 4.7e-17 
Provider Trust 0.139 1.6e-04  0.218 6.4e-09 
Altruism 0.060 0.092    
Privacy Concerns -0.110 0.002  -0.115 0.001 
Recent events concern      
Sloan Kettering    -0.139 5.4e-06 
Demographic Factors      
Education      
Less than High School ref     
High School 0.149 0.022    
Some college 0.201 6.7e-04    
BA or above 0.298 2.6e-06    
Employment      
Employed    ref  
Not employed    0.089 0.016 
Retired    0.005 0.83 
Disabled/Other    -0.052 0.11 
Self-Reported Health      
Poor    ref  
Fair    -0.059 0.31 
Good    -0.001 0.99 
Very Good    -0.048 0.44 
Excellent    -0.073 0.11 
      
b* = standardized beta 
 
3.5 Discussion 
Previous research on the effect of data breaches on consumers has shown that trust in the 
organization mitigates the negative effects of data breaches (Chakraborty et al., 2016; McKnight 
et al., 2002) and is of greater importance than privacy and security features (Belanger et al., 
2002). These conclusions from other studies comport with the main finding of this research: trust 
in the health system has a far greater association with comfort with sharing health data with 
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third-party commercial companies than does concern about privacy or experience of a past data 
breach. It is thus possible that regardless of the privacy protections put in place, privacy controls 
alone will not be enough to assuage concerns about the use of health data if trust is not already 
secured.  
 
Research on the neuroscience of trust shows that “reputational priors”, or prior 
information about a given individual or company, reduced individual uncertainty about any 
subsequent decisions. Moreover, in this same study, participants continued to rely on these 
reputational priors even when the behavior of the individual or company that followed was not 
consistent with that given reputation (Fouragnan et al., 2013). In the wake of a breach event, 
trusted organizations with strong “reputational priors” will bounce back more quickly after the 
breach event, and the breach itself will take a smaller role in the mind of the public or patient. 
Fouragnan’s study and the results of this study agree with Ari Waldman’s assertion that “seeing 
trust as antecedent to privacy judgments is a step in the right direction”. Waldman argues that 
users make privacy-related decisions based on their existing perception of the trustworthiness of 
the companies or individuals they transact with, and that “seeing trust as a byproduct of a 
functioning privacy regime misses the fact that sharers tend to expect privacy protection where 
trust exists already” (Waldman, 2016). The results of this study suggest that without trust in the 
health system already secured, privacy controls will be insufficient in assuaging concerns. The 
importance of trust in the decision to reveal or conceal information can explain why there is little 
clarity about the meaning or importance of privacy to the public, or guidance on what tactics can 
be employed to meet privacy needs.  
 
This study also found significant associations between concern about recent data breach 
events and comfort with sharing health data with third-party commercial companies for business 
purposes in our univariate analysis, but these associations did not remain in the final 
multivariable model. These results suggest that although privacy violations are occurring in other 
sectors, their effect on health data privacy concerns is limited. This results also shows that while 
some may believe that “privacy is dead” or that it is impossible to maintain one’s privacy in 
today’s digitized experience, health data, and data use in health systems, remains separate and 
distinct.  
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Concern about the Memorial Sloan Kettering Paige.AI startup, however, did remain in 
the final multivariable model, suggesting that perceived data violation events in healthcare 
specifically may have deleterious effects for other health systems. It may be considered that 
individuals in this study who expressed more concerned about the use of health data for a start-
up venture may have had pre-existing reservations about the use of health data by commercial 
companies, or became warier about the use of their personal health information in the wake of 
the event. More research is needed to examine whether other perceived data misuse events 
similar to Sloan Kettering’s start-up do in fact have a deleterious after-effect on the public’s 
subsequent comfort sharing health data with third-party commercial companies for health 
systems at large.  
 
3.5.1 Implications for policy and practice 
Healthcare research is rapidly becoming dependent on the large data sets provided by 
electronic personal health information (ePHI) and data partnerships with companies like Google 
and Amazon are increasingly being sought in order to expand the data processing and research 
capabilities of healthcare systems. The results of this research underscore the importance of 
maintaining patient and public trust in the organization and in their providers while conducting 
research on electronic health information. Trust has long been a prerequisite in healthcare – 
patients, who are often vulnerable when they seek medical attention and care, must trust in the 
competence and integrity of their physician (Goold, 2002). In health research, trust can be 
increased with the use of community-based participatory research (CBPR), which engenders 
trust by communicating research findings back to study participants and through engaging 
community members and patient representatives in every step of the research process (Israel et 
al., 2005; McDavitt, 2016).  
 
In this research we found that trust in the health system is associated with comfort with 
sharing health data with third-party commercial companies, and that greater trust indicates 
greater comfort. However, 42.26% of participants believe that it is fairly or very true that these 
organizations “would try to hide a serious mistake they made” and that only 29.11% of 
participants in this study indicated that it was either fairly or very true that the organizations that 
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have their health information and share it “would never mislead me about how my health 
information is used”. Policies can be put in place that create clear expectations for 
communication of serious mistakes as well as reporting the use of healthcare data. Adverse event 
reporting is already mandated by many states, Minnesota being the first state in 2003 (Minnesota 
Department of Health, n.d.). Health data use reporting, however, has neither an existing policy 
nor a clear forward progression. HIPAA has long managed the use of data, but as deidentified 
data is increasingly packaged and sold and resold, the guidelines provided by HIPAA are no 
longer sufficient.  Future research is needed to understand how reporting can be done from the 
perspective of both providers and patients 
 
3.5.2 Implications for research 
 Trust in the health system displayed stronger associations with comfort with sharing 
health data with third-party commercial companies than did privacy concerns. As health systems 
negotiate the possibilities of big data research with the potential risks to patient privacy, 
provision of health data use controls to patients has been offered as a solution. The results of this 
study suggest that the effect of privacy controls may be limited if trust in the health system is 
already low. As discussed in earlier chapters, individuals constantly negotiate and renegotiate 
their privacy boundaries without their knowing, and as a result find it difficult to tune 
preferences when presented with the option to control their health data. Research on what 
privacy control or notification structures are most valued by patients is important to establish 
next steps to protect patient privacy and engender trust in the health system.  
 
3.5.3 Limitations 
As with any survey, this study is merely a snapshot of patient beliefs and preferences, 
limited due to the nature of survey questions – different aspects of the healthcare experience that 
may provide a more complete portrait of the public’s comfort with sharing health data with third-
party commercial companies may not be captured here. Additionally, a stepwise regression 
model is a conservative model that eliminates factors that might be important to understanding 
patient and public comfort with sharing health data with third-party commercial companies.  
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The circumstances of data sharing and the privacy context in which that sharing will 
occur will continue to evolve as laws, expectations, and experiences of healthcare data sharing 
change. Longitudinal studies that evaluate changes in comfort with sharing health data with 
third-party commercial companies would be superior, especially in light of changing media 
coverage of these partnerships. In subsequent research, we will examine the public’s confidence 
in current laws and policies that protect their data, and explore the public’s preferences for 
control and notification of information sharing.   
 
3.5.4 Conclusion 
This study revealed that trust in the health system, more than any other variable examined 
here, is associated with increased comfort with sharing health data with third-party commercial 
companies for patient as well as business purposes. This study also opened the possibility that 
data breach and data misuse events might have lasting consequences on the public’s overall 
comfort with sharing health data with third-party commercial companies. The magnitude of these 
consequences may also be impacted by trust in the health system. More research is needed on 
how much trust may impact the deleterious effects of data breaches.   
 
As was stated in previous research (Chapter 2), healthcare systems embarking on new 
third-party data partnerships to expand their ability to process and analyze health data can benefit 
from early identification and communication of the patient-centered benefits that will result from 
their third-party commercial partnerships. Engaging patients at the inception of these 
partnerships – taking a community based participatory research approach to partnerships with 
third-party commercial companies – can engender trust in the partnership and strengthen patient 
trust in the organization overall.   
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Chapter 4 Desire for Control Over Data or Data Use Notification and the Public’s Comfort 
with Sharing Health Data with Third-Party Commercial Companies 
 
4.1 Abstract 
Background: Healthcare partnerships with third-party commercial companies, while critical to 
the goal of realizing a learning health system, have been met with reservations from the public 
about the privacy of health information and concerns about how this data is used. While research 
points to the need to provide patients greater control over the use of their data, or notification of 
data use, it is not yet clear how to move forward with this effort while balancing the needs of 
researchers for quality data sets.  
  
Objective: To examine the relationships between the public’s comfort sharing health data with 
third-party commercial companies for patient and business purposes with the public’s comfort 
with researchers, quality analysts, commercial companies, and law enforcement, the public’s 
confidence in existing laws and policies, and desire for control over their health data and 
notification of data use.  
  
Methods: We surveyed the US public (n = 1841) to assess comfort with sharing health data with 
third-party commercial companies for patient or business purposes. Weighted Ordinary Least 
Squares (OLS) Regression analysis was used to first estimate the linear relationship between 
comfort with third-party commercial companies for patient and business purposes (dependent 
variables) and comfort with researchers, quality analysts, commercial companies and law 
enforcement, confidence in existing laws and policies, and desire for control over data and 
notification of use (independent variables), followed by stepwise regression modeling to estimate 
a full model of contributing factors to the public’s comfort with sharing health data with third-
party commercial companies—demographic variables, trust in the health system and in 
providers, privacy concerns, altruism, experience of a data breach, and concern about recent 
events and data breaches are included in this final analysis.  
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Findings: In this analysis, three variables were strongly associated with respondent’s comfort 
with sharing health data with third-party commercial companies for both patient and business 
purposes: trust in the health system, confidence in existing laws and policies, and desire for 
notification. Trust in the health system persisted in this full model of the public’s comfort third-
party commercial companies for both patient purposes (𝑏∗ = 0.235,𝑝 = 2.6 ∗ 1089<)	and 
business purposes (𝑏∗ = 0.159,𝑝 = 3.0 ∗ 108=L).	 Confidence in the existing laws and policies 
governing health data was also strongly associated with comfort with third-party commercial 
companies for both patient purposes (𝑏∗ = 0.136, 𝑝 = 0.0003)	and business purposes (𝑏∗ =0.102, 𝑝 = 0.00012).	Notably, desire for control over how health information was shared did 
not persist in the final model—instead, desire for notification displayed a positive association 
with comfort with sharing health data with third-party commercial companies for patient 
purposes (𝑏∗ = 0.118,𝑝 = 0.00064), and an inverse association with comfort sharing health 
data with third-party commercial companies for business purposes (𝑏∗ = −0.096, 𝑝 = 1.6 ∗108=K). 
  
Implications:  The results of this study suggest that increasing trust in the health system may 
have a greater impact on the public’s comfort than efforts to address privacy concerns alone. 
Desire for notification was also more significant than the desire for control over health data. 
Patients may be better served by focusing on efforts to build trust in the health system and 
provide notification of health data use instead of providing granular control over data use.  
 
4.2 Introduction 
4.2.1 Background 
Google, Facebook, Amazon, Comcast, and Apple all have their eyes on healthcare. 
Driven by an aging population and a rise in prevalence of chronic conditions, demand for 
healthcare is growing faster than any industry in the United States and worldwide—by 2022, the 
global healthcare market is expected to grow to $11.9 trillion (Business Wire, 2019). Given this 
enduring growth and market size, it is no surprise that companies like Google and Apple have 
aggressively expanded their businesses into health services. These commercial entrants into 
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healthcare, however, pose huge challenges for current healthcare data policy. As these 
companies push their own healthcare products to meet the very real demands of patients—
products that offer better telehealth services (Quil Health by Comcast, Google, and Facebook), 
better heart monitoring devices and wearables (Apple and Google), and applications and data 
platforms for patients and providers (IBM, Google, Amazon, and Facebook)—they upturn 
existing models of patient data management and privacy.  
 
The Health Insurance Portability and Accountability Act (HIPAA) provides most of the 
regulatory restrictions on the use of health data, and third-party companies typically come under 
the purview of HIPAA if and when they became a business associate (BA) of a healthcare 
provider or payer. However, by providing healthcare services directly to the patient consumer 
and bypassing healthcare systems and payors, companies may fall outside of that regulatory 
system. Additionally, HIPAA provisions apply only to identified health data—deidentified data, 
or data that has been stripped of identifiers, is not restricted. Deidentified data is aggregated, 
packaged, and sold by healthcare systems, insurers, and now technology companies, resulting in 
a worldwide data market estimated at $67 billion (Merken & Elfin, 2018). It is important to 
understand whether the public feels comfortable with the shifting landscape of health data 
organizations and the policy that regulates them.   
 
The privacy risks of deidentified data, however, are significant in our current data driven 
landscape. In October 2019, Facebook announced a health initiative called Preventative Health, 
which intended to send Facebook users reminders about flu shots, cancer screenings, and blood 
pressure checks in order to assist physicians in the management of chronic conditions (Ousfar, 
2019). True to Facebook’s core business of data collection, however, the initiative hoped to 
“leverage the cache of data users already give [Facebook] – about their education, relationships, 
habits, spoken languages, employment status, and more, all of which have an enormous impact 
on health outcomes—to create a sort of subclinical health-care system [that would warn] 
providers if, for example, a user recovering from surgery had a small support group” (Fussell, 
2020). Both Facebook and Google state in their privacy notices that individual user data is never 
shared or sold to third-parties—which sidesteps the fact that the real monetary value of the data 
collected is in the behavioral meta-data that belongs to no individual user but aids in the 
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generation of probability-based health profiles on all users. Machine learning and artificial 
intelligence techniques have made it possible to create individual-specific health profiles based 
on browser histories, social media activity, and social connections. Moreover, data that has been 
deidentified can be reidentified (Hoffman, 2020) through processes like geocoding (Rushton et 
al., 2006). Further, “anecdotal evidence suggests [that] algorithms already exist that can re-
identify patient information with prescription drug information after third-party data mining 
companies ostensibly de-identify the information” (Gellman, 2011).  
 
Recent changes to the management of patient data make the problems of data privacy and 
security all the more salient. In March 2020, HHS finalized “two transformative rules that will 
give patients unprecedented safe, secure access to their health data” (HHS Press Release, 2020). 
One of those rules “establishes secure, standards-based application programming interface (API) 
requirements to support a patient’s access and control of their electronic personal health 
information (ePHI)” so that patients can “securely and easily obtain and use their electronic 
health information […] using an app of their choice” (HHS Press Release, 2020). While these 
rules go far in putting control of health information in the hands of patients as intended, they are 
out of sync with existing HIPAA regulations. Per HIPAA as it currently stands, if the patient is 
the initiator of a relationship with a third-party commercial company, then HIPAA regulations no 
longer apply, and the patient’s data is no longer protected (Davis, 2019; Singer, 2019). 
Furthermore, the individual patient’s right of access to their ePHI will prevent healthcare 
organizations from refusing to share the patient’s health data with the application or company, 
regardless of organizational concerns that the chosen application may be a possible threat to the 
patient’s data security and privacy.  
 
In this data environment, patients are both winners and losers. The healthcare 
marketplace is expanding to provide new offerings to patients who have been frustrated by poor 
healthcare access and availability (Batbaatar et al., 2017), but in so doing, companies outside of 
the dyadic patient-provider relationship are poised to collect even more health data than they 
already have. Previous research has indicated patients are largely unaware of how their identified 
and deidentified data can be and is used by third-party commercial companies (C. Smith, 2011), 
and case studies provided by Google and Facebook, among others, indicate that third-party data 
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efforts are unfavorably received by the public. Literature examining patient willingness to share 
health information for research broadly has found that generally patients are unwilling to share 
information beyond what is necessary to provide care, do not like to be surprised about how their 
data are used (Jilka et al., 2015; Kim et al., 2019; Shen et al., 2019), and desire greater control 
over the use and dissemination of their health data (Damschroder et al., 2007; Jilka et al., 2015). 
Patient reservations about the use of health data also apply to deidentified health data (Cohen & 
Mello, 2018; C. Smith, 2011). While an abundance of research has been conducted on the 
privacy concerns of the public, provision of health data privacy controls to patients are still 
lacking or inadequate. While the reasons for this include both technical and bureaucratic issues, 
healthcare researchers have also indicated concerns that wholesale control over health data will 
compromise data sets and limit research efforts that intend to improve healthcare, especially 
amongst underrepresented populations. Furthermore, privacy expectations differ greatly from 
person to person. Any substantial effort made is bound to be adequate for some and inadequate 
for others. Better understanding of the factors that influence patient comfort with commercial 
companies is needed to guide future approaches to regulatory management, patient consent, and 
patient notification.  
 
4.2.2 Problem Statement 
Current research emphatically recommends providing privacy controls to patients; 
however, there has not been much clarity on what controls to provide and what impact they may 
have on patient satisfaction and resolution of privacy concerns. Examination of public attitudes 
towards these companies and how these attitudes intersect with trust and privacy concerns is 
needed to help guide privacy efforts as patient data is increasingly shared with and generated by 
third-party commercial companies.  
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4.2.3 Conceptual Model 
 
Figure 4-1 Conceptual Model of Dissertation Research – this analysis focuses on stakeholders and policy, all variables are 
included in the final multivariable regression model 
 
Difference between business and patient purposes 
Third party commercial companies are those companies that typically fall outside of 
usual “covered entities”. Covered entities include healthcare systems or providers who transmit 
any health information, health care plans, and health care clearinghouses (billing services, 
community health information systems, etc.) (Office for Civil Rights (OCR), 2013). In this 
analysis we examine the public’s comfort sharing health data with third-party commercial 
companies, investigating comfort when data is shared for patient purposes, i.e., to improve care, 
diagnosis, or treatment, versus comfort when data is shared for business purposes such as selling 
de-identified data. In chapter two we closely examined the division of patient-focused versus 
business-focused health data sharing and found a statistically significant difference between 
comfort with sharing data for patient and business purposes, results which will be reviewed and 
restated here for continuity. The public is more comfortable with sharing health data with third-
party commercial companies if the benefits to the patient or to the public are clear, which 
comports with past research that also concluded patients are more willing to provide access to 
their health information if the potential health benefits are clear (Anderson & Agarwal, 2011), 
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and are less willing to provide access if their health data will be used for profit-generating 
research (Willison et al., 2009). We expand that analysis here.  
 
Comfort with Researchers, Quality Analysts, Commercial Companies 
Multiple studies have shown that on the whole, patients are willing to share their health 
data with researchers (Damschroder et al., 2007; Karampela et al., 2019; Seltzer et al., 2019; 
Spencer et al., 2016; Teixeira et al., 2011). Despite dissatisfaction about how the results of 
researcher studies were communicated back to participants, patients were also willing to share 
data beyond their personal health information for the purposes of research, including tax records 
and credit card histories (Seltzer et al., 2019). This willingness to share health information is, 
however, largely confined to research efforts only. As an example of willingness to share health 
data with third-party commercial companies, a 2019 survey conducted by the Chicago 
Booth/Kellogg School Financial Trust found that 93% of survey participants were unwilling to 
share their health data with Facebook (Promarket, 2020). This study limited their question to 
Facebook only, when the health data industry contains so many other players vying for patient 
data.  
 
Comfort with Law Enforcement 
Third-party access to health data also includes police. A 2019 survey conducted by the 
Pew Research Center found that 48% of Americans consider it acceptable for DNA testing 
companies (23andMe, Ancestry.com) to share their customers’ data with law enforcement, while 
one-third (34%) of respondents said sharing with law enforcement was unacceptable, and 18% 
were unsure whether the practice was acceptable or unacceptable (Perrin, 2020). As third-party 
companies command ever greater access to health data as well as data that can be considered 
health data (web histories, fitness applications), law enforcement is also gaining an increasingly 
robust data set with which to conduct investigations. In 2019, a Florida judge granted a warrant 
that allowed the police to search the complete genetic database of GEDMatch. The terms of the 
warrant included all customers of GEDMatch, including those who didn’t opt-in to any data 
sharing agreement. Following this event, GEDMatch updated their terms of agreement to ensure 
that only those who consent to a search of their genetic information will be access. Notably, as of 
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November 2019, only 185,000 of the company’s total population of 1.3 million users, a mere 7% 
of the total user population, have provided this consent (Tiller, 2019).  
 
Confidence in existing laws and policies 
As healthcare breaches increase year after year, patient confidence in the ability of the 
health system to protect their health information is decreasing (HIPAA Journal, 2017). In a 2016 
survey, 89% of healthcare consumers reported withholding health information during their visit 
because of privacy and security concerns (Black Book Market Research, 2017). Research shows 
patients desire clear and consistent consequences for anyone who violates patient privacy, and 
for researchers to be held accountable for maintaining confidentiality (Damschroder et al., 2007), 
but changes to regulations governing information sharing have not yet occurred. In 2007, only 
25% of participants were aware that researchers could use their medical records without explicit 
permission from the patient (Damschroder et al., 2007). In 2016, 81% of respondents to a Black 
Book Market Research survey (Black Book Market Research, 2017) reported concern that their 
chronic condition data was being shared with retailers, employers, or the government without 
their knowledge (Gooch, 2017).  
 
Desire for control and notification 
Research on willingness to allow for personal health data to be used for research have 
found that in general, 96% of patients were willing to provide their data for research, yet 78% 
also indicated their desire for more control over how their information was used (Damschroder et 
al., 2007). Patients have consistently reported wanting to know how their health data may have 
contributed to helping others, and who was using their medical records for what purpose 
(Damschroder et al., 2007; Kim et al., 2019; Weitzman et al., 2010). Desire for notification 
persists even when there is high institutional trust, as seen by Damschroder et al in their research 
on veterans (Damschroder et al., 2007). 
 
4.2.4 Study Objective 
The aims of this study are to a) examine the relationship between the public’s comfort 
with sharing health data with third-party commercial companies and their comfort with 
researchers, quality analysts, commercial companies, and law enforcement; b) examine the 
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public’s comfort with sharing health data with third-party commercial companies for patient and 
business purposes and their confidence in existing health data privacy laws and policies; and c) 
examine the public’s comfort with sharing health data with third-party commercial companies 
and their desire for control over their health information or desire for notification of health data 
use.  
 
4.3 Methods 
Respondent comfort with sharing health data with third-party commercial companies was 
captured using a 20-minute online survey of US adults. In this section I explain how the concepts 
described above are operationalized in this survey, followed by an explanation of the statistical 
methods used to analyze this data. 
 
4.3.1 Participants 
Respondents were surveyed using the National Opinion Research Center’s (NORC) 
probability-based, nationally representative sample of US adults, based on 2010 Census 
Information. NORC’s national sample frame employs a two-stage probability sample design to 
select a representative sample of households in the United States, oversampling African 
American, Hispanic populations, as well as households 200% below the federal poverty level. 
Survey recruitment and deployment was done in May 2019. Data collection was completed by 
June 2019. Eligible participants (at least 21 years old and able to read and write in English) were 
contacted via email to participate in the online survey, resulting in a total of 2,157 participants 
(66% response rate). The first component of the survey was a short (90 seconds) animated video 
describing how health data of a fictional patient is shared through the duration of care—to 
insurers, billers, and analysts learning from the outcomes of treatment. Definitions of important 
terms such as “healthcare system”, “healthcare providers”, “electronic health record”, “de-
identified health information [or biospecimens]”, and “commercial companies” were provided to 
survey participants wherever those terms appeared. “Commercial companies” was defined for 
respondents to this survey as “third-party companies that are not part of a hospital. For example, 
a third-party commercial company may conduct genetic tests and analyze information for a 
hospital or healthcare provider for a fee when a hospital is not able to conduct the test on their 
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own.”  “De-identified [health information or biospecimens]” was defined for respondents in the 
following manner: “de-identified means that “identifying information” about you is removed 
from your health information. Identifying information includes things like your name, address, 
date of birth, etc.”  
 
NORC calculated post-stratification weights according to US Census demographic 
benchmarks for age, sex, household income, education, as well as race and ethnicity to reduce 
sampling bias. For the purposes of this paper, records with missing responses to one or more of 
the questions used in this analysis were not included, resulting in a final analyzed sample of 
1,841 responses. This study protocol was approved by the University of Michigan Health 
Sciences Institutional Review Board.  
 
4.3.2 Survey Design 
Variables used in this study were derived from a 20-minute, 164-item survey created to 
examine knowledge, attitudes, and beliefs about data sharing. Trust measures were adapted from 
the work of Mark Hall and colleagues (Hall, Camacho, et al., 2002; Hall et al., 2001; Hall, 
Zheng, et al., 2002). Altruism measures were adapted from the General Social Survey (T. Smith 
et al., 2019), the National Election Survey (Feldman & Steenbergen, 2001), and the General 
Self-Efficacy Scale (Schwarzer & Jerusalem, 1992). Privacy measures were adapted from 
Anderson’s research on consumer willingness to disclose personal health information and the 
California Health Foundation’s 2005 National Consumer Health Privacy survey (Anderson & 
Agarwal, 2011; Bishop et al., 2005). Privacy measures also include questions about deception 
and medical mistrust (Boulware et al., 2003; LaVeist et al., 2009) and have been used in previous 
studies (Platt et al., 2018).  
 
4.3.3 Measurements used in this study 
The Public’s Comfort with Sharing Health Data with Third-Party Commercial Companies for 
Patient and Business Purposes 
To explore public comfort with sharing health data with third-party commercial 
companies for patient purposes, respondents answered questions about “how comfortable” they 
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were with three statements regarding data sharing with third-party commercial companies, each 
along a 4-point Likert scale. Participants were asked “How comfortable are you with a third-
party commercial company using your DNA and health information to improve the diagnosis 
and treatment of cancer in other patients?” and “How comfortable are you with a third-party 
commercial company developing predictions about how you will respond to a particular cancer 
treatment?: “not at all comfortable” (1), “somewhat comfortable” (2), “fairly comfortable” (3), 
and “very comfortable” (4). Participants were also asked “how true” it was that “The 
organizations that have my health information and share it can use large amounts of data to 
improve patient care”: “not true” (1), “somewhat true” (2), “fairly true” (3), and “very true” (4).  
 
To examine participant comfort with sharing health data with third-party commercial 
companies for business purposes, participants were asked “How comfortable are you with a 
third-party commercial company storing your DNA and health information?”; “How comfortable 
are you with a third-party commercial company sharing predictions about how you will respond 
to cancer treatment with insurance companies?”; and “How comfortable are you with a third-
party commercial company selling de-identified health information to a pharmaceutical 
company?”. “Business purpose” in this research is understood as storage of health data beyond 
the purposes of clinical care and sharing information with third-party commercial companies to 
improve their own business processes without explicitly stated direct benefit to patients. 
Respondents were provided with the options “not at all comfortable” (1), “somewhat 
comfortable” (2), “fairly comfortable” (3), and “very comfortable” (4). Indices for data use for 
patient purposes and business purposes were then calculated as the sum of participant responses 
to the three questions in each index divided by the number of questions.  
 
The Cronbach’s alpha for these questions was 0.766 for comfort with sharing health data 
with third-party commercial companies for patient purposes and 0.786 for comfort with sharing 
health data for business purposes. 
 
Comfort with Researchers, Quality Analysts, Commercial Companies 
Comfort with researchers, quality analysts, and commercial companies was measured 
using a 4-item index for each group. Respondents were asked “how true” the following 
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statements were for themselves: a) “I am comfortable with [Researchers/Quality 
Analysts/Commercial Companies] using my de-identified health information”, b) “I am 
comfortable with [Researchers/Quality Analysts/Commercial Companies] using my identified 
health information”, c) “I am comfortable with [Researchers/Quality Analysts/Commercial 
Companies] using my de-identified biospecimens”, d) “I am comfortable with 
[Researchers/Quality Analysts/Commercial Companies] using my identified biospecimens. 
Respondents were provided with options along a Likert scale ranging from 1 (“not true”) to 4 
(“very true”). The final comfort scores for each group is the total of participant responses for that 
group divided by the number of questions for that group index. The Cronbach’s alpha for 
questions comprising the comfort with researchers index is 0.791, the comfort with quality 
analysts index is 0.809, and the comfort with commercial companies index is 0.813.  
 
Comfort with Law Enforcement 
In this study we focus on law enforcement access to health information and genetic data 
specifically, consistent with recent events whereby law enforcement collected genetic data from 
direct-to-consumer companies such as 23andMe and Ancestry.com. Respondents were asked 
“how true” they found the following statement: “It is okay for law enforcement to access health 
information”. Choices for this question ranged from 1 (“not true”) to 4 (“very true”). 
Respondents were asked a second question regarding law enforcement access to genetic data: 
“Are you comfortable with law enforcement using genetic and ancestry data from companies like 
23andMe and AncestryDNA?”. Options for this latter question were “yes” (1) and “no” (2).  
 
Confidence in Existing Laws and Policies 
Two questions were used to assess respondent confidence in existing laws and policies. 
Respondents were asked to evaluate “For you, how true are the following statements”: a) 
“Existing laws provide a reasonable level of protection for the privacy of patients” and b) “I am 
confident that electronic health information is sufficiently protected by current law and 
regulation”. Available responses were provided along a Likert scale ranging from 1 (“not true”) 
to 4 (“very true”).  
 
Desire for Control and Notification 
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Desire for greater control over the use of health data and notification of the use of health 
data was examined using three questions. Each of the three questions asked respondents to 
evaluate “For you, how true are the following statements”: a) “I should have more control over 
how my health information is used”, b) “It is important I know who has health information about 
me”, and c) “I should be able to find out how my health information is shared”. All three 
questions were accompanied by response options along a Likert scale ranging from 1 (“not true”) 
to 4 (“very true”).  
 
4.3.4 Data Analysis 
For this analysis we first generated summary descriptive statistics on each question 
included in this analysis – comfort with researchers, quality analysts, commercial companies, 
law enforcement, confidence in existing laws and policies, and desire for control over the use of 
health data and desire for notification of the use of health data.  
 
Weighted Ordinary Least Squares (OLS) Regression analysis was used to estimate the 
linear relationship between comfort with third-party commercial companies for patient and 
business purposes and each demographic and health variable separately. We then estimated a 
multivariable model with all demographic and health variables and conducted a stepwise 
regression model to identify a parsimonious set of variables that explained the greatest amount of 
variability in the two outcomes – comfort with sharing data with commercial companies for 
business or patient purposes.  For the stepwise regression model, we set statistical significance at 
a=0.05 (p<0.002) for inclusion and a=0.01 for exclusion, applying a Bonferroni correction to 
minimize Type I error. To enable comparison of effect sizes, regression coefficients were 
normalized (mean = 0, SD = 1).  
 
4.4 Results 
To examine predictors of comfort with third-party commercial companies using health 
information for patient and business purposes, we first examined the descriptive statistics for 
each of the independent variable and then conducted univariable and multivariable stepwise 
regression to identify predictors.  Statistical significance was set at the 0.05 level.  
 122 
4.4.1 Sample Demographics 
The resulting weighted sample of 1,841 participants shows a near even split between 
male and female participants (49% male). Approximately 12% of participants were under the age 
of 29, and 31% of participants were over the age of 60. Nearly 60% of participants identified as 
white non-Hispanic, 15% as black, non-Hispanic, 19% as Hispanic, 3% as Asian, non-Hispanic, 
2% of participants identified race and ethnicity as “other”, and 3% identified as multiethnic, 
consistent with 2016 data from the US Census Bureau (12.3% of the US population identifies as 
black or African-American, non-Hispanic). Nearly half of participants completed some college 
(46%), and 33% of participants have a bachelor’s degree. While the proportion of participants 
with a bachelor’s degree is consistent with national percentages (30%, 2016 census data), the 
proportion of participants with some college, no degree is much higher in this study than national 
percentages (21%, 2016 census data). Just over half of participants (59%) made an income less 
than $60,000, consistent with the median household income for 2018 (Guzman, 2019). Over half 
of participants (60%) had employment. Of the health questions included in this analysis, 89% of 
study participants reported having health insurance of some type, which is slightly lower than 
reported national percentages - 92% of the US population according to the 2018 US Census (US 
Census Bureau, 2019). The mean self-reported health score of participants was 3.08, suggesting 
that on average, the respondents were of “good” health.  
 
Table 4-1 Demographic descriptive statistics 
Table 4.1 Demographic descriptive statistics (N = 1841)  
  
N 
 
Frequency 
Sex   
 Male 903 49.05%  
 Female 938 50.95% 
Age   
 18-29 227 12.33% 
 30-44 554 30.09% 
 45-59 483 26.24% 
 60+ 577 31.34% 
Race/Ethnicity   
 White 1086 58.99% 
 Black, NH 273 14.83% 
 Other, NH 30 1.63% 
 Hispanic 358 19.45% 
 Multiracial, NH 47 2.55% 
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 Asian, NH 47 2.55% 
Education   
 Less than High School 73 3.97% 
 High School 317 17.22% 
 Some college 841 45.68% 
 BA or above 610 33.13% 
Income   
 Less than $60,000 1082 58.77% 
 $60,000 or greater 759 41.23% 
Employment   
 Employed 1112 60.40% 
 Not employed 87 4.73% 
 Retired 373 20.26% 
 Disabled/Other 269 14.61 
Insured   
 Is insured 1638 88.97% 
 Is not insured 203 11.03% 
Self-reported health   
 Range: 1 (Poor) to 5 (Excellent)  Mean: 3.08 
(SD=0.92) 
    
 
 
4.4.2 Public Comfort with Sharing Healthcare Data with Third-Party Commercial 
Companies for Patient and Business Purposes 
Public comfort with sharing health data with third-party commercial companies was 
evaluated using two indices: 1) comfort with sharing health data with third-party commercial 
companies for patient purposes, and 2) comfort with sharing health data with third-party 
commercial companies for business purposes (Table 2.2). The resulting mean of comfort with 
sharing data with third-party commercial companies for patient purposes was 2.54 (SD = 0.81) or 
between “somewhat comfortable” and “fairly comfortable”. Roughly half of participants 
indicated that they were either fairly for very comfortable sharing data with third-party 
commercial companies for patient purposes as expressed by the component questions of the 
index: (53.39% are comfortable with a third-party commercial company using their DNA and 
health information to improve the diagnosis and treatment of cancer in other patients , 49.16% 
are comfortable with third-party commercial companies developing predictions about how they 
will respond to a particular cancer treatment, and 47.80%  believe that the organizations that 
have their health information and share it can use large amounts of data to improve patient care). 
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Comfort with sharing health data with third-party commercial companies for business purposes 
had a resulting mean of 1.93 (SD = 0.85) or “somewhat comfortable”. One quarter to one third of 
participants indicated they were either fairly or very comfortable with each of the component 
questions in comfort sharing health data third-party commercial companies for business purposes 
(28.90% are comfortable with a third-party commercial company storing their DNA and health 
information, 31.02% are comfortable with a third-party company sharing predictions about how 
they will respond to cancer treatment with insurance companies, and 24.39% are comfortable 
with a third-party commercial company selling de-identified health information to a 
pharmaceutical company). Figure 2.1 shows the distributions of the two indices. 
 
A paired t-test was conducted on both comfort indices, the results of which show that 
there is a statistically significant difference between comfort with sharing health data with third-
party commercial companies for patient purposes and comfort sharing health data with third-
party commercial companies for business purposes only, paired 𝑡 = 39.83, 𝑝 < 0.001.  
 
 
Figure 4-2 Box plot distributions of indices measuring Comfort Sharing Health Data with Third-Party Commercial Companies 
for Patient Purposes and Business Purposes 
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Table 4-2 Descriptive statistics for survey questions used in indices measuring comfort sharing health data with third-party 
commercial companies for patient and business purposes 
Table 4.2 Descriptive statistics for survey questions used in indices measuring comfort sharing health 
data with third-party commercial companies for patient purposes and comfort sharing health data with 
third-party commercial companies for business purposes. (N = 1841) 
 
 
Frequency 
(% fairly or very 
comfortable/ fairly 
or very true) 
 
 
 
Mean (SD) 
Comfort Sharing Health Data with Third-Party Commercial 
Companies for Patient Purposes 
  
How comfortable are you with a third-party commercial 
company using your DNA and health information to improve 
the diagnosis and treatment of cancer in other patients? 
53.39% 2.58 (1.05) 
How comfortable are you with a third-party commercial 
company developing predictions about how you will respond to 
a particular cancer treatment? 
49.16% 2.48 (1.02) 
The organizations that have my health information and share it 
can use large amounts of data to improve patient care 
47.80% 2.56 (0.86) 
Comfort sharing health data with third-party commercial 
companies for patient purposes index (Cronbach’s a=0.769) 
Median: 2.67 2.54 (0.81) 
Comfort Sharing Health Data with Third-Party Commercial 
Companies for Business Purposes 
  
How comfortable are you with a third-party commercial 
company storing your DNA and health information? 
28.90% 1.98 (1.01) 
How comfortable are you with a third-party commercial 
company sharing predictions about how you will respond to 
cancer treatment with insurance companies? 
31.02% 2.00 (1.04) 
How comfortable are you with a third-party commercial 
company selling de-identified health information to a 
pharmaceutical company? 
24.39% 1.81 (1.01) 
Comfort sharing health data with third-party commercial 
companies for business purposes index (Cronbach’s a=0.786) 
Median: 1.67 1.93 (0.85) 
* Range of indices: 1 = not comfortable sharing health data with third-party commercial companies; 2 = 
somewhat comfortable sharing health data with third-party commercial companies; 3 = fairly 
comfortable sharing health data with third-party commercial companies; 4 = very comfortable sharing 
data with third-party commercial companies 
 
4.4.3 Comfort with Researchers, Quality Analysts, Commercial Companies 
Comfort with researchers, quality analysts, and commercial companies was assessed 
using a four-item index for each group. Over sixty percent of respondents indicated that it was 
either fairly or very true that they were comfortable with university researchers using their de-
identified health information (65.24%) and their de-identified biospecimens (65.73%). 
Comparatively, however, just over a quarter of respondents indicated that it was either fairly or 
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very true that they were comfortable with university researchers using their identified health 
information (28.36%) and their identified biospecimens (29.93%). The total comfort with 
researchers index score was 2.44 (SD=0.85), corresponding with an assessment between 
“somewhat” and “fairly true” that respondents were comfortable with researchers.  
 
Table 4-3 Descriptive statistics for survey questions used in indices measuring Comfort with Researchers using patient health 
information and biospecimens 
Table 4.3 Descriptive statistics for survey questions used in indices measuring Comfort with 
Researchers using patient health information and biospecimens (N=1841) 
 Frequency 
(% fairly or very 
true) 
 
 
Mean (SD) 
Comfort with Researchers Index   
I am comfortable with university researchers using my de-
identified health information 
65.24% 2.93 (1.06) 
I am comfortable with university researchers using my 
identified health information 
28.36% 1.93 (1.06) 
I am comfortable with university researchers using my de-
identified biospecimens 
65.73% 2.91 (1.09) 
I am comfortable with university researchers using my 
identified biospecimens 
29.93% 1.99 (1.10) 
Comfort with researchers index (Cronbach’s a=0.791) Median: 2.5 2.44 (0.85) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
Similar to comfort with researchers, over sixty percent of respondents indicated that it 
was either fairly or very true that they were comfortable with quality analysts using their de-
identified health information (64.10%) and their de-identified biospecimens (60.89%). Just over 
a quarter of respondents indicated that it was either fairly or very true that they were comfortable 
with quality analysts using their identified health information (30.53%) and their identified 
biospecimens (28.68%). The total comfort with quality analysts index score was 2.42 (SD=0.86), 
also corresponding with an assessment between “somewhat” and “fairly true” that respondents 
were comfortable with quality analysts, again, similar to university researchers.  
 
Table 4-4 Descriptive statistics for survey questions used in indices measuring Comfort with Quality Analysts using patient 
health information and biospecimens 
Table 4.4 Descriptive statistics for survey questions used in indices measuring Comfort with Quality 
Analysts using patient health information and biospecimens (N=1841) 
 Frequency  
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(% fairly or very 
true) 
Mean (SD) 
Comfort with Quality Analysts Index   
I am comfortable with quality analysts using my de-identified 
health information 
64.10% 2.89 (1.08) 
I am comfortable with quality analysts using my identified 
health information 
30.53% 2.00 (1.07) 
I am comfortable with quality analysts using my de-identified 
biospecimens 
60.89% 2.82 (1.10) 
I am comfortable with quality analysts using my identified 
biospecimens 
28.68% 1.96 (1.06) 
Comfort with Quality Analysts index (Cronbach’s a=0.809) Median: 2.5 2.42 (0.86) 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
Only 40% of respondents indicated that it was either fairly or very true that they were 
comfortable with commercial companies using their de-identified health information (40.47%) 
and their de-identified biospecimens (41.01%). Only 16.03% of respondents indicated that it was 
either fairly or very true that they were comfortable with commercial companies using their 
identified health information and only 17.11% of respondents indicated that it was either fairly or 
very true that they were comfortable with commercial companies using their identified 
biospecimens (28.68%). The total comfort with quality analysts index score was 1.95 (SD=0.84), 
corresponding with an assessment of “somewhat true” that respondents were comfortable with 
commercial companies.  
 
Table 4-5 Descriptive statistics for survey questions used in indices measuring Comfort with Commercial Companies using 
patient health information and biospecimens 
Table 4.5 Descriptive statistics for survey questions used in indices measuring Comfort with 
Commercial Companies using patient health information and biospecimens (N=1841) 
 Frequency 
(% fairly or very 
true) 
 
 
Mean (SD) 
Comfort with Commercial Companies Index   
I am comfortable with commercial companies using my de-
identified health information 
40.47% 2.30 (1.16) 
I am comfortable with commercial companies using my 
identified health information 
16.03% 1.59 (0.94) 
I am comfortable with commercial companies using my de-
identified biospecimens 
41.01% 2.31 (1.15) 
I am comfortable with commercial companies using my 
identified biospecimens 
17.11% 1.62 (0.95) 
Comfort with Commercial Companies index  
(Cronbach’s a=0.813) 
Median: 2.00 1.95 (0.84) 
 128 
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
4.4.4 Comfort with Law Enforcement 
Comfort with law enforcement was assessed using two questions. Only 17.22% of 
respondents indicated that it was either fairly or very true that “it is okay for law enforcement to 
access health data” (mean 1.73, SD=0.88) while 37.26% of respondents responded “yes”, they 
were comfortable with law enforcement using genetic and ancestry data from sites like 23andMe 
and AncestryDNA. This latter question has been reverse-coded in the univariate and 
multivariable models that follow so that higher scores consistently indicate greater comfort.  
 
Table 4-6 Descriptive statistics for comfort with law enforcement access to health data 
Table 4.6 Descriptive statistics for comfort with law enforcement access to health data (N=1841) 
 Frequency (% 
fairly or very) 
 
Mean (SD) 
Comfort with law enforcement access to health data   
It is okay for law enforcement to access health 
information*  
17.22% 1.73 (0.88) 
Comfortable with law enforcement using genetic and 
ancestry data  
37.26% 
(yes) 
1.63 (0.48) 
Yes = 1 
No = 2 
   
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
4.4.5 Confidence in existing laws and policies 
Less than half of participants indicated they had confidence in existing health privacy 
laws and policies for both questions. Only 42.02% of respondents responded that it was “fairly or 
very true” that existing laws provided a reasonable level of protection for the privacy of patient 
information (mean 2.43, SD=0.90), and only 33.78% (mean 2.19, SD=0.92) responded that it 
was “fairly or very true” that they were confident that electronic health information was 
sufficiently protected by current laws and regulations.  
 
Table 4-7 Descriptive statistics for confidence in current privacy law 
Table 4.7 Descriptive statistics for confidence in current privacy law (N=1841) 
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 Frequency (% 
fairly or very) 
 
Mean (SD) 
Confidence in Current Privacy Law   
Existing laws provide a reasonable level of protection for 
the privacy of patient information 
42.02% 2.43 (0.90) 
I am confident that electronic health information is 
sufficiently protected by current law and regulation 
33.78% 2.19 (0.92) 
   
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
4.4.6 Desire for control and notification 
The majority of respondents indicated their desire for both control over and notification 
of the use of their health data. Over 60% of respondents (63.17%) stated that it was either fairly 
or very true that they should have more control over how their health information is used (mean 
2.93, SD=0.98). Desire for notification was even greater with 80.12% of respondents indicating 
that it was either fairly or very true that it was important they know who has health information 
about themselves (mean 3.38, SD=0.87) and 84.31% indicating that it was fairly or very true that 
they should be able to find out how their health information was shared (mean 3.51, SD=0.82).  
 
Table 4-8 Descriptive Statistics for desire for control and notification of health information sharing 
Table 4.8 Descriptive Statistics for desire for control and notification of health information sharing 
(N=1841) 
 Frequency (% 
fairly or very) 
 
Mean (SD) 
Desire for control and notification of health information 
sharing 
  
I should have more control over how my health 
information is used 
63.17% 2.93 (0.98) 
It is important I know who has health information about 
me  
80.12% 3.38 (0.87) 
I should be able to find out how my health information is 
shared 
84.31% 3.51 (0.82) 
   
* Range: 1 = “not true”; 2 = “somewhat true”; 3 = “fairly true”; 4 = “very true” 
 
 130 
4.4.7 Univariate linear regression 
Univariate examination of comfort sharing health data with third-party commercial 
companies for patient and business purposes show statistically significant relationships with 
comfort with researchers (𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.517,𝑝 = 7.9 ∗ 108A?, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.520, 𝑝 = 2.0 ∗ 108A?), quality analysts (𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ =0.505, 𝑝 = 3.9 ∗ 108KA, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.533, 𝑝 = 4.2 ∗ 108K@), and commercial 
companies (𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.479, 𝑝 = 1.6 ∗ 108K<, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ =0.589, 𝑝 = 8.9 ∗ 108L9). Comfort with law enforcement access to health data also showed 
significant associations with comfort sharing health data with third-party commercial companies 
for both access to and use of genetic data provided by 23andMe and AncestryDNA 
(𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.209, 𝑝 = 4.7 ∗ 10899, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.249,𝑝 = 6.4 ∗1089:) and access to health information more broadly (𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.118, 𝑝 =0.001, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.253, 𝑝 = 1.7 ∗ 10899).  
 
Confidence in existing laws and policies was also significantly associated with comfort 
with commercial companies. Belief that existing laws provide a reasonable level of protection 
associated with greater comfort sharing health data with third-party commercial companies 
(𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.318, 𝑝 = 4.4 ∗ 108<J, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.338,𝑝 = 1.7 ∗108<K), as did confidence that electronic health information was sufficiently protected 
(𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.273, 𝑝 = 6.3 ∗ 1089A, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = 0.372,𝑝 = 9.1 ∗108<L).     
 
Desire for control over and notification of the use of health data displayed strong 
associations with respondent comfort with sharing health data with third-party commercial 
companies for both patient and business purposes, but for business purposes especially. Desire 
for more control over health information generally (“I should have more control over how my 
health information is used”) was significantly associated with comfort with sharing with sharing 
health data with commercial companies for both patient purposes and business purposes 
(𝑝𝑎𝑡𝑖𝑒𝑛𝑡	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = −0.126,𝑝 = 0.00014, 𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ = −0.162, 𝑝 = 2.5 ∗108=A). Desire to know who has their health information (𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ =−0.211, 𝑝 = 2.9 ∗ 1089=)	and how that information is shared (𝑏𝑢𝑠𝑖𝑛𝑒𝑠𝑠	𝑝𝑢𝑟𝑝𝑜𝑠𝑒𝑠	𝑏∗ =
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−0.173, 𝑝 = 4.2 ∗ 108=?)	was strongly associated with comfort with sharing health data with 
third-party commercial companies for business purposes only. 
 
Table 4-9 Univariate associations for comfort (with researchers, quality analysts, commercial companies, and law enforcement), 
confidence in existing privacy laws and protections, and desire for control and notification of health data sharing 
Table 4.9 Univariate associations for comfort (with researchers, quality analysts, commercial 
companies, and law enforcement), confidence in existing privacy laws and protections, and desire for 
control and notification of health data sharing with comfort sharing health data with third-party 
commercial companies for patient purposes and business purposes (N=1841) 
 Patient Purposes 
(univariate) 
 Business Purposes 
(univariate) 
 b* p-value 𝑅<  b* p-value 𝑅< 
Comfort        
Comfort with Researchers 0.517 7.9*10-67 0.268  0.520 2.0*10-67 0.271 
Comfort with Quality Analysts 0.505 3.9e*10-56 0.255  0.533 4.2*10-59 0.284 
Comfort with Commercial 
Companies 
0.479 1.6*10-52 0.229  0.589 8.9*10-81 0.347 
Comfort with Law Enforcement 
Access 
       
It is okay for law enforcement to 
access health information 
0.118 0.001 0.014  0.253 1.7*10-11 0.064 
Comfortable with law 
enforcement using genetic and 
ancestry data 
0.209 4.7*10-11 0.044  0.249 6.4*10-14 0.062 
Confidence in Current Privacy 
Law 
       
Existing laws provide a 
reasonable level of protection 
0.318 4.4*10-23 0.101  0.338 1.7*10-25 0.115 
I am confident that electronic 
health information is sufficiently 
protected 
0.273 6.3*10-16 0.075  0.372 9.1*10-28 0.138 
Desire for control and 
notification of health 
information sharing 
       
I should have more control over 
how my health information is 
used 
-0.126 0.00014 0.016  -0.162 2.5*10-06 0.026 
It is important I know who has 
health information about me  
-0.073 0.029 0.005  -0.211 2.9*10-10 0.045 
I should be able to find out how 
my health information is shared  
0.028 0.40 0.001  -0.173 4.2*10-07 0.030 
        
b* = standardized beta 
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4.4.8 Stepwise regression model 
In the Bonferroni-corrected stepwise regression model, both comfort with researchers and 
quality analysts remained in the final model, accounting for 25% and 13% of variability in 
comfort with sharing health data with third-party commercial companies for patient and business 
purposes, respectively. Comfort with law enforcement accessing genetic data also remained in 
this model for both patient purposes (𝑏∗ = 0.102,𝑝 = 5.8 ∗ 108=K)	and business purposes (𝑏∗ =0.095, 𝑝 = 7.6 ∗ 108=K).	Desire to find out how health information is shared (“I should be able 
to find out how my health information is shared”) accounted for 12% of the variability in 
comfort with sharing health data with third-party commercial companies for patient purposes (𝑏∗ = 0.118,𝑝 = 0.00064) and 10% of the variability in comfort with sharing health data with 
third-party commercial companies for business purposes (𝑏∗ = −0.096, 𝑝 = 1.6 ∗ 108=K).  
 
As was mentioned in the methods section of this chapter, demographic variables and 
attitude measures from previous chapters were included in this final, complete model. Amongst 
the demographic variables explored in Chapter 2, education remained a significant variable in 
this final model of comfort with sharing health data with third-party commercial companies for 
patient purposes (high school: 𝑏∗ = 0.148,𝑝 = 0.007; 	some	college:	𝑏∗ = 0.177,𝑝 =0.00041;	BA or above: 𝑏∗ = 0.252, 𝑝 = 3.1 ∗ 10=A) and unemployment remained a significant 
variable for comfort with sharing health data with third-party commercial companies for business 
purposes (not employed: 𝑏∗ = 0.108,𝑝 = 0.0002). Trust in the health system (system trust), 
which was discussed in Chapter 3, accounted for 24% of variability in the final model of comfort 
with sharing health data with third-party commercial companies for patient purposes (𝑏∗ =0.235, 𝑝 = 2.6 ∗ 1089<) and 16% of the variability in comfort sharing health data with third-
party commercial companies for business purposes (𝑏∗ = 0.159,𝑝 = 3.0 ∗ 108=L).  
 
Concern about the Sloan Kettering Paige.AI event, originally discussed in Chapter 3, 
remained in this final model as well, accounting for 8% of variability in comfort sharing health 
data with third-party commercial companies for business purposes only (𝑏∗ = −0.079,𝑝 =0.0018).  
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Table 4-10 Stepwise regression modeling of predictors of comfort sharing health data with third-party commercial companies for 
patient and business purposes (full model) 
Table 4.10 Stepwise regression modeling of predictors of comfort sharing health data with third-party 
commercial companies for patient purposes and comfort sharing health data with third-party 
commercial companies for business purposes (N=1841) 
 Patient Purposes 
Multivariable stepwise 
Bonferroni corrected  
(𝛼 =	0.002) 
 Business Purposes 
Multivariable stepwise 
Bonferroni corrected  
(𝛼 =	0.002) 
 Model 𝑅< 0.417  Model 𝑅< 0.473 
 b* p-value  b* p-value 
Comfort      
 Comfort with Researchers 0.250 6.1*10-12  0.134 0.0023 
 Comfort with Quality Analysts    0.101 0.023 
 Comfort with Commercial 
Companies 
0.207 4.0*10-08  0.301 5.1*10-15 
Comfort with Law Enforcement      
 It is okay for law enforcement 
to access health information  
-0.055 0.037    
 Comfortable with law 
enforcement using genetic and 
ancestry data 
0.102 5.8*10-05  0.095 7.6*10-05 
Confidence in Current Privacy Law      
 Existing laws provide a 
reasonable level of protection  
0.136 0.0003  0.102 0.00012 
 I am confident that electronic 
health information is 
sufficiently protected 
-0.067 0.082    
Desire for control and notification of 
information sharing 
     
 It is important I know who has 
health information about me  
-0.094 0.012    
 I should be able to find out 
how my health information is 
shared 
0.118 0.00064  -0.096 1.6*10-05 
Concern about recent events      
 Concern about Sloan Kettering 
startup and conflict of interest  
   -0.079 0.0018 
Attitudes      
Trust      
 System Trust 0.235 2.6*10-12  0.159 3.0*10-08 
Altruism      
 Altruism 0.062 0.036    
Demographics      
Age      
 18-29 ref     
 30-44 -0.046 0.26    
 45-59 -0.098 0.023    
 60+ -0.080 0.058    
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Education      
 Less than High School ref     
 High School 0.148 0.007    
 Some college 0.177 0.00041    
 BA or above 0.252 3.1*10-06    
Income      
 Less than $60,000 ref     
 $60,000 or greater 0.045 0.088    
Employment      
 Employed    ref  
 Not employed    0.108 0.0002 
 Retired    -0.013 0.56 
 Disabled/Other    -0.034 0.19 
       
b* = standardized beta 
 
4.5 Discussion 
To better understand the public’s comfort with sharing health data with third-party 
commercial companies, this study sought to examine differences in comfort sharing health data 
for patient purposes and comfort sharing health data for business purposes. Our analysis 
concludes with three main findings. First, trust in the health system had a greater impact on 
comfort with sharing health data with third-party commercial companies for patient or business 
purposes did than any other variable—including privacy concerns. Second, respondent’s 
confidence in existing laws and policies was significantly associated with comfort with sharing 
health data. Third, desire for notification of health data sharing events was strongly associated 
with comfort with sharing health data with third-party commercial companies for both patient 
and business purposes and persisted in the multivariable model. Desire for control over how 
health data is shared, although significant in the univariate analysis, did not persist in the final 
multivariable model.  
 
That trust in the health system showed a stronger association with comfort with sharing 
health data with third-party commercial companies, comports with research that positions trust as 
an antecedent to privacy concerns (Bijlsma & Koopman, 2003; Waldman, 2016). In a study of 
trust in the workplace, the “higher the level of trust, the lower the costs of monitoring and other 
control mechanisms” (Bijlsma & Koopman, 2003). In the context of health data sharing, patients 
with more trust in the health system will be less concerned about the privacy and security of their 
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health data. That trust in the health system has so great of an effect on comfort with third-party 
commercial companies reinforces the numerous downstream effects of trust on the healthcare 
experience – patients with a high degree of trust in the health system are more likely to adhere to 
their treatment regimen (Sweeney, 2018), perceive their care as high quality (Cunningham, 
2009), and, based on the results of this study, confer the benefits of that trust onto third-party 
partners outside of the health system.  
 
Respondent comfort with sharing health information with third-party commercial 
companies was strongly associated not only with respondent comfort with commercial 
companies having access to both identified and de-identified data, but was also strongly 
associated with respondent’s comfort with both researchers and quality analysts having access to 
identified and de-identified data. Only 40% of participants reported being fairly or very 
comfortable sharing de-identified health information with commercial companies, while 60-65% 
of participants were fairly or very comfortable sharing de-identified health information with 
researchers and quality analysts. As the nature of healthcare research shifts to a greater number 
of partnerships with commercial companies, patients’ willingness to share health information 
with researchers may come to resemble their reluctance to share their health information with 
third-party commercial companies, leading to even greater withholding and compromised data 
sets. Although we cannot conclude from this study whether the Sloan Kettering event had an 
impact on subsequent comfort with sharing health information with third-party commercial 
companies, or if those who were already least comfortable with third-party commercial 
companies indicated that lack of comfort in their concern about the Sloan Kettering/Paige.AI 
event. That this event persisted in the final model leads one to speculate that events such as these 
may have a lasting effect on patients’ willingness to share their health information with 
commercial companies, and, by extension, health system researchers and quality analysts (table 
2.1.5: “65.07% of respondents were fairly or very concerned about Sloan Kettering hospital 
executives using hospital data for their own startup company”). 
 
Confidence in existing laws that protect health information is important to assuaging 
patient concerns about the use of personal health information. As advances in medical 
technologies outpace the ability of regulators to respond, it is increasingly difficult for patients to 
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be confident that their health data is protected, as well as increasingly difficult for health systems 
to balance the demand for innovation with a changing legal landscape out of sync with patient 
expectations. That only 42.02% of respondents thought that it was fairly or very true that 
“existing laws provide a reasonable level of protection for the privacy of patient information” 
underscores the inadequacy of current regulation and/ or that patients are unaware, and if they 
find out may be unpleasantly surprised.  
 
One of the most significant findings in this study was that desire for notification 
remained strongly associated with comfort with sharing health information with third-party 
commercial companies in the final multivariable model, while desire for control over health data 
did not. Privacy management is both context dependent and individual specific (Nissenbaum, 
2009) and efforts to provide privacy controls in healthcare are likely to be met with criticism by 
the more privacy-minded public, and apathy by others who may have no patience for managing 
and tuning their individual privacy preferences (Guo & Chen, 2012). Notification, however, 
while providing patients with information about where their data is being shared, can also 
provide the transparency necessary to enable greater trust in health data partnerships and 
confidence that the health system is acting with the patient’s own best interests in mind.  
 
4.5.1 Implications for research 
Healthcare research is rapidly becoming dependent on the large data sets provided by 
electronic personal health information (ePHI), and increasingly partnering with third-party 
commercial companies to leverage their data analysis capabilities and computing power. As it 
currently stands, patients are by and large willing to share their personal health information for 
research purposes. As research efforts become increasingly involved with commercial 
companies, it is possible that that the high degree of comfort with researchers reported in this 
study (65.24% of respondents were fairly or very comfortable with university researchers using 
their de-identified health information) may gradually shift towards the lower degree of comfort 
respondents reported having with commercial companies (41.01% of respondents were fairly or 
very comfortable with commercial companies using their de-identified health information). In 
the face of diminishing trust in the health system, involvement of patient stakeholders at the 
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inception of these partnerships is critical in order to provide transparency about the nature of data 
sharing and the potential benefits to patient care, and in so doing, mitigate fears of data abuse.   
 
4.5.2 Implications for policy and practice 
Federal adoption of a comprehensive law governing medical privacy is likely to go much 
further than the efforts of any one health system to improve trust. As previously stated, HIPAA is 
unable to sufficiently protect patient privacy in the era of big data. Adding to the difficulty 
inherent in regulatory management of both de-identified and identified health data, each state has 
their own laws in addition to HIPAA—but most do not have their own comprehensive laws 
governing medical privacy. Two states have added wide-reaching obligations to protect patient 
confidentiality: California and Texas. The California Medical Information Act (CMIA) explicitly 
covers mobile health apps, software, and hardware designed to maintain medical information. 
Failure to obtain authorization from the patient or violation of patient privacy can lead to 
penalties including civil lawsuits, administrative fines, or civil penalties (Solove & Schwartz, 
2019). The Texas Medical Privacy Act is, as of this writing, the broadest and strictest medical 
privacy laws in the United States, in short, expanding application of HIPAA to not only covered 
entities, but any organization that collects and stores protected health information (Solove & 
Schwartz, 2019), and prohibiting the re-identification of deidentified data under any 
circumstance (Luna, 2011). Adoption of either of these two standards would raise the floor of 
medical privacy protections and give both providers and patients a clear standard to which they 
must adhere.   
 
4.5.3 Implications for design 
Health systems navigating consumer-facing data for the first time may glean insight on 
how to handle designing for trust and privacy from the work done by researchers of electronic 
commerce. In their research on trustworthiness of electronic commerce, Belanger et al. (2002) 
concluded that winning public trust was the primary hurdle to e-commerce growth, and, based on 
their research and the research of others, offer six web design features were key to increasing 
consumer’s ratings of trustworthiness: 1) safeguard assurances, 2) company reputation, 3) ease of 
navigation, 4) robust order fulfillment, 5) professionalism of the website, and 6) use of state-of-
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the-art web design (Belanger et al., 2002). While these features were designed for online 
commerce sites, very similar criteria can be applied to health systems. Application to health 
systems can mean 1) providing “plain language” explanation of technical and regulatory privacy 
protections to patients, as well as the consequences of violation; 2) maintenance of reputation 
through transparency – companies have been shown to recover trust more quickly in the wake of 
a data breaches if customers are notified of the breach in a timely manner (Bansal & Zahedi, 
2015); 3) designing electronic health information portals and notification dashboards to be easy 
to navigate for patients; 4) responding quickly to patient inquiries about their data; 5) 
maintaining professional websites; 6) using state-of-the art web design. In future research we 
will conduct more in-depth research on these design features as they apply to healthcare.  
 
4.5.4 Limitations 
As with any survey, this study is merely a snapshot of patient beliefs and preferences, 
limited due to the nature of survey questions – other demographic variables, attitude measures, 
and questions exploring comfort with data sharing generally that may provide a more complete 
portrait of the public’s comfort with sharing health data with third-party commercial companies 
may not be captured here. Additionally, a stepwise regression model is a conservative model that 
eliminates factors that might be important to understanding patient and public comfort with 
sharing health data with third-party commercial companies.  
 
4.5.5 Conclusion 
The results of this study, as well as the results of the chapter that precedes it, underscore 
the importance of trust in the health system as healthcare systems navigating increasing numbers 
of partnerships with third-party commercial companies and patients’ comfort with sharing health 
data with those third-party commercial companies. This study also provided more insight into the 
relationship between comfort with third-party commercial companies and notification of data use 
versus control over data use. Healthcare systems can begin patient privacy efforts by focusing 
not on data control, which is fraught with a myriad number of technological issues, but on data 
use notification. That confidence in existing laws remained significantly associated with comfort 
with sharing health data with third-party commercial companies adds to the growing body of 
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research and commentary that states current laws and regulations are inadequate for our current 
data landscape and demand revision.  
 
4.6 Acknowledgements 
Research reported in this manuscript was supported by the National Cancer Institute of 
the National Institutes of Health under award number 5 R01 CA214829-03. 
 
4.7 References 
Anderson, C., & Agarwal, R. (2011). The Digitization of Healthcare: Boundary Risks, Emotion, 
and Consumer Willingness to Disclose Personal Health Information. Information Systems 
Research, 22(3), 469–490. https://doi.org/10.1287/isre.1100.0335 
Bansal, G., & Zahedi, F. M. (2015). Trust violation and repair: The information privacy 
perspective. Decision Support Systems, 71, 62–77. 
https://doi.org/10.1016/j.dss.2015.01.009 
Batbaatar, E., Dorjdagva, J., Luvsannyam, A., Savino, M. M., & Amenta, P. (2017). 
Determinants of patient satisfaction: A systematic review. Perspectives in Public Health, 
137(2), 89–101. https://doi.org/10.1177/1757913916634136 
Belanger, F., Hiller, J. S., & Smith, W. J. (2002). Trustworthiness in electronic commerce: The 
role of privacy, security, and site attributes. The Journal of Strategic Information 
Systems, 11(3), 245–270. https://doi.org/10.1016/S0963-8687(02)00018-5 
Bijlsma, K., & Koopman, P. (2003). Introduction: Trust within organisations. Personnel Review, 
32(5), 543–555. https://doi.org/10.1108/00483480310488324 
Bishop, L. “Sam,” Holmes, B., & Kelley, C. (2005). National Consumer Health Privacy Survey 
2005. California Health Care Foundation. https://www.chcf.org/publication/national-
consumer-health-privacy-survey-2005/ 
 140 
Black Book Market Research. (2017, January 3). Healthcare’s Digital Divide Widens, Black 
Book Consumer Survey. Black Book Market Research. 
https://blackbookmarketresearch.newswire.com/news/healthcares-digital-divide-widens-
black-book-consumer-survey-18432252 
Boulware, L. E., Cooper, L. A., Ratner, L. E., LaVeist, T. A., & Powe, N. R. (2003). Race and 
Trust in the Health Care System. Public Health Reports, 118, 8. 
Business Wire. (2019, June 25). The $11.9 Trillion Global Healthcare Market: Key 
Opportunities & Strategies (2014-2022) - ResearchAndMarkets.com. Businesswire. 
https://www.businesswire.com/news/home/20190625005862/en/11.9-Trillion-Global-
Healthcare-Market-Key-Opportunities 
Cohen, I. G., & Mello, M. M. (2018). HIPAA and Protecting Health Information in the 21st 
Century. JAMA, 320(3), 231–232. https://doi.org/10.1001/jama.2018.5630 
Cunningham, P. J. (2009). High Medical Cost Burdens, Patient Trust, and Perceived Quality of 
Care. Journal of General Internal Medicine, 24(3), 415–420. 
https://doi.org/10.1007/s11606-008-0879-3 
Damschroder, L. J., Pritts, J. L., Neblo, M. A., Kalarickal, R. J., Creswell, J. W., & Hayward, R. 
A. (2007). Patients, privacy and trust: Patients’ willingness to allow researchers to access 
their medical records. Social Science & Medicine, 64(1), 223–235. 
https://doi.org/10.1016/j.socscimed.2006.08.045 
Davis, J. (2019, April 15). Third-Party Vendors Behind 20% of Healthcare Data Breaches in 
2018. HealthITSecurity. https://healthitsecurity.com/news/third-party-vendors-behind-20-
of-healthcare-data-breaches-in-2018 
 141 
Feldman, S., & Steenbergen, M. R. (2001). The Humanitarian Foundation of Public Support for 
Social Welfare. American Journal of Political Science, 45(3), 658–677. JSTOR. 
https://doi.org/10.2307/2669244 
Fussell, S. (2020, January 8). The Sneaky Genius of Facebook’s New Preventive Health Tool. 
The Atlantic. https://www.theatlantic.com/technology/archive/2020/01/facebook-
launches-new-preventative-health-tool/604567/ 
Gellman, R. (2011). The Deidentification Dilemma: A Legislative and Contractual Proposal. 
Fordham Intellectual Property, Media and Entertainment Law Journal, 21(1), 31. 
Gooch, K. (2017, January 3). Privacy issues drive health IT consumer skepticism: 10 Black Book 
survey findings. Becker’s Health IT. https://www.beckershospitalreview.com/healthcare-
information-technology/privacy-issues-drive-health-it-consumer-skepticism-10-black-
book-survey-findings.html 
Guo, S., & Chen, K. (2012). Mining Privacy Settings to Find Optimal Privacy-Utility Tradeoffs 
for Social Network Services. 2012 International Conference on Privacy, Security, Risk 
and Trust and 2012 International Confernece on Social Computing, 656–665. 
https://doi.org/10.1109/SocialCom-PASSAT.2012.22 
Guzman, G. G. (2019). American Community Survey Briefs—Household Income: 2018. United 
States Census Bureau, 13. 
Hall, M. A., Camacho, F., Dugan, E., & Balkrishnan, R. (2002). Trust in the Medical Profession: 
Conceptual and Measurement Issues: Trust in the Medical Profession: Conceptual and 
Measurement Issues. Health Services Research, 37(5), 1419–1439. 
https://doi.org/10.1111/1475-6773.01070 
 142 
Hall, M. A., Dugan, E., Zheng, B., & Mishra, A. K. (2001). Trust in Physicians and Medical 
Institutions: What Is It, Can It Be Measured, and Does It Matter? The Milbank Quarterly, 
79(4), 613–639. https://doi.org/10.1111/1468-0009.00223 
Hall, M. A., Zheng, B., Dugan, E., Camacho, F., Kidd, K. E., Mishra, A., & Balkrishnan, R. 
(2002). Measuring Patients’ Trust in their Primary Care Providers. Medical Care 
Research and Review, 59(3), 293–318. https://doi.org/10.1177/1077558702059003004 
HHS Press Release. (2020, March 6). HHS Finalizes Historic Rules to Provide Patients More 
Control of Their Health Data [Text]. HHS.Gov. 
https://www.hhs.gov/about/news/2020/03/09/hhs-finalizes-historic-rules-to-provide-
patients-more-control-of-their-health-data.html 
HIPAA Journal. (2017, January 5). Patients Holding Back Health Information Over Data Privacy 
Fears. HIPAA Journal. https://www.hipaajournal.com/patients-holding-back-health-
information-over-fears-of-data-privacy-8634/ 
Hoffman, S. (2020). Citizen Science: The Law and Ethics of Public Access to Medical Big Data. 
Berkeley Tech. LJ, 30(3), 66. 
Jilka, S. R., Callahan, R., Sevdalis, N., Mayer, E. K., & Darzi, A. (2015). “Nothing About Me 
Without Me”: An Interpretative Review of Patient Accessible Electronic Health Records. 
Journal of Medical Internet Research, 17(6), e161. https://doi.org/10.2196/jmir.4446 
Karampela, M., Ouhbi, S., & Isomursu, M. (2019). Connected Health User Willingness to Share 
Personal Health Data: Questionnaire Study. Journal of Medical Internet Research, 
21(11). https://doi.org/10.2196/14537 
Kim, J., Kim, H., Bell, E., Bath, T., Paul, P., Pham, A., Jiang, X., Zheng, K., & Ohno-Machado, 
L. (2019). Patient Perspectives About Decisions to Share Medical Data and 
 143 
Biospecimens for Research. JAMA Network Open, 2(8), e199550–e199550. 
https://doi.org/10.1001/jamanetworkopen.2019.9550 
LaVeist, T. A., Isaac, L. A., & Williams, K. P. (2009). Mistrust of Health Care Organizations Is 
Associated with Underutilization of Health Services. Health Services Research, 44(6), 
2093–2105. https://doi.org/10.1111/j.1475-6773.2009.01017.x 
Luna, J. (2011). Texas Medical Privacy Act, Health Law & Policy Institute. University of 
Houston Law Center. 
https://www.law.uh.edu/healthlaw/perspectives/Privacy/010830Texas.html 
Merken, S., & Elfin, D. (2018, October 31). What’s Your Health Data Worth? Startups Want to 
Help You Sell It. Bloomberg Law. https://news.bloomberglaw.com/tech-and-telecom-
law/whats-your-health-data-worth-startups-want-to-help-you-sell-it 
Nguyen, G. C., LaVeist, T. A., Harris, M. L., Datta, L. W., Bayless, T. M., & Brant, S. R. 
(2009). Patient Trust-in-Physician and Race Are Predictors of Adherence to Medical 
Management in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 15(8), 
1233–1239. https://doi.org/10.1002/ibd.20883 
Nissenbaum, H. (2009). Privacy in Context: Technology, Policy, and the Integrity of Social Life. 
Stanford University Press. 
Office for Civil Rights (OCR). (2013). 190-Who must comply with HIPAA privacy standards 
[Text]. HHS.Gov. https://www.hhs.gov/hipaa/for-professionals/faq/190/who-must-
comply-with-hipaa-privacy-standards/index.html 
Ousfar, E. (2019, October 29). Facebook announces new health tool that urges users to get 
preventive care. News Center Maine. 
https://www.newscentermaine.com/article/news/health/facebook-announces-new-health-
 144 
tool-that-urges-its-users-to-get-preventive-care/97-93a45c7f-03e6-47d2-b608-
60732a2f64d8 
Perrin, A. (2020, February 4). About half of Americans are OK with DNA testing companies 
sharing user data with law enforcement. Pew Research Center. 
https://www.pewresearch.org/fact-tank/2020/02/04/about-half-of-americans-are-ok-with-
dna-testing-companies-sharing-user-data-with-law-enforcement/ 
Platt, J. E., Jacobson, P. D., & Kardia, S. L. R. (2018). Public Trust in Health Information 
Sharing: A Measure of System Trust. Health Services Research, 53(2), 824–845. 
https://doi.org/10.1111/1475-6773.12654 
Promarket. (2020, February 7). The Real Price of Health Data: Americans Don’t Want to Share 
Their Records for Free. Pro Market. https://promarket.org/2020/02/07/the-real-price-of-
health-data-americans-dont-want-to-share-their-records-for-free/ 
Rushton, G., Armstrong, M. P., Gittler, J., Greene, B. R., Pavlik, C. E., West, M. M., & 
Zimmerman, D. L. (2006). Geocoding in cancer research: A review. American Journal of 
Preventive Medicine, 30(2 Suppl), S16-24. https://doi.org/10.1016/j.amepre.2005.09.011 
Schwarzer, R., & Jerusalem, M. (1992). General Self-Efficacy- Schwarzer (GSES). Statistics 
Solutions. https://www.statisticssolutions.com/general-self-efficacy-schwarzer-gses/ 
Seltzer, E., Goldshear, J., Guntuku, S. C., Grande, D., Asch, D. A., Klinger, E. V., & Merchant, 
R. M. (2019). Patients’ willingness to share digital health and non-health data for 
research: A cross-sectional study. BMC Medical Informatics and Decision Making, 19(1), 
157. https://doi.org/10.1186/s12911-019-0886-9 
Shen, N., Bernier, T., Sequeira, L., Strauss, J., Silver, M. P., Carter-Langford, A., & Wiljer, D. 
(2019). Understanding the patient privacy perspective on health information exchange: A 
 145 
systematic review. International Journal of Medical Informatics, 125, 1–12. 
https://doi.org/10.1016/j.ijmedinf.2019.01.014 
Singer, N. (2019, September 3). When Apps Get Your Medical Data, Your Privacy May Go 
With It. The New York Times. 
https://www.nytimes.com/2019/09/03/technology/smartphone-medical-records.html 
Smith, C. (2011). Somebody’s Watching Me: Protecting Patient Privacy in Prescription Health 
Information Constitutional Constraints on State Health Care & Privacy Regulation after 
Sorrell v. IMS Health. Vermont Law Review, 36(4), 931–994. 
Smith, T., Davern, M., Freese, J., & Morgan, S. (2019). General Social Surveys, 1972-2018. 
NORC, 11. 
Solove, D. J., & Schwartz, P. M. (2019). Privacy Law Fundamentals (SSRN Scholarly Paper ID 
1790262). Social Science Research Network. https://papers.ssrn.com/abstract=1790262 
Spencer, K., Sanders, C., Whitley, E. A., Lund, D., Kaye, J., & Dixon, W. G. (2016). Patient 
Perspectives on Sharing Anonymized Personal Health Data Using a Digital System for 
Dynamic Consent and Research Feedback: A Qualitative Study. Journal of Medical 
Internet Research, 18(4), e66. https://doi.org/10.2196/jmir.5011 
Teixeira, P. A., Gordon, P., Camhi, E., & Bakken, S. (2011). HIV patients’ willingness to share 
personal health information electronically. Patient Education and Counseling, 84(2), e9–
e12. https://doi.org/10.1016/j.pec.2010.07.013 
Tiller, J. (2019, November 12). If you’ve given your DNA to a DNA database, US police may 
now have access to it. The Conversation. http://theconversation.com/if-youve-given-
your-dna-to-a-dna-database-us-police-may-now-have-access-to-it-126680 
 146 
US Census Bureau. (2019). Health Insurance Coverage in the United States: 2018. The United 
States Census Bureau. https://www.census.gov/library/publications/2019/demo/p60-
267.html 
Waldman, A. E. (2016). Privacy, sharing, and trust: The Facebook study. Case Western Reserve 
Law Review, 67(1), 193-. Academic OneFile. 
Weitzman, E. R., Kaci, L., & Mandl, K. D. (2010). Sharing Medical Data for Health Research: 
The Early Personal Health Record Experience. Journal of Medical Internet Research, 
12(2). https://doi.org/10.2196/jmir.1356 
Willison, D. J., Steeves, V., Charles, C., Schwartz, L., Ranford, J., Agarwal, G., Cheng, J., & 
Thabane, L. (2009). Consent for use of personal information for health research: Do 
people with potentially stigmatizing health conditions and the general public differ in 
their opinions? BMC Medical Ethics, 10(1), 10. https://doi.org/10.1186/1472-6939-10-10 
 
 
 
 
 
 
 147 
Chapter 5 Conclusion 
 
5.1 Summary of findings 
Health systems and patients are navigating new challenges to privacy and trust as the 
number of third-party commercial companies operating in the healthcare space continues to 
increase. My dissertation research sought to understand the public’s comfort with sharing health 
data with third party commercial companies and explore the issues and concerns healthcare 
systems must anticipate. Anticipation of these concerns, proactive engagement with patients, and 
protection of patient privacy in the absence of regulatory guidance can mitigate the backlash 
suffered by other health systems at the announcement of their third-party commercial 
partnerships.   
 
 In the analysis comparing the public’s comfort with sharing health data with third-party 
commercial companies for patient purposes with the public’s comfort with sharing health data 
with third-party commercial companies for business purposes, a statistically significant 
difference emerged between the two purposes. Respondents reported greater comfort with 
sharing health data with third-party commercial companies for patient purposes.  
 
Factors positively associated with the public’s comfort with sharing health data with third 
party commercial companies for patient purposes were: having some college education or a 
college degree, system trust, provider trust, comfort with researchers and commercial companies, 
comfort with law enforcement accessing genetic information, confidence in existing laws, desire 
to know how health information is shared, and altruism. Factors positively associated with the 
public’s comfort with sharing health data with third-party commercial companies for business 
purposes were system trust, provider trust, employment status, comfort with researchers, quality 
analysts, and commercial companies, comfort with law enforcement accessing genetic 
information, and confidence in existing laws. Factors negatively associated with the public’s 
comfort with sharing health data with third-party commercial companies for patient purposes 
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were respondent age between 45-59, privacy concerns, comfort with law enforcement accessing 
health information, desire to know with whom health information is shared. Factors negatively 
associated with the public’s comfort with sharing health data with third-party commercial 
companies for business purposes were privacy concerns, concern about Memorial Sloan 
Kettering’s start-up company, Paige.AI, and desire to know how health information is shared.  
 
Amongst these significant variables, three emerged as the greatest predictors of comfort 
with sharing health data with third-party commercial companies for both patient and business 
purposes: trust in the health system, confidence in existing laws, and desire for notification. Trust 
in the health system displayed the strongest association with comfort with sharing health data 
with third-party commercial companies. Privacy concern, although strongly associated with 
comfort with third-party commercial companies in Chapters 2 and 3 of this dissertation, did not 
persist in the final model presented in Chapter 4. As was discussed in Chapter 4, legal 
scholarship in privacy and research in consumer behavior have positioned trust as an antecedent 
to privacy concern – when trust between parties is high, the need for mechanisms of control 
(laws, regulation, monitoring) decreases. This finding also indicates that regardless of the 
privacy controls provided to consumers or to patients, comfort with the third-party commercial 
partners of health systems will remain low if trust is not secured. The public’s low confidence in 
current health data privacy laws and regulations is likely also a product of diminished trust in the 
health system. Only 42.02% of respondents felt that “existing laws provided a reasonable level of 
protection for the privacy of patient information” and only 33.78% were “confident that 
electronic health information is sufficiently protected by current law and regulation”. Desire for 
notification remained significant in the multivariable model while desire for control over how 
health information is used did not. Research on usage rates of available privacy controls in social 
media might provide insight into this.  
 
Education persisted in the final model but displayed a relationship with comfort with 
sharing health data with third-party commercial companies for patient purposes that is contrary 
to existing research (Blank et al., 2014; Kim et al., 2019; Sheehan, 1999). These studies have 
found that greater educational attainment is associated with decreased comfort with sharing 
health data with third-party commercial companies. In this analysis, we found the opposite was 
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true when the purpose and intent of the health data sharing partnership was differentiated. 
Educational attainment, which includes having some college experience, was negatively 
associated with greater comfort with sharing health data with third-party commercial companies 
for business purposes, but was positively associated with greater comfort with sharing health 
data with third-party commercial companies for patient purposes.  
 
Respondent age between 45-59 also remained in the final model of the public’s comfort 
with sharing health data with third-party commercial companies for patient purposes. The 
negative association seen here potentially reflects a product of what has been referred to as the 
“grey” digital divide – individuals who came of age in the time before the explosion of the 
internet and digital technologies use the internet and digital technologies at lower rates than 
digital natives (Zhou & Salvendy, 2017) and are thus less comfortable with online transactions 
and are also the age most concerned about online fraud (Milewski, 2016).    
 
Perceived healthcare access displayed strong association with the public’s comfort with 
sharing health data for patient purposes only, but this association did not persist in the 
multivariable regression conducted in chapter 3 (table 3.10). The reasons for this are likely the 
introduction of measures evaluating trust in the health system (system trust) and measures 
evaluating altruism. That perceived healthcare access did not persist in the multivariable model 
at the introduction of the latter two is consistent with research on trust in healthcare systems. 
Trust in the health system is high when communication between patient and provider is positive 
and patients feel able to access sufficient health services reliably (Thiede, 2005).  
 
Notably, while past experience of a data breach and concern about recent data breach 
events were significantly associated with comfort with sharing health data with third-party 
commercial companies for business purposes in the univariate analysis, these variables did not 
remain in the final multivariable model (chapter 3). As discussed in chapter 3, these results 
suggest that although the number of data breach events in other sectors that magnify the salience 
of privacy issues is increasing, their effect on the public’s concerns about health data is limited. 
That concern about the Memorial Sloan Kettering Paige.AI startup did persist in the final model 
underscores this distinction. Health data violations, real or perceived, may in turn affect other 
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health systems, diminishing trust and increasing privacy concerns for all patients in all health 
systems. As the number of healthcare partnerships with commercial companies and the number 
of commercial entrants into the healthcare market continue to increase, these results suggest that 
failure to address privacy and health data protection in the ways most meaningful to patients will 
only accelerate the deterioration of trust in the health system.  
 
Comfort with researchers, quality analysts, and commercial companies was positively 
associated with comfort with sharing health data with third-party commercial companies. This 
intuitive finding confirms consistency with the measures created to evaluate the public’s comfort 
with sharing health data with third-party commercial companies for patient and business 
purposes. Examination of the descriptive statistics of comfort with commercial companies 
having access to both identified and de-identified data shows low rate of comfort when compared 
to researchers and quality analysts. In chapter 4 I argue that the increasing number of commercial 
partnerships might create drag on the relatively high rate of comfort the public current has with 
both researchers and quality analysts.  
 
Examination of the measures used to evaluate the public’s comfort with law enforcement 
displays an interesting contrast: only 17.22% of respondents felt it was fairly or very true that it 
was “okay for law enforcement to access health information” but 37.26% of these same 
respondents were fairly or very comfortable with law enforcement using genetic and ancestry 
data. Further research is needed to illuminate this difference, but it may be a function of 
ubiquitous advertising and normalization of at-home genetic tests by 23andMe and 
Ancestry.com. By the start of 2019, more than 26 million consumers had added genetic 
information to a commercial ancestry database (Regalado, 2019).  
 
From these results, health care systems might do the following to increase the public’s 
comfort with third-party commercial companies and minimize the possibility of public backlash 
and media outcry:  
 
• Emphasize the intended patient care and improvements that are expected to result 
from a partnership with a third-party commercial company (practice).  
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• Improve trust in the health system (practice).  
• Advocate for changes to health data privacy laws and rules, modeled after Texas 
and California health data privacy legislation (policy).  
• Focus health privacy efforts on notification rather than on the provision of privacy 
controls (research and design).  
 
5.2 Implications for practice 
From the perspective of the healthcare system, any improvements to the business of 
healthcare in turn improve patient care and outcomes. For the public, however, this may not be 
well understood. Chapter 2 of this dissertation describes the statistically significant difference 
between comfort with sharing health data for patient purposes versus sharing health data for 
business purposes (data sent to insurers, data that is stored), and the surprising positive 
association between educational attainment and comfort with sharing health data for patient 
purposes. These results underscore the importance of emphasizing to the public how patient care, 
treatment, and delivery might be improved through a partnership with a third-party commercial 
company, and to proactively communicate both the terms of the partnership and desired insights 
that might result from the venture. 
 
Trust in the health system emerged in this study as the strongest predictor of comfort with 
sharing health data with third-party commercial companies. Trust recommendations abound as 
health and legal researchers realize the extent to which trust in health systems predicts care 
outcomes, regimen adherence, and patient satisfaction, as discussed in chapters 3 and 4 of this 
dissertation. In the interest of proactive communication of the terms and desired outcomes of 
third-party partnerships, health systems may benefit tremendously from the inclusion of patient 
advocates at the inception of these partnerships.  
 
5.3 Implications for policy  
Confidence in existing laws regulating health data sharing was positively associated with 
comfort with sharing health data with third-party commercial companies, but a minority of 
participants in this study felt that existing laws provided them “reasonable” or “sufficient” 
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protection. As detailed in chapter 2, California and Texas are the only states with comprehensive 
patient privacy laws that go above and beyond the protections currently offered by HIPAA. 
These policy weaknesses will undermine efforts to improve trust in health systems and de-
incentivize investment in the data infrastructure necessary to provide privacy controls or data use 
notification to patients.  
 
5.4 Implications for Design  
That notification persisted in the final model of the public’s comfort with sharing health 
data with third-party commercial companies and desire for control over health data may indicate 
that patients first need to know how and where their health data is being used, and from that 
informed starting point, may make more stringent or relaxed privacy decisions based on this 
information. As stated in chapter 4 of this dissertation, health systems are having to quickly 
navigate the changing business of healthcare whereby patients expect the same convenience 
afforded them by other industries. Proactive communication of third-party partnerships can occur 
via press releases and media reports or can occur through notification dashboards in the patient’s 
health profile. This option is an attractive one for health systems to consider for two reasons: 1) 
notification can, in theory, be automated; 2) the myriad number of ways patient data is shared is 
so wide that it would be an inconceivable task for any one health system or department to 
undertake manually.  
 
Health systems navigating consumer-facing data for the first time may glean insight on 
how to handle designing for trust and privacy from the work done by researchers of electronic 
commerce. I restate here the work of Belanger (2002), who concluded that winning public trust 
was the primary hurdle to e-commerce growth, and, based on their research and the research of 
others, offer six web design features were key to increasing consumer’s ratings of 
trustworthiness: 1) safeguard assurances, 2) company reputation, 3) ease of navigation, 4) robust 
order fulfillment, 5) professionalism of the website, and 6) use of state-of-the-art web design 
(Belanger et al., 2002). While these features were designed for online commerce sites, very 
similar criteria can be applied to health systems. Application to health systems can mean 1) 
providing “plain language” explanation of technical and regulatory privacy protections to 
patients, as well as the consequences of violation; 2) maintenance of reputation through 
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transparency – companies have been shown to recover trust more quickly in the wake of a data 
breaches if customers are notified of the breach in a timely manner (Bansal & Zahedi, 2015); 3) 
designing electronic health information portals and notification dashboards to be easy to navigate 
for patients; 4) responding quickly to patient inquiries about their data; 5) maintaining 
professional websites; 6) using state-of-the art web design. In the computing environment, 
interface design, the quality of a website, grammatical errors, poor navigation structure, and 
broken links can also influence perceptions of trustworthiness. Based on the results of this study, 
healthcare systems may consider notification dashboards in lieu of granular control over health 
data sharing.  
 
5.5 Implications for research  
 In future studies I will further explore notification design and the accompanying technical 
issues, visual and design options, and communication techniques on which notification depends. 
The research team of Professor Jodyn Platt has conducted two focus group deliberation sessions 
with Michigan residents to explore patient’s understanding of how their health data is used inside 
and outside of the healthcare system. In just the two sessions that have been conducted, we have 
gained insight into how patients would like to be notified, how they would like to retrieve that 
information, and what information is most valuable to them. In my subsequent research I will 
expand on the findings presented here, designing and testing a potential data use notification 
interface for patients.  
 
5.6 Conclusion  
As technology companies increasingly enter the healthcare marketplace, they are doing 
so in a regulatory environment that is out of sync with our current digital reality –data that is 
collected, sold, and bartered not only increases the likelihood of re-identification, but also 
increases the likelihood of a data breach. Patients are aware of these risks, as evidenced by the 
low comfort with sharing health data with third-party commercial companies and by the 
increased prevalence of reported information withholding by patients. Healthcare systems can no 
longer rely on de-identification alone to protect patient privacy. Machine learning techniques 
have provided university researchers as well as companies with the ability to combine data sets 
 154 
and glean insights into individual behavior. Healthcare systems can build trust by being 
transparent at the inception of a third-party commercial partnerships and prevent the public 
surprise and backlash that has characterized the announcements of recent partnerships with third-
party commercial companies. Comprehensive patient privacy protection regulation and efforts to 
provide data use more transparent to patients is necessary for patients, providers, as well as 
technology companies, to advance innovation in healthcare and protect patient privacy. 
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NORC AmeriSpeak Survey 
 
Client University of Michigan 
Project Name Longitudinal Survey of Epidemiology 
Project Number 8478 
Survey length (median)  20-minute survey 
Population 21+ gen pop 
African American/Hispanic and <=200% FPL oversamples 
Pretest  N=100 
Main  N=2000 
MODE Web only 
Language English 
Incentive 5,000 points 
Survey description Healthcare issues 
Eligibility Rate 100% 
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Standard demographic preloads: 
Var Name Var Type Var length Variable Label 
S_AGE Numeric 5 Age 
S_GENDER String 8 Gender 
S_RACETH Numeric 8 Race/ethnicity 
S_EDUC Numeric 6 Education 
S_MARITAL Numeric 9 Marital Status 
S_EMPLOY Numeric 8 Current employment status 
S_INCOME Numeric 8 Household income 
S_STATE String 7 State 
S_METRO Numeric 7 Metropolitan area flag 
S_INTERNET Numeric 10 Household internet access 
S_HOUSING Numeric 9 Home ownership 
S_HOME_TYP
E 
Numeric 11 Building type of panelist’s 
residence 
S_PHONESER
VC 
Numeric 11 Telephone service for the 
household 
S_HHSIZE Numeric 8 Household size (including children) 
S_HH01 Numeric 6 Number of HH members age 0-1 
S_HH25 Numeric 6 Number of HH members age 2-5 
S_HH612 Numeric 7 Number of HH members age 6-12 
S_HH1317 Numeric 8 Number of HH members age 13-17 
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S_HH18OV Numeric 8 Number of HH members age 18+ 
S_file_date Date 11  
S_GENFRACE Numeric 8 GenF custom race 
These populated as a pre-load when the panelists get sampled into the survey 
 
Standard sample preloads 
Variable 
Name 
Variable 
Type 
Variable Label 
Username Numeric Analogous to Member_PIN 
P_Batch Numeric Batch Number (if only one assignment, then 
everyone will be 1) 
Dialmode Numeric CATI Dialmode (predictive, preview, etc) 
P_LCS Numeric Life cycle stage, 0=released but not touched 
Y_FCELLP String  
Surveylength Numeric Estimated length of survey 
SurveyId Numeric Survey ID# in A4S 
Incentwcomma String Study specific  
P_Hold01 Numeric Prevents dialing cases without phone numbers 
 
Custom survey-specific preloads  
Variable 
Name 
Variable 
Type 
Variable Label 
P_PARTYID7 Numeric 1 "Strong Democrat" 
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2 "Moderate Democrat" 
3 "Lean Democrat"  
4 "Don't Lean/Independent/None" 
5 "Lean Republican" 
6 "Moderate Republican" 
7 "Strong Republican" 
*only preload responses IF NOT MISSING 
PARTYID7 
FPL200 Numeric 1 “200FPL” 
0 “Not 200FPL” 
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This survey will use the following RND_xx variables: 
Note, these are randomized in the script (NOT preloads) 
RND_xx Associated survey 
Qs 
RND_00  
RND_01  
RND_02  
RND_03  
RND_04  
RND_05  
RND_06  
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Please include the following options for all questions in CATI: 
77 DON’T KNOW 
99 REFUSED 
 
Please code refusals in CAWI: 
98 IMPLICIT REFUSAL, WEB SKIP 
Do not code 77 Don’t Know/99 Refused options in CAWI unless written in item response 
options 
 
 
Text shown in green includes researcher notes and should not be included in the programming. 
 
 
[START OF SURVEY] 
 
CREATE DATA-ONLY VARIABLE: QUAL 
1=Qualified Complete 
2=Not Qualified 
3=In progress 
 
AT START OF SURVEY COMPUTE QUAL=3 “IN PROGRESS” 
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CREATE MODE_START 
1=CATI 
2=CAWI 
 
 
HOVER TEXT PROGRAMMING: BELOW IS THE HOVER TEXT THAT SHOULD BE 
DISPLAYED WHERE INDICATED THROUGHOUT THE SURVEY 
 
HT_1: My healthcare system 
“Your healthcare system” refers to the healthcare professionals and institutions that you 
personally interact with when getting health care.  
 
HT_2: The healthcare system 
“The healthcare system” refers generally to the healthcare system in this country. 
 
HT_3: Healthcare providers 
Health care providers include people such as doctors and nurses who provide medical treatment. 
 
HT_4: Electronic health record 
A digital version of your paper chart or medical record. An electronic health record contains your 
medical and treatment history including diagnoses, medications, treatment plans, immunization dates, 
allergies, radiology images, and laboratory and test results.   
 
HT_5: Health information 
Health information includes information about you and your medical treatment history including 
diagnoses, medications, treatment plans, immunization dates, allergies, radiology images, and 
laboratory and test results.   
 
HT_7: De-identified [health information or biospecimens] 
De-identified means that “identifying information” about you is removed from your health information. 
Identifying information includes things like your name, address, date of birth, etc.     
 
HT_8: University researcher 
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A university researcher is a person who works for colleges or universities. University researchers might use health 
information to understand how people use the healthcare system, how healthcare providers treat patients, and a 
wide variety of other health related topics. University researchers might also use biospecimens for research on 
how illness works, which treatments are most effective, or how genetics affect illness. University researchers may 
or may not be connected to your hospital in some way. 
 
HT_9: Biospecimens 
Biospecimens include blood from a blood test, or tissue or tumor samples from a biopsy. Your 
biospecimens contain your DNA.  
 
HT_10: Identified [health information or biospecimens] 
Identifying information includes things like your name, address, date of birth, etc.  Identified 
biospecimens are biospecimens that include identifying information about you.  
 
HT_11: Quality analysts 
Quality analysts are people who work for hospitals or clinics. They use patient health information at their hospital 
or clinic to check on, and improve, how their organization is working. They often study the cost of healthcare, their 
organization’s efficiency on things like waiting room times, and the health of patients at their hospital or clinic. 
 
HT_12: Commercial companies 
Commercial companies are third-party companies that are not part of a hospital. For example, a third-party 
commercial company may conduct genetic tests and analyze information for a hospital or healthcare provider for a 
fee when a hospital is not be able to conduct the test on their own.  
 
 
(Project name) Draft 
Date: (Quex start date)  
 
 
[DISPLAY – WINTRO_1] 
Thank you for agreeing to participate in our new AmeriSpeak survey! To thank you for sharing 
your opinions, we will give you a reward of [INCENTWCOMMA] AmeriPoints after 
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completing the survey. As always, your answers are confidential. 
 
Please use the "Continue" and "Previous" buttons to navigate between the questions within the 
questionnaire. Do not use your browser buttons. 
 
[DISPLAY_1]  
This is a survey about your healthcare experience and your opinions about how [HT_5] health 
information is used and shared.  
[SPACE] 
The survey includes a short video, which <u>needs to be viewed with sound</u>. If you are not able to 
have your sound on at this time, feel free to take this survey later when you can. Alternatively, if you will 
not be able to view the video with sound, we have a transcript of the video that can be read instead.  
 
 
[DISPLAY_2] 
We all use [HT_2] the healthcare system or know people who do.  This system includes the healthcare 
provider, like a doctor or nurse, who you visit when you’re sick or for routine visits.  It also includes 
hospitals and people who work on quality improvement, and administrators who make decisions about 
how clinics and hospitals are run.  
[SPACE] 
When we ask about <i>“[HT_2] the healthcare system”</i> we are asking generally about [HT_2] the 
healthcare system in this country. When we ask about “your healthcare system” we are asking about the 
healthcare professionals and institutions that you personally interact with.  
[SPACE] 
We are interested in your thoughts and ideas.  There are no “right” or “wrong” answers. 
 
 
[GRID; SP] 
Q1. 
Please state if the following are true or false:  
 
GRID ITEMS [RANDOMIZE]: 
A. My [HT_3] healthcare provider uses an [HT_4] electronic health record 
B. I have used a patient portal to access my [HT_5] health information online  
C. I am worried about being able to pay medical bills 
D. I am confident my health insurance covers my medical needs 
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RESPONSE OPTIONS: 
1. True  
2. False 
77. Not sure 
 
 
PM: PLEASE MAKE SURE THE DATE TIME RULE ALWAYS FOLLOWS FIRST 
QUESTION 
INSERT ITEM TIMESTAMPS: TIME_FIRST, DATE_FIRST 
 
 
THE REST OF THE CLIENT INSTRUMENT GOES HERE.  
 
 
 
[SHOW IF Q1_2=1] 
[SP] 
Q1A1 
I have more than one patient portal.  
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
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[RANDOMIZE RESPONSE OPTIONS] 
[MP] 
Q2. 
In the past 12 months, have you...  
[SPACE] 
<unbold><i>Please select all that apply.<unbold></i> 
 
RESPONSE OPTIONS: 
1. …seen a [HT_3] healthcare provider? 
2. …been seen in the emergency room?  
3. …spent one or more nights in the hospital?  
4. …been screened for cancer? (mammogram, Pap test, colonoscopy, lung cancer) 
5. …been treated for cancer?  
[SPACE] 
6. None of the above [SP] [ANCHOR] 
 
 
[RANDOMIZE RESPONSE OPTIONS] 
[MP] 
Q3. 
In the past 12 months, have <i><u>any of your loved ones...</u></i> 
 
RESPONSE OPTIONS: 
1. …been seen in the emergency room? 
2. …spent one or more nights in the hospital? 
3. …been treated for cancer? 
[SPACE] 
4. None of the above [SP] [ANCHOR] 
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[SHOW Q4 AND Q5 ON THE SAME PAGE] 
[SP] 
Q4. 
Have you ever been told by a [HT_3] healthcare provider that you have cancer?  
 
RESPONSE OPTIONS: 
1. Yes 
2. No  
 
[SP] 
Q5. 
Do you have a family history of cancer?  
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
[SP] 
Q6. 
Would you say that in general your health is… 
 
RESPONSE OPTIONS: 
1. Poor 
2. Fair 
3. Good 
4. Very Good 
5. Excellent 
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[RANDOMIZE RESPONSE OPTIONS] 
 [SP] 
Q8. 
What kind of [HT_3] healthcare provider do you typically go if you are sick or need advice 
about your health??  
 
RESPONSE OPTIONS: 
  
1. A [HT_3] healthcare provider’s office 
2. A hospital clinic  
3. Other clinic or health center 
4. Urgent care 
5. Emergency room 
6. Other [TEXTBOX] [ANCHOR] 
7. I don’t have a regular healthcare provider 
 
 
 
[SP] 
Q9. 
Approximately when was the last time you saw a [HT_3] healthcare provider? 
 
RESPONSE OPTIONS: 
 
1. Within the past year 
2. Within the past 2 years 
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3. Within the past 5 years 
4. More than 5 years ago 
5. Have never seen a healthcare provider  
 
[SP] 
Q10. 
Are you now covered by any form of health insurance or health plan (this includes Medicare, 
Medicaid, private health insurance and insurance plans available through healthcare.gov)? 
 
RESPONSE OPTIONS: 
 
1. Yes 
2. No 
 
 
[GRID; SP] 
Q11. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. [HT_2] The healthcare system in this country is easy to use 
B. I can get the healthcare I need when I need it 
C. I get all the information I need about my health from my [HT_3] healthcare provider  
D. I could access my [HT_4] electronic health record if I wanted to 
E. In general, I am satisfied with the treatment I receive from my [HT_3] healthcare providers  
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RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true  
4. Very true 
 
 
[GRID; SP] 
Q12. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. Most healthcare systems in this country are too big to care about individual patients 
B. [HT_1] My healthcare system is too big to care about me 
C. Healthcare systems in this country work to prevent harm to their patients 
D. I feel respected when I seek health care 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true  
4. Very true 
 
 
[GRID; SP] 
Q13. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. [HT_1] My healthcare system treats me fairly 
B. [HT_1] My healthcare system treats me with kindness 
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RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true  
4. Very true 
 
 
[SP] 
Q14. 
Have <u>you<u> ever experienced discrimination, or been hassled or made to feel inferior while getting medical 
care?  
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
[SHOW IF Q14=1] 
Q14AA. 
[SP] 
 
How often has this happened? 
RESPONSE OPTIONS: 
1. Once 
2. 2 or 3 times 
3. 4 or more times 
 
 
[SHOW IF Q14=1] 
Q14A. 
[SP] 
What do you think was the <u>main<u> reason for this experience? 
RESPONSE OPTIONS: 
1. Ancestry or national origin 
2. Gender 
3. Race 
4. Age 
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5. Religion 
6. Height  
7. Weight 
8. Shade of skin color 
9. Sexual orientation 
10. Education or income level 
11. Physical disability 
12. Speaking English as a second language 
13. Other/ please specify [TEXTBOX] 
 
 
Q15. 
How often do you feel that racial/ethnic groups who are not white, such as African Americans and Latinos, are 
discriminated against in [HT_2] the healthcare system? 
 
RESPONSE OPTIONS: 
1. Never 
2. Rarely  
3. Sometimes 
4. Often 
 
 
[GRID; SP] 
Q16. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I find ways to help others less fortunate than me 
B. The dignity and well-being of all should be the most important concern in any society 
C. One of the problems of today’s society is that people are often not kind enough to others 
D. All people who are unable to provide for their own needs should be helped by others 
 
RESPONSE OPTIONS: 
1. Not true  
2. Somewhat true  
3. Fairly true 
4. Very true 
 
 
[SP] 
VIDEO_INT. 
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In the next section of the survey you will see a two-minute video that explains how [HT_5] health information is 
used and shared in [HT_2] the healthcare system. There will be questions that follow the video.  
[SPACE] 
<u>You will need to have your sound on while viewing this video. <u>  
[SPACE] 
Are you able to turn your sound on now? 
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
[SHOW IF VIDEO_INT=1] 
VIDEO1. 
<u>Instructions for watching your video</u>: 
• The continue button will appear once the video has ended. 
• Do not fast forward through the video. 
• Do not skip past the video before viewing it once. 
• You may re-watch the video multiple times. 
• The video is best viewed horizontally if watched on a mobile phone. 
• Click on the image to start watching the video. Make sure you hear it. 
[PLAY VIDEO HERE: Link to Video] 
[DELAY PRESENTATION OF CONTINUE BUTTON FOR 120 SECONDS] 
 
 
SHOW IF VIDEO_INT=1 
VIDEO. 
Were you able to <u>see<u> and <u>hear<u> the video? 
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
SHOW IF VIDEO_INT=2,98 OR VIDEO=2,98 
[DISPLAY] 
TRANSCRIPT. 
Today’s technologies, from genome sequencing to [HT_4] electronic health records, are turning [HT_5] 
health information into a valuable resource for answering health questions and improving care.  
[SPACE] 
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Imagine you have a friend, Florence, who was recently diagnosed with breast cancer. The handling of 
her [HT_5] health information looks very different today than it did 10 years ago. This will impact the 
care that she and other patients will receive.  
[SPACE] 
Florence’s doctors will collect information about her health history, health behaviors, family history and 
maybe even her neighborhood and job. Doctors might also collect her genetic information using 
samples of her tumor as well as her normal blood cells to more precisely tailor or personalize her 
treatment. Blood left over from those tests might be set aside to be used for research. Using a team 
approach, dozens of people involved in her treatment may look at her chart to help support her care… 
[SPACE] 
[HT_5] Health information from patients like Florence also typically travels out to many other users in 
her health system who may not be involved directly in her care – insurers, billers, and analysts who 
could learn from the outcomes of her treatment.  
[SPACE] 
Precision health companies might collect and store archives of health data or use it to develop new 
drugs or digital tools for improving diagnosis and treatment. There are laws designed to protect 
Florence’s privacy, but some of her information can still be shared after personal “identifiers” like her 
name and address are removed.  
[SPACE] 
With all of these users and uses of patients’ data, Florence, and patients like her, are able to contribute 
to the improvement of their own medical care and the care of other patients like them. But these 
changes in the ways health care is conducted also come with some new questions for Florence and for 
all of us – questions about trust, privacy, duty, and the tradeoffs that come with sharing data.  
[SPACE] 
This survey asks you to reflect on what you think about the use and sharing of all of this health data.  
Thank you for your time! 
 
 
[GRID; SP] 
Q17. 
Based on what you saw in the video or read in the transcript, are the following statements true or false?   
 
GRID OPTIONS [RANDOMIZE]: 
A. [HT_5] Health information can only be used for treating patients.  (F) 
B. Blood left over from tests used for treating or diagnosing a disease might be set aside to 
be used for research. (T) 
C. Florence has cancer. (T) 
 
RESPONSE OPTIONS: 
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1. True  
2. False 
 
 
[DISPLAY] 
Now that you’ve heard Florence’s story and seen how health information can be shared, we’d 
like to know what you think about the use and sharing of health information.    
[SPACE] 
The next questions are about the use of your health information for research. 
[SPACE] 
Your <u>health information</u> is information about you and your medical treatment history 
including diagnoses, medications, treatment plans, immunization dates, allergies, radiology 
images, and laboratory and test results.  
[SPACE] 
Your health information can be <i> “de-identified.”</i> This means that “identifying 
information” about <i>you</i> <u>is</u> <i> removed</i> from your health information. 
Identifying information includes things like your name, address, date of birth, etc. De-identified 
information can then be given to researchers to study things like healthcare costs, quality, and 
diseases.   
[SPACE] 
<u>University researchers</u> are people who work for colleges or universities. These researchers might use 
health information to understand how people use [HT_2] the healthcare system, how [HT_3] healthcare providers 
treat patients, and a wide variety of other health related topics. University researchers might also use [HT_9] 
biospecimens for research on how illness works, which treatments are most effective, or how genetics affect 
illness. University researchers may or may not be connected to your hospital in some way. 
 
 
[GRID; SP] 
Q18. 
For you, how true are the following statements? 
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GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with <u>[HT_8] university researchers</u> using my [HT_7] <i>de-
identified</i> [HT_5] health information 
B. I would like to be notified if <u>[HT_8] university researchers</u> will use my [HT_7] 
<i>de-identified</i> [HT_5] health information 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q19. 
Your [HT_5] health information can be “<u>identified</u>.” This means that 
[HT_10]“identifying information” about you <u>is linked to</u> your health information. 
Identifying information includes things like your name, address, date of birth, etc.  Identified 
information can then be given to researchers to study things like healthcare costs, quality, and 
diseases.   
[SPACE] 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with [HT_8] <u>university researchers</u> using my <i>identified</i> health 
information.  
B. I would like to be notified if [HT_8] <u>university researchers</u> will use my 
<i>identified</i> health information. 
 
RESPONSE OPTIONS: 
1. Not true 
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2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q20. 
Your <u>biospecimens</u> may be collected during the course of your treatment.  
Biospecimens include blood from a blood test, or tissue or tumor samples from a biopsy. Your 
biospecimens contain your DNA. Sometimes when there are biospecimens left over from your 
healthcare (such as blood or urine left over from a diagnostic test) that otherwise would be 
thrown away, those leftover biospecimens might be used for research. 
[SPACE] 
Biospecimens can be “<u>[HT_7]de-identified</u>.” This means that [HT_10] “identifying 
information” about you <u>is not linked to your</u> biospecimens. Identifying information 
includes things like your name, address, date of birth, etc.  De-identified biospecimens can be 
given to researchers to study things like healthcare costs, healthcare quality, and diseases.   
[SPACE] 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with [HT_8] <u>university researchers<u> using my <i>de-
identified</i> biospecimens.  
B. I would like to be notified if [HT_8] <u>university researchers</u> use my <i>de-
identified</i> biospecimens. 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
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3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q21. 
[HT_9] Biospecimens can be “<u>identified</u>.” This means that [HT_10] “identifying 
information” about you <u>is linked to</u> your biospecimens. Identifying information includes 
things like your name, address, date of birth, etc.  Identified [HT_9] biospecimens can be given 
to researchers to study things like health care costs, quality, and diseases.   
[SPACE] 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with [HT_8] <u>university researchers<u> using my <i>identified</i> 
biospecimens.  
B. I would like to be notified if [HT_8] <u>university researchers<u> use my 
<i>identified</i>  biospecimens. 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q22. 
The next questions are about the use of your [HT_5] health information by <u>quality analysts</u>.  
[SPACE] 
<u>Quality analysts<u> are people who work for hospitals or clinics. They use patient health information at their 
hospital or clinic to check on, and improve, how their organization is working. They often study the cost of 
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healthcare, their organization’s efficiency on things like waiting room times, and the health of patients at their 
hospital or clinic. 
[SPACE] 
For you, how true are the following statements about <u>health information<u>? 
 
GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with quality analysts using my [HT_7] <i>de-identified</i>  <u>health 
information</u>.  
B. I would like to be notified if quality analysts use my [HT_7] <i>de-identified</i>  
<u>health information</u>. 
C. I am comfortable with quality analysts using my [HT_10] <i>identified</i>  <u>health 
information</u>.  
D. I would like to be notified if quality analysts use my [HT_10] <i>identified</i>  <u>health 
information</u>. 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
 
[GRID; SP] 
Q23. 
For you, how true are the following statements about [HT_9] <u>biospecimens</u>? 
 
GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with [HT_11] quality analysts using my [HT_7] <i>de-identified</i>  
<u>biospecimens</u>. 
B. I would like to be notified if [HT_11] quality analysts use my [HT_7] <i>de-identified</i> 
<u>biospecimens</u>. 
C. I am comfortable with [HT_11] quality analysts using my [HT_10] <i>identified</i>  
<u>biospecimens</u>.  
D. I would like to be notified if [HT_11] quality analysts use my [HT_10] <i>identified</i> 
<u>biospecimens</u>. 
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RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP;4,4] 
Q24. 
The next questions are about the use of your [HT_5] health information by <u>commercial companies</u>. 
[SPACE] 
<u>Commercial companies</u> are third-party companies that are not part of a hospital. For example, a third-
party commercial company may conduct genetic tests and analyze information for a hospital or [HT_3] healthcare 
provider for a fee when a hospital is not be able to conduct the test on their own. Commercial companies may 
keep the information for their own use.  
[SPACE] 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I am comfortable with commercial companies using my [HT_7] <i>de-identified</i> 
<u>health information</u>.  
B. I would like to be notified if commercial companies use my [HT_7] <i>de-identified</i>  
<u>health information</u>. 
C. I am comfortable with commercial companies using my [HT_10] <i>identified</i>  
<u>health information</u>.  
D. I would like to be notified if commercial companies use my [HT_10] <i>identified</i> 
<u>health information</u>. 
E. I am comfortable with commercial companies using my [HT_7] <i>de-identified</i> 
[HT_9] <u>biospecimens</u>.  
F. I would like to be notified if commercial companies use my [HT_7] <i>de-identified</i> 
[HT_9] <u>biospecimens</u>. 
G. I am comfortable with commercial companies using my [HT_10] <i>identified</i> [HT_9] 
<u>biospecimens</u>.  
H. I would like to be notified if commercial companies use my [HT_10] <i>identified</i> 
[HT_9] <u>biospecimens</u>. 
 
RESPONSE OPTIONS: 
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1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[SP] 
Q25. 
How confident are you that [HT_7] de-identifying [HT_5] health information protects your privacy?  
 
RESPONSE OPTIONS: 
1. Not at all confident  
2. Somewhat confident 
3. Fairly confident 
4. Very confident 
 
 
[GRID; SP] 
Q26. 
How often would you like to be notified about the use of each of the following in research studies that start at your 
hospital and are shared with a [HT_12] commercial company? 
 
GRID ITEMS [RANDOMIZE]: 
A. Your genetic information or DNA  
B. Your [HT_9] biospecimens  
C. Your [HT_10] identified [HT_5] health information  
D. Your [HT_7] de-identified [HT_5] health information  
 
RESPONSE OPTIONS: 
1. Never  
2. Just once  
3. Once every five years 
4. Once a year 
5. Every time I visit my [HT_3] healthcare provider 
6. Every time the information is used 
 
 
[GRID; SP] 
Q27. 
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Suppose you are a cancer patient at a leading cancer center and your [HT_3] healthcare provider wants to use your 
DNA to see if you might be a good candidate for a particular cancer treatment. Your cancer center shares DNA and 
[HT_5] health information with third-party [HT_12] commercial companies when it is unable to perform the 
analysis themselves.  
[SPACE] 
How comfortable are you with a third-party commercial company… 
 
GRID ITEMS [RANDOMIZE]: 
A. …using your DNA and health information to improve the diagnosis and treatment of cancer in 
<u><i>other</i></u> patients 
B. …developing predictions about how you will respond to a particular cancer treatment 
C. …storing your DNA and health information 
D. …sharing predictions about how you will respond to cancer treatment with insurance 
companies 
E. …selling [HT_7] de-identified health information to pharmaceutical companies 
 
RESPONSE OPTIONS: 
1. Not comfortable 
2. Somewhat comfortable 
3. Fairly comfortable 
4. Very comfortable 
 
 
[GRID; SP] 
Q28. 
In the future, [HT_3] healthcare providers may be able to treat some diseases by making changes to patients’ DNA, 
which is also called gene-editing. To make this possible, researchers need to use [HT_9] biospecimens (e.g. blood 
or tissue) donated from research participants. 
[SPACE] 
How comfortable are you with sharing <u>your own</u> [HT_7] <i>de-identified</i> biospecimen for research on 
gene-editing in the following ways? 
 
GRID ITEMS [RANDOMIZE]: 
A. To develop gene-editing methods that treat disease or disability. 
B. To develop gene-editing methods that enhance a person physically (make them stronger or faster) or 
mentally (increase intelligence). 
 
RESPONSE OPTIONS: 
1. Not comfortable 
2. Somewhat comfortable 
3. Fairly comfortable 
4. Very comfortable 
 
 
[GRID; SP] 
Q29. 
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In some cases, researchers would like to use [HT_10] <i>identified</i> [HT_9] biospecimens—samples linked to 
information that would identify you as the donor. 
[SPACE] 
How comfortable are you with sharing <u>your own</u> <i>identified</i> biospecimens for research on gene-
editing in the following ways? 
 
GRID ITEMS [RANDOMIZE]: 
A. To develop gene-editing methods that treat disease or disability. 
B. To develop gene-editing methods that enhance a person physically (make them stronger or faster) or 
mentally (increase intelligence). 
 
RESPONSE OPTIONS: 
1. Not comfortable 
2. Somewhat comfortable 
3. Fairly comfortable 
4. Very comfortable 
 
 
 
[SP] 
Q30. 
In the U.S., the federal government is a major funder of medical research using tax revenue.  
[SPACE] 
How comfortable are you with your tax dollars being used to support research on gene-editing? 
 
RESPONSE OPTIONS: 
1. Not comfortable 
2. Somewhat comfortable 
3. Fairly comfortable 
4. Very comfortable 
 
 
[GRID; SP] 
Q31. 
How optimistic are you that gene-editing will have a <u>positive</u> impact: 
 
GRID ITEMS [RANDOMIZE]: 
A. On you 
B. On your family 
C. On society 
 
RESPONSE OPTIONS: 
1. Not at all optimistic 
2. Somewhat optimistic 
3. Quite optimistic 
4. Very optimistic 
 
 
[GRID; SP] 
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Q32. 
How fearful are you that gene-editing will have a <u>negative</u> impact: 
 
GRID ITEMS [RANDOMIZE]: 
A. On you 
B. On your family 
C. On society 
 
RESPONSE OPTIONS: 
1. Not at all fearful 
2. Somewhat fearful 
3. Quite fearful  
4. Very fearful 
 
 
[GRID; SP] 
Q33. 
The next questions ask for your opinions about whether people should share their [HT_5] health information in 
general. 
[SPACE] 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. People have an ethical obligation to allow their  health information to be used for <u>healthcare quality 
analysis</u> 
B. People have an ethical obligation to allow their health information to be used for <u>research</u> 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q34. 
For you, how true are the following statements about the organizations that have your [HT_5] health information 
and share it?  Organizations include groups such as [HT_3] healthcare providers’ offices, hospitals, insurance 
companies, and [HT_8] university researchers. (If you are unsure, please make your best guess.)   
[SPACE] 
<i>The organizations that have my health information and share it...</i>  
 
GRID ITEMS [RANDOMIZE]: 
A. Try hard to be fair in dealing with others  
B. Would try to hide a serious mistake they made 
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C. Tell me how my health information is used 
D. Would never mislead me about how my health information is used 
E. Have a particular interest in collecting my [HT_9] biospecimens compared to other people’s 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q35. 
<i>The organizations that have my [HT_5] health information and share it...</i>  
 
GRID ITEMS [RANDOMIZE]: 
A. Are not good at their jobs 
B. Have specialized capabilities that can promote innovation in health  
C. Can use large amounts of data to improve patient care 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q36. 
<i>The organizations that have my [HT_5] health information and share it...</i>   
 
GRID ITEMS [RANDOMIZE]: 
C. Can be trusted to use my health information responsibly 
D. Think about what is best for me 
E. Act in an ethical manner  
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
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[GRID; SP] 
Q37. 
<i>The organizations that have my [HT_5] health information and share it...</i>   
 
GRID ITEM [RANDOMIZE]: 
A. Deliberately withhold important information from me about my medical care 
B. Disclose their financial conflicts of interest 
C. Experiment on patients without telling them 
D. Treat everyone the same, regardless of their race or ethnicity 
E. Treat everyone the same, regardless of their income 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q38. 
For you, how true are the following statements about [HT_3] <u><i>health care providers</i></u>? 
 
GRID ITEMS [RANDOMIZE]: 
A. Health care providers care most about making money for themselves 
B. Health care providers do not care about helping people like me 
C. I trust health care providers to use my [HT_5] health information responsibly  
D. Health care providers disclose their conflicts of interest 
E. All things considered, health care providers in this country can be trusted 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
  
[GRID; SP] 
Q39. 
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For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. The privacy policies of [HT_1] my healthcare system are clear to me 
B. I am satisfied with the level of access I have to information in my [HT_4] electronic health record 
C. I am confident in my ability to manage how my [HT_5] health information is used 
D. [HT_1] My healthcare system respects my privacy 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q40. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I should have more control over how my [HT_5] health information is used 
B. [HT_1] My healthcare system is transparent about how my [HT_5] health information is used 
C. [HT_1] My healthcare system would notify me if the security of my [HT_5] health information 
had been compromised 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q41. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
B. I worry that private information about my health could be used against me 
C. I worry my [HT_5] health information is available to people who have no business seeing it  
D. There are some things I would not tell my [HT_3] healthcare providers because I can't trust 
them with the information 
E. [HT_1] My healthcare system discloses its conflicts of interest 
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RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[SP] 
Q42. 
Have you ever kept information from your [HT_3] healthcare provider because you were 
concerned about privacy or security?  
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
[GRID;3,3; SP] 
Q43. 
What do you think of the following statements: true or false? 
 
GRID ITEMS [RANDOMIZE]: 
A. My [HT_3] healthcare provider is the only person who decides how information in my [HT_4] electronic 
health record is used 
B. Health insurance companies are prohibited from using my [HT_5] health information to deny me coverage 
C. I own my [HT_5] health information 
D. My permission is required for research using my [HT_7] de-identified [HT_5] health information 
E. My genetic code is specific to me 
F. Health organizations are required to report large-scale data breaches 
 
RESPONSE OPTIONS: 
1. True  
2. False 
77. I don’t know 
 
 
[GRID; SP] 
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Q44. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. [HT_1] My healthcare system will use my [HT_5] health information how they see fit, regardless 
of my preferences 
B. Healthcare systems in this country respect patients’ opinions about how their [HT_5] health 
information should be used 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q45. 
The next questions ask about your perceptions of the uses of [HT_5] health information and the policies 
that are in place to protect it. 
[SPACE] 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. I should have a right to participate in medical research 
B. Information about my health should be kept indefinitely in my [HT_4] electronic health record 
C. I should be able to delete my [HT_4] electronic health record 
D. I should be able to access all of my [HT_3] healthcare providers through a single patient portal 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID; SP] 
Q46. 
For you, how true are the following statements? 
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GRID ITEMS [RANDOMIZE]: 
A. It is important that I know who has [HT_5] health information about me 
B. I should be able to find out how my [HT_5] health information has been shared 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
 
[GRID; SP] 
Q47. 
For you, how true are the following statements? 
 
GRID ITEMS [RANDOMIZE]: 
A. It is okay for law enforcement to access [HT_5] health information  
C. Existing laws provide a reasonable level of protection for the privacy of patient 
information 
D. I am confident that electronic [HT_5] health information is sufficiently protected by current law and 
regulation 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[GRID;3,3; SP] 
Q48. 
Suppose [HT_1] your healthcare system charges a fee to third-party [HT_12] commercial companies that want to 
keep [HT_9] biospecimens left over after testing.   This makes money for the hospital.  
[SPACE] 
For you, how true are the following statements? 
[SPACE] 
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If my healthcare system makes money from my biospecimens… 
 
GRID ITEMS [RANDOMIZE]: 
A. …they should use the money to provide health care for other people who can’t afford it. 
B. …they should use the money to provide health care for other people who have the same 
health problems as me. 
C. …they should use the money to improve quality of care in my healthcare system. 
D. …they should use the money to support future research on my health problems.  
E. …they should use the money to support future research on any kind of health problem.  
F. …they should use it however they want. 
 
RESPONSE OPTIONS: 
1. Not true 
2. Somewhat true 
3. Fairly true 
4. Very true 
 
 
[SP] 
Q49. 
Some companies like 23andMe and AncestryDNA test people’s genetic material from saliva to 
trace their ancestry.  
[SPACE] 
Given what you know about companies like 23andMe and AncestryDNA, do you generally have 
a favorable or unfavorable opinion of these companies? 
 
RESPONSE OPTIONS: 
1. Very favorable 
2. Somewhat favorable 
3. Somewhat unfavorable 
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4. Very unfavorable 
 
 
[SP] 
Q50. 
Are you comfortable with <u>drug companies</u> purchasing genetic and ancestry data from 
companies like 23andMe or AncestryDNA?  
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
[SP] 
Q51. 
Are you comfortable with <u>law enforcement</u> using genetic and ancestry data from 
companies like 23andMe or AncestryDNA?  
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
  
 
[SP] 
Q53. 
Have you experienced problems with stolen or misused personal information (e.g., social security number, credit 
or debit cards, and bank accounts) within the last five years? For example, have you spent time clearing up credit 
accounts or your credit report because someone stole your personal information?  
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RESPONSE OPTIONS: 
1. Yes, I am currently experiencing problems 
2. Yes, but all problems have been resolved 
3. No, I have not experienced any problems within the past five years 
 
 
[SP] 
Q54. 
I believe my financial information has been compromised as the result of a data breach or hacking. 
 
RESPONSE OPTIONS: 
1. Yes 
2. No 
 
 
[GRID; SP] 
Q55. 
How concerned are you about the following recent events:  
 
GRID ITEMS [RANDOMIZE]: 
A. Facebook sharing information with Cambridge Analytica for political purposes 
B. Data breach of people’s social security numbers and driver’s license numbers at Equifax 
C. Sloan Kettering hospital executives using hospital data for their own startup company 
D. Marriott data breach of passport numbers and credit card numbers 
 
RESPONSE OPTIONS: 
1. Not at all concerned  
2. Somewhat concerned 
3. Fairly concerned 
4. Very concerned 
 
 
[SHOW IF MISSING P_PARTYID7] 
[SP] 
 195 
PID1. 
Do you consider yourself a Democrat, a Republican, an independent or none of these? 
 
RESPONSE OPTIONS: 
1. Democrat   
2. Republican 
3. Independent 
4. None of these 
 
 
Previously programmed as PIDA from TESS 007  
[SHOW IF PID1=1] 
[SP] 
PIDA. 
Do you consider yourself a strong or moderate Democrat?  
 
RESPONSE OPTIONS: 
1. Strong Democrat   
2. Moderate Democrat   
 
 
Previously programmed as PIDB from TESS 007 
[SHOW IF PID1=2] 
[SP] 
PIDB. 
Do you consider yourself a strong or moderate Republican?  
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RESPONSE OPTIONS: 
1. Strong Republican   
2. Moderate Republican   
  
 
Previously programmed as PIDi from TESS 007 
[SHOW IF PID1=3, 4, 77, 98, 99] 
[SP] 
PIDi. 
Do you lean more toward the Democrats or the Republicans? 
 
RESPONSE OPTIONS: 
1.    Lean Democrat 
2.    Lean Republican 
3. Don’t lean 
 
 
[DOUBLE PROMPT IF REFUSED] 
[NUMBERBOX; RANGE 1-20] 
HHSIZE2. 
<u>Including yourself</u>, how many people live in your household? 
 
 
[NUMBERBOX; RANGE 0-999,000]  
[PROMPT TWICE IF REFUSED WITH CUSTOM MESSAGE “We know that questions about 
income are sensitive, and understand if you would not like to answer this question. However, 
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some of our key research questions require us to have this information for respondents of this 
survey.” 
INCOME2. 
What was your total <u>household,/u. income in 2018? 
 
 
COMPUTE DOV_FPL BASED ON THE CHART BELOW. IF INCOME2 IS AT OR BELOW A GIVEN VALUE FOR A 
SPECFIC HHSIZE2 DOV_FPL=1. NOTICE THERE ARE DIFFERENT INCOME2 CRITERIA DEPENDING ON 
S_STATE VALUES AS INDICATED BY THE 3 INCOME2 COLUMNS 
 
HHSIZE2 
INCOME2 FOR S_STATE 
NE AK (Alaska) or HI 
(Hawaii) 
INCOME2 FOR S_STATE= AK (Alaska) 
INCOME2 FOR S_STATE= HI 
(Hawaii) 
1 $24,980  $31,200  $28,760  
2 33,820 42,260 38,920 
3 42,660 53,320 51,080 
4 51,500 64,380 59,240 
5 60,340 75,440 69,400 
6 69,180 86,500 79,560 
7 78,020 97,560 89,720 
8 86,860 108,620 99,880 
9 95,700 119,680 110,040 
10 104,540 130,740 120,200 
11 113,380 141,800 130,360 
12 122,220 152,860 140,520 
13 131,060 163,920 150,680 
14 139,900 174,980 160,840 
15 148,740 186,040 171,000 
16 157,580 197,100 181,160 
17 166,420 208,160 191,320 
18 175,260 219,220 201,480 
19 184,100 230,280 211,640 
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20 192,940 241,340 221,800 
 
 
[TEXTBOX] 
CLOSE1. 
In thinking about [HT_5] health information sharing, do you have any comments you would like to 
share? 
 
[MEDIUM TEXTBOX] 
 
 
PM PLEASE ALWAYS HAVE THIS AND THE FOLLOWING LOGIC FOLLOW THE 
FINAL SUBSTANTIVE QUESTION OF THE SURVEY, AHEAD OF QFINAL  
INSERT ITEM TIMESTAMPS: TIME_END, DATE_END 
 
 
COMPUTE TEST_TIME 
 TEST_TIME = TIME_END – TIME_START 
 
COMPUTE TEST_DATE = DATE_END 
 
DISPLAY TESTING-ONLY SCREEN WITH VALUE FOR TEST_TIME & TEST_DATE 
 
 
 
RE-COMPUTE QUAL=1 “COMPLETE” 
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SET CO_DATE, CO_TIME, CO_TIMER VALUES HERE 
 
CREATE MODE_END 
1=CATI 
2=CAWI 
 
 
SCRIPTING NOTES: PUT QFINAL1, QFINAL2, QFINAL3 in the same screen.  
[SINGLE CHOICE] 
QFINAL1.  
Thank you for your time today. To help us improve the experience of AmeriSpeak members like 
yourself, please give us feedback on this survey.  
  
[RED TEXT – CAWI ONLY] If you do not have any feedback for us today, please click 
“Continue” through to the end of the survey so we can make sure your opinions are counted and 
for you to receive your AmeriPoints reward. 
 
Please rate this survey overall from 1 to 7 where 1 is Poor and 7 is Excellent. 
 
Poor      Excellent 
1 2 3 4 5 6 7 
 
[SINGLE CHOICE – CAWI ONLY] 
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QFINAL2.  
Did you experience any technical issues in completing this survey?  
 
1. Yes – please tell us more in the next question 
2. No 
 
[TEXT BOX] [CATI version needs “no” option] 
QFINAL3.  
Do you have any general comments or feedback on this survey you would like to share?  If you 
would like a response from us, please email support@AmeriSpeak.org or call (888) 326-9424. 
 
 
[DISPLAY] 
END.  
[CATI version] 
Those are all the questions we have. You have earned a reward of [INCENTWCOMMA] 
AmeriPoints for completing the survey. If you have any questions at all for us, you can email us 
at support@AmeriSpeak.org or call us toll-free at 888-326-9424. Let me repeat that again: email 
us at support@AmeriSpeak.org or call us at 888-326-9424. Thank you for participating in our 
new AmeriSpeak survey!   
 
[CAWI version] 
Those are all the questions we have. You have earned a reward of [INCENTWCOMMA] 
AmeriPoints for completing the survey. If you have any questions at all for us, you can email us 
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at support@AmeriSpeak.org or call us toll-free at 888-326-9424. Thank you for participating in 
our new AmeriSpeak survey!  
 
You can close your browser window now if you wish or click Continue below to be redirected to 
the AmeriSpeak member website. 
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